{
  "name" : "twin.sci-hub.se_7011_4850949a1ef6efba4e6d4086799e3d1b_baldrighi2016.pdf",
  "metadata" : {
    "source" : "CRF",
    "title" : "Carbon Nanomaterials Interfacing with Neurons: An In vivo Perspective",
    "authors" : [ "Michele Baldrighi", "Raffaella Tonini", "Silvia Giordani" ],
    "emails" : [ "silvia.giordani@iit.it" ],
    "sections" : [ {
      "heading" : null,
      "text" : "REVIEW published: 09 June 2016 doi: 10.3389/fnins.2016.00250\nFrontiers in Neuroscience | www.frontiersin.org 1 June 2016 | Volume 10 | Article 250\nEdited by: Michele Giugliano,\nUniversity of Antwerp, Belgium\nReviewed by: Antonio Malgaroli,\nUniversity San Raffaele, Italy Laura Ballerini, International School for Advanced Studies & University of Trieste, Italy\n*Correspondence: Silvia Giordani\nsilvia.giordani@iit.it\nSpecialty section: This article was submitted to\nNeural Technology, a section of the journal Frontiers in Neuroscience\nReceived: 27 December 2015 Accepted: 20 May 2016\nPublished: 09 June 2016\nCitation: Baldrighi M, Trusel M, Tonini R and\nGiordani S (2016) Carbon Nanomaterials Interfacing with Neurons: An In vivo Perspective. Front. Neurosci. 10:250.\ndoi: 10.3389/fnins.2016.00250\nCarbon Nanomaterials Interfacing with Neurons: An In vivo Perspective Michele Baldrighi 1, Massimo Trusel 2, Raffaella Tonini 2 and Silvia Giordani 1*\n1 Nano Carbon Materials Laboratory, Istituto Italiano di Tecnol gia, Genova, Italy,2 Neuroscience and Brain Technology, Istituto Italiano di Tecnologia, Genova, Italy\nDeveloping new tools that outperform current state of the art technologies for imaging, drug delivery or electrical sensing in neuronal tissues is one of the great challenges in neurosciences. Investigations into the potential use of carbon nanomaterials for such applications started about two decades ago. Since then, numerous in vitrostudies have examined interactions between these nanomaterials and neurons, either by evaluating their compatibility, as vectors for drug delivery, or for their potential use in electric activity sensing and manipulation. The results obtained indicate that carbon nanomaterials may be suitable for medical therapies. However, a relatively small number of in vivo studies have been carried out to date. In order to facilitatethe transformation of carbon nanomaterial into practical neurobiomedical applications, it is essential to identify and highlight in the existing literature the strengths and weakness that different carbon nanomaterials have displayed when probedin vivo. Unfortunately the current literature is sometimes sparse and confusing. To offer a clearer picture of the in vivo studies on carbon nanomaterials in the central nervous system, we provide a systematic and critical review. Hereby we identify properties and behavior of carbon nanomaterialsin vivo inside the neural tissues, and we examine key achievements and potentially problematic toxicological issues.\nKeywords: carbon nanomaterials, in vivo studies, central nervous system, neuroprotection, drug del ivery, imaging\nINTRODUCTION\nIn the last two decades carbon nanomaterials (CNMs) experienced an exponential increase in the number of application elds where they demonstrate excellent performances. As for many other nanomaterials, the interest from the scienti c community on carbon nanomaterials is devoted to exploring their potential use in biomedicine in addition to engi eering their application for goods manufacturing. Their nano-size enables to exploit unconventional interaction pathways with living systems (Freitas, 2005), for example allowing the delivery in the brain tissues of molecules that are usually rejected by the blood-brain barrier (BBB).\nCarbon nanomaterials exhibit big diversity in structure, morphology, physical properties and chemical reactivity. Carbon nanotubes (CNTs), carbon nanohorns (CNHs), nanodiamonds (NDs), fullerenes, carbon nano-onions (CNOs), graphene and derivatives have emerged as promising classes of nanomaterials for imaging, diagnostic and therapeutic applications. Their atomic composition, i.e., carbon, has a much lower inherent toxic potential than the atomic species used in the manufacturing of other kinds of nanoparticles (usually transition metals or silica; Sohaebuddin et al., 2010; Shari et al., 2012). In addition, their peculiar physical properties and shapes display di erent interaction behaviors within cells andtissues, and their properties can\nbe tailored by covalent and non-covalent functionalization that allows to modify their surface charge and to introduce uoresc nt tags (Bartelmess et al., 2015a), cell-speci c and disease-speci c targeting molecules (Fabbro C. et al., 2012), Magnetic Resonance Imaging (MRI) contrast agents (Hahn et al., 2011), as well as drugs and nucleic acids (Bianco et al., 2005a; Cheung et al., 2010). Finally, the synthesis of raw carbon nanomaterials usuallyre ies on very cheap sources and involves few synthetic steps, making cost-e ective their large scale production (De Volder et al., 2013).\nCarbon nanotubes are the most studied carbon nanomaterials for biomedical applications (Bianco et al., 2005b; Liu Z. et al., 2009; Gong et al., 2013; Lamberti et al., 2015). In the last few years, however, the scienti c community has been showing a growing interest in graphene and graphene oxide (Zhang Y. et al., 2012; Zhang H. et al., 2013; Yang et al., 2013a), n nodiamonds (Mochalin et al., 2011; Perevedentseva et al., 2013) and carbon dots (Shen et al., 2012; Luo et al., 2013). On the opposite fullerenes, which attracted a lot of attention in the past, are now experiencing a gradual loss of interest due to concerns regarding toxicity (Zhu et al., 2006; Kolosnjaj et al., 2007; Partha and Conyers, 2009; Matija et al., 2013). Carbon nano-onions also are attracting attention for their possible biomedical application (Ghosh et al., 2011; Sonkar et al., 2012; Yang M. et al., 2013; Bartelmess et al., 2014, 2015b,c; Giordani et al., 2014; Frasconi et al., 2015a,b). Notably, it has been demonstrated eitherin vitro and in vivo that carbon nanomaterials can be e ciently degraded by means of enzymatic catalytic oxidation processes that are occurring either in plants, prokaryotes and eukaryotes (Kotchey et al., 2012, 2013; Bussy et al., 2015; Elgrabli et al., 2015; Sureshbabu et al., 2015) thus helping to dispel doubts regarding possible bioaccumulation hazards. A number of studies highlight high toxicity of carbon nanomaterials for shes and amphibians (Zhu et al., 2006; Smith et al., 2007; Mouchet et al., 2008; Li J. et al., 2015). However, such non-speci c and important toxicity is not observed in mammals, and studies regarding these species are not considered in this review.\nSeveral e orts from the scienti c community are devoted to investigate how carbon nanomaterials functionally interface with the central nervous system (CNS). There are great expectations on these materials since they show excellent compatibility wih\nAbbreviations: ACh, acetylcholine; AD, Alzheimer’s disease; FALS, familial amyotrophic lateral sclerosis; BBB, blood-brain barrier; CD, carbon dots; CED, convection-enhanced delivery; CNFs, carbon nano bers;CNHs, carbon nanohorns; CNMs, carbon nanomaterials; CNOs, carbon nano-onions; CNS, central nervous system; CNTs, carbon nanotubes; CVD, chemicalvapor deposition; DEX, dextran; DOX, doxorubicin; DTPA, diethylene triam ne pentaacetic acid; EPI, epirubicin; FUS, focused ultrasounds; GFAP, glial brillary acidic protein; GI, gastrointestinal; GlcNF, glucosamine conjugate fullerenol; GO, graphene oxide; HIV, human immunode ciency virus;i.c.v., intracerebrovascular;i.p., intraperitoneal;i.v., intravenous; LFUS, low intensity focused ultrasound; MCAO, middle cerebral arteria occlusion; MPTP, 1-methyl-4phenyl-1,2,3,6-tetrahydropyridine; MRI, magnetic resonance imaging; MWCNTs, multi-wall carbon nanotubes; NDs, nanodiamonds; NK, natural killer; NO, nitric oxide; PCBM, phenyl-C61-butyric acid methyl ester; PD, Parkinson’s disease; PEG, polyethylenglycol; PERF, perfenidone; PF-127, Pluronic F127; PVP, polyvinylpyrrolidone; QDs, quantum dots; RDX, cyclotrimethylenetrinitramine; ROS, reactive oxygen species; SCI, spinal cord injury; siRNA, smallinterfering RNA; SWCNHs, single-wall carbon nanohorns; SWCNTs, single-wallc rbon nanotubes; TLR9, toll-like receptor 9; Tf, transferrin; TNT, 2,4,6-trinitrotoluene.\nneuronal cellsin vitro (Mattson et al., 2000; Webster et al., 2004; Li et al., 2011; Hopper et al., 2014), which makes them good candidates for the development of innovative diagnostic systems and therapeutic agents for brain pathologies such as neuronal or glial tumors. Moreover, the peculiar physical features of some of them, like the very high mechanical strength and the electrical conductivity, combined with their very low dimensions which provide an intimate contact with cells, enable a possible application both as support materials for neuroregeneration, e.g., after spinal cord injuries (Roman et al., 2011), as well as interface materials for high-e ciency recording and stimulation of the neuronal activity. Despite carbon nanomaterials are extensiv ly probed for a number of biomedical applications usingin vivo models (Yang K. et al., 2010; Gong et al., 2013; Perevedentseva et al., 2013; Hong et al., 2015), the number of studies dedicated to the CNS is substantially lower. It should be noted that in most cases the results are of great interest and undoubtedly depicta great potential for these materials.\nIn this review we focus our attention on thein vivo studies in the CNS in order to provide a comprehensive view of past and ongoing research in this eld, highlighting the goals achieved, the interaction with neural tissues and the toxicity.\nCARBON NANOTUBES\nCarbon Nanotubes (CNTs) (Iijima, 1991) are the mostknown and widest studied carbon nanomaterials. Their mechanical, thermal and electrical properties have been extensively investigated (Mintmire and White, 1995; Ruo and Lorents, 1995; Salvetat et al., 1999; Odom et al., 2000; Dai, 2002; Cao et al., 2003; Popov, 2004), leading to their successful application in several commercial and prototype products (De Volder et al., 2013). From the structural point of view, CNTs consist of continuous rolled-up graphitic foils. They can be either single-walled (SWCNTs), if consisting of a single graphitic tube, or multi-walled (MWCNTs), if more concentric tubes are present. Their diameter ranges from 0.7 to 5 nm for SWCNTs and from 2 to> 30 nm for MWCNTs, and their length can vary from a few hundreds of nm to several hundreds of microns (Figure 1). Although di erent fabrication methods are possible, chemical vapor deposition (CVD) using hydrocarbons as feed material and metal nanoparticles as catalyst is the most used (Cassell et al., 1999; Andrews et al., 2002). Several chemical reactions have been developed in order to modify their surface properties and to introduce functional molecules important for biological research (Tasis et al., 2006; Battigelli et al., 2013a).\nThe use of CNTs for the development of new diagnostic and therapeutic agents is of primary interest in biomedical research. Carbon nanotubes are successfully applied in sensing, imaging, drug delivery, and also nucleic acid delivery applications bothin single cells andin vivo (Kateb et al., 2007; Ladeira et al., 2010; Wu et al., 2010; Al-Jamal et al., 2011; Liu Z. et al., 2011; Bates and Kostarelos, 2013; Battigelli et al., 2013a,b; Hong et al., 2015).\nToxicity of carbon nanotubes is a matter of debate: a number of studies highlight toxic e ects in cells upon CNTs exposure (Muller et al., 2005; Magrez et al., 2006; Smith et al., 2007;\nFrontiers in Neuroscience | www.frontiersin.org 2 June 2016 | Volume 10 | Article 250\nFIGURE 1 | Schematic representation of (A) SWCNTS and (C) MWCN Ts. (B) HRTEM micrograph of a single SWCNT; reprinted with permission from Zhang Y. et al. (2010), Copyright (2010) American Chemical Society.(D) HRTEM micrograph of MWCNTs, functionalized with N-methylpyrrolidine groups to improve their solubility in organic solvents; adapted from Cellot et al. (2011), copyright Society for Neurosciences (2011).\nMouchet et al., 2008; Shari et al., 2012; Li J. et al., 2015). It should be noted, however, that a great contribution to these adverse e ects could be led back to Fe, Ni, Co, and Y nanoparticles deriving from the CNTs synthesis, that are still present in variable amounts in raw CNTs samples. The careful removal of metal contaminants as well as chemical functionalization in factlead to a drastic reduction of the nanomaterial toxicity (Pulskamp et al., 2007; Movia et al., 2011; Movia and Giordani, 2012). A further source of concerns is their similar behavior to that of asbestos bers: their tendency to aggregate in bundles (especially for unfunctionalized CNTs) can lead to the occurrence of important in ammatory responses (Poland et al., 2008), which can be alleviated by improving the nanomaterial dispersibility thanks to its covalent or noncovalent functionalization with polar moieties (Ali-Boucetta et al., 2013). In experiments involving neuronal cells, which are commonly considered particularly sensitive to toxicants and in ammation, high purity and functionalized carbon nanotubes seldom show toxicity (Bardi et al., 2009; Gaillard et al., 2009; Vittorio et al., 2009; Yang Z. et al., 2010; Zhang Y. et al., 2010, 2011; Bussy et al., 2015). Finally, it has been discovered that CNTs can be enzymatically degraded by peroxidases (Kotchey et al., 2012, 2013) in macrophages (Kagan et al., 2014), eosinophils (Andón et al., 2013), neutrophyls (Bhattacharya et al., 2014), and microglia (Bussy et al., 2016), as well as in the extracellular space (Farrera et al., 2014), thus mitigating the concerns regarding possible toxic e ects due to their accumulation inside the body.\nCNTs are permissive substrates for the adhesion and growth of primary neurons (Mattson et al., 2000; Hu et al., 2004; Gabay et al., 2005; Gheith et al., 2005; Lovat et al., 2005; Dubin et al., 2008; Gaillard et al., 2009; Kam et al., 2009; Tran et al., 2009; Jin et al., 2011; Park et al., 2011a). They also\npromote stem cells di erentiation into neurons (Chao et al., 2009; Park et al., 2011a), ction potential appearance in immature neurons (Fabbro et al., 2013) and they stimulate the propagation of dendritic backcurrents in isolated neurons (Cellot et al., 2009). Collectively, this evidence suggests their possible use for the therapy of neurodegenerative pathologies and spinal cord injuries. Moreover, CNTs are applied to record and stimulate neural activity in single neurons, arti cial ganglia and spinal cord sections (Gheith et al., 2006; Mazzatenta et al., 2007; Kam et al., 2009; Shein et al., 2009; Shoval, 2009; Cellot et al., 2011; Fabbro A. et al., 2012; David-Pur et al., 2014). Microelectrodes coated with CNTs show enhanced sensitivity in neuronal activity recordings compared to state of the art devices (Keefer et al., 2008; Jan et al., 2009; Luo et al., 2011). Finally, CNTs are also able to deliver functional molecules inside neurons (Kateb et al., 2007; Wang C.-H. et al., 2009; Cellot et al., 2010; Ren et al., 2012).\nCNTs show in general good compatibilityin vivo with neuronal tissues. Intravenous (i.v.) administration of 13Cenriched SWCNTs in mice (Yang et al., 2007) demonstrates that these nanomaterials (10 30 nm 2 3 mm bundles) are able to cross the BBB and accumulate inside the brain tissues, although to a little extent. Furthermore, this study indicates that SWCNTs do not show acute toxicity despite their accumulation in several organs (especially liver, lungs, and spleen) and their low clearance. However, it has to be underlined that the long persistency of SWCNTs in lungs and in the liver can provide moderate toxicity in these organs (Yang et al., 2008).\nA very recent report indicates that high doses of PEG-SWCNTs (1 10 mm bundles) display toxicity when stereotactically injected in rat hippocampus (Dal Bosco et al., 2015). Apparently PEG-SWCNTs are impairing contextual fear memory after long-term exposure at 0.5 and 1 mg/mL concentrations because of the oxidative stress generated by the nanomaterial. Although this study highlights how an eventual accumulation of CNTs inside the brain tissues can potentially lead to toxic e ects, it is extremely unlikely that such high concentrations can be reached in localized regions of the CNS, unless local administration is used. Moreover, no explanation can be found to the evidence that higher concentrations of PEG-SWCNTs (2.1 mg/mL) do not cause oxidative stress and in general toxicity in the hippocampal tissues.\nMWCNTs display in general a high biocompatibilityin vivo with neural tissues: direct injection of a suspension of MWCNTs (10 30 nm 2mm) coated with the nonionic surfactant Pluronic F127 (PF-127) in mice visual cortex (Bardi et al., 2009) results in no substantial morphological di erences observed in brain tissues comparing to a control injection, also in terms of injection lesion volume. Later timepoint analysis too revealed no sign of damage to the surrounding tissues apart from the expected gliosis engul ng the nanotubes (Figure 2). MWCNTs are also able to cross the BBB: [111In]-DTPA-MWCNTs (20 nm 0.5 mm) administeredin vivoby tail vein injection (Kafa et al., 2015) display a maximum brain accumulation of 1.1% of injected dose per gram of tissue 5 min after the injection, followed by a gradu l slow excretion. Micropinocytosis from the perivascular epithel al cells seems in this case to be the main internalization mechanism and therefore transcellular uptake is hypothesized as the primary\nFrontiers in Neuroscience | www.frontiersin.org 3 June 2016 | Volume 10 | Article 250\nFIGURE 2 | Coronal brain slices showing short and long term ef fects of PF-127 coated MWCNTs intracortical injection. (A) Localization of the injection site (star); cc, cerebral cortex; wm, white matter.(B,C) Magni cations of the injection site 3 days after the injection: outside the lesion area (dashed line) cerebral tissues show normal neuronal density and tissue layering.(D,E) Control mice and (F,G) PF-127 coated MWCNTs injected mice brain slices 18 days after the injection: both the lesion sites present normal gliosis surrounding the injection site. Reprinted fromBardi et al. (2009), Copyright (2009), with permission from Elsevier.\nmechanism for the BBB crossing (Kafa et al., 2015). As SWCNTs however, also MWCNTs tend to accumulate in the liver and the lungs where they can possibly produce toxicity in the long term.\nTheir morphological characteristics and their tendency to agglomerate are found to play a role in determining the nanomaterial’s fate and in ammatory potential inside the brain: long ammonium MWCNTs (MWCNTs-NHC3 , 20 30 nm 0.5 1 mm) and short oxidized ammonium-MWCNTs (oxMWCNTs-NHC3 , 20 30 nm 0.2 0.3 mm) display in fact remarkable di erences after direct local injection in mice motor cortex (Bardi et al., 2013). Short ox-MWCNTs-NHC3 are con ned in a very narrow area forming compact agglomerates and they can be found into the cytoplasm exclusively inside vesicles. Moreover, they show in ammatory potential, although it should be underlined that within 1 week the expression levels of the in ammatory cytokines return to normality. On the contrary, long MWCNTs-NHC3 distribute over a very large area, they are found into the cells both inside vesicles and free- oating ithe cytoplasm and have low in ammatory potential. Remarkably, microglia is found to be able to degrade long MWCNTs-NHC3 even at early time points (Nunes et al., 2012), providing partial to complete loss of their morphology. Also, it has been recently demonstrated that di erent CNTs functionalizations can vary the short-term kinetics of CNTs biodegradation by microglia (Bussy et al., 2016), however not providing relevant di erences in the nanomaterial’s long-term fate. These evidences indicate that the\npossible accumulation of CNTs, which may eventually produce toxic e ects, can be e ciently prevented also in the brain thanks to the natural body defense mechanisms.\nBesides the compatibility studies, CNTs have been also probed in vivo for their possible use as therapeutic agents, in particular as neuroprotectants against ischemic damages. In this context, CNTs covalent amino/ammonium derivatives and their further modi cations display very promising results. SWCNTs amino derivatives (SWCNTs-NH2, 4 10 nm 0.5 1.5 mm) are able to drastically reduce the brain damages induced by stroke whn preventively administered in lateral ventricles (Lee H. J. et al., 2011): after surgical transitory middle cerebral arteria occlusion (MCAO), SWCNTs-NH2 treated rats display a much lower cerebral infarction volume with respect to untreated rats. Also apoptosis, in ammatory, neurogenesis and angiogenesis levels in SWCNTs-NH2 treated rats’ brains indicate that the nanotubes are e ective in reducing cell death and in ammatory response and in promoting neuroregeneration. Most impressively, a complete restoring of motor function can be achieved in rats 7 days after the ischemic insult (Figure 3). The therapeutic e cacy of CNTs against brain ischemic damages can be improved by using the nanomaterial in order to deliver neuroprotective siRNAs. Ammonium-MWCNTs (MWCNTs-NHC3 , 20 30 nm 0.5 2 mm), are known in fact to be e cient siRNA delivery systems (Al-Jamal et al., 2010), and can be loaded with Caspase-3 siRNA (siCAS3), which is able to inhibit the expression of caspase-3, an\nFrontiers in Neuroscience | www.frontiersin.org 4 June 2016 | Volume 10 | Article 250\nFIGURE 3 | Morphological and functional neuroprotective effe cts of the SWCNTs-NH 2pretreatment after ischemia-reperfusion. (A) Coronal brain sections (stained with tetrazolium chloride) of sham, PBS and SWCNTs-NH2 (here called a-SWNT) treated mice, where white areas correspond to the infarcted regions after MCAO.(B) Quanti cation of the lesion in the brain sections showed in(A). (C) Schedule of motor functionality experiments.(D) Motor coordination results from Rotarod tests indicating complete recovery ofmotor coordination in SWCNTs-NH2 treated mice. Data reported as meanC s.e.m. *P < 0.001 vs. pre-MCAO. Reprinted by permission from Mcmillan Publishers Ltd.: Nature Nanotechnology,Lee H. J. et al. (2011), Copyright (2011).\nenzyme involved in apoptosis (Al-Jamal et al., 2011). Preventive administration of the nanomaterial inside rats brain parenchyma and its internalization by neurons within 48 h from the injection can therefore guarantee motor ability retention in rats after the induction of the ischemic insult. The combined neuroprotective e ect of the nanomaterial and of the siRNA is particularly evident if considering that, after the ischemic insult, treated animals brains show apoptosis markers levels that are substantially similar to those of healthy animals. Unfortunately, similar resultscould not be obtained if the nanomaterial is administered after the stroke event.\nDrug delivery into the brain is also one of the most desired biomedical applications of nanomaterials. By simply exploiting that unfunctionalized but shortened SWCNTs (0.8 1.2 nm 50 300mm) administered through the gastrointestinal (GI) tract are able to cross the BBB and preferentially localize in neurons’ lysosomes, it is possible to use these same SWCNTs to deliver Acetylcholine (ACh) in Alzheimer’s disease (AD) model mice’s brains through the GI tract. Once in the neuronal lysosomes, the acidic pH triggers the release of the drug from the AChSWCNTs to the neuron cytosol, providing the recovery of the mice’s learning abilities (Yang Z. et al., 2010). Also the more bulky MWCNTs can show very interesting drug delivery abilities in the CNS, when opportunely functionalized in order to improve their dispersibility in aqueous media; moreover, the concomitant\ngrafting of targeting biomolecules to the nanomaterial sca old increases the speci city of the therapeutic action: doxorubicin (DOX) loaded oxidized MWCNTs (DOX-oMWCNTs, 10 nm 5 15 mm) possessing a PEG unit and grafted with angiopep2 (ANG, a peptide targeting both the BBB and the LRP receptor expressed by glioma cells) demonstrate to be highly e ective against glioma (Ren et al., 2012). Angiopep-2-targeted oMWCNTs are able to cross the BBB in higher quantity with respect to unfunctionalized or PEG-DOX functionalized MWCNTs, and to accumulate more selectively into the tumor mass. As result, mice treated with DOX-oMWCNTs-PEG-ANG show a 20% increase in survival compared to mice treated with the untargeted nanomaterial and by 42% with respect to mice treated with only DOX. DOX-oMWCNTs-PEG-ANG also display a little higher liver and spleen accumulation than DOX and DOX-oMWCNTs-PEG but lower kidney and lung accumulation, and a markedly reduced cardiac toxicity with respect to DOX, a characteristic which also represents a remarkable improvement.\nE cient delivery of therapeutic genetic material in the CNS can be also achieved thanks to SWCNTs. Alongside with the previously mentioned delivery of siRNA for ischemic damage reduction purposes, SWCNTs, and in particular PEGfunctionalized SWCNTs (1 3 nm 0.2 0.4 mm), are able to deliverCpGoligonucleotide (CpG-CNTs), which has antitumor\nFrontiers in Neuroscience | www.frontiersin.org 5 June 2016 | Volume 10 | Article 250\nactivity via activation of TLR9-mediated immune response, tothe tumor-associated in ammatory cells in brain implanted glioma in mice (Zhao et al., 2011). The intracranial injection ofCpGCNTs provides the recruitment of Natural Killer (NK) and CD8C cells and the development of immune response against the glioma cells, which results in tumor cells depletion and survival of 50 60% of treated mice, while no survival is observed when mice are treated with a single dose of non-conjugated CpG oligonucleotide. Moreover, the adverse e ects commonly associated with the standardCpG antitumor therapy are not observed when usingCpG-CNTs. Finally, the surviving treated mice develop immunity against glioma, therefore they undergo spontaneous remission of the tumor when this is re-injected into their brains.\nCNTs were also probed for neuroregeneration applications in spinal cord injury (SCI) model rats. Post-injury administration of PEG-functionalized SWCNTs (PEG-SWCNTs) in the lesion site is found to promote axonal survival and repair, while delayd administration is able to achieve a dose-dependent reduction in the lesion volume in both gray and white matter, and an increase in the number of neuronal bers in the lesion epicenter with a modest sprouting of corticospinal tract axons into this region (Roman et al., 2011). Neither alterations in reactive astrogliosis at the lesion site nor toxicity or neuropathic pain are present. As outcome, a dose-dependent moderate recovery of motility in treated rats is achieved.\nTaking into account the studies above mentioned, carbon nanotubes emerge as extremely versatile materials for a number of useful applications in the CNS. Besides their singlewall or multi-wall nature, appropriately functionalized CNTs demonstrate to be good therapeutic agents against ischemic damage as well as excellent vectors for drug delivery in the CNS. Apparently MWCNTs are preferred to SWCNTs for delivery applications in the CNS, despite the fact that the latter display a higher speci c surface area and therefore a higher loading capacity. Economical reasons may also play a role in the choice. CNTs show high biocompatibility with the brain tissue , contrary to the data reported in some cells studies and when administered in the lungs and in the GI tract. Important in this sense is that the CNTs used in these studies have been in general functionalized with highly polar moieties or they display structural characteristics that prevent their excessive aggregation in aqueous media, which can potentially give rise to immune response. Furthermore CNTs also demonstrate the ability to mitigate the toxicity of some drugs. In summary, we believe that CNTs have to be still considered cutting-edge nanomaterials for the therapy of CNS diseases.\nFULLERENES\nFullerenes are de ned molecular entities with a precise atomic composition and hollow spherical shape. Buckminsterfullerene, better known as C60 fullerene, is the rst and the smallest stable fullerene isolated, and the most studied because of its relative ease of synthesis. It is obtained in relatively good yields from graphite using the arc-discharge technique, and\npuri ed from byproducts by solvent extraction followed by chromatography. In its structure the 60 sp2-hybridized carbon atoms arrange to form a truncated icosahedron structure with a diameter of 0.7 nm (Figure 4). Several derivatives with hydrophilic (carboxyfullerenes) or lipophilic (PCBM) behavior were synthesized in order to increase the solubility in water nd organic solvents.\nFullerenes are extensively studied in a number of applications such as organic photovoltaics (Brabec et al., 2010; Kirner et al., 2014), gas storage (Gadd et al., 1999), and molecular sensing (Baena et al., 2002; Sherigara et al., 2003). In the last 30 years fullerenes, alongside CNTs, were considered among the cuttingedge nanomaterials for biomedical applications: they were proposed as oxidative damage protecting agents, photosensitizers for photodynamic therapy of cancer, antiretroviral agents and s drugs and gene delivery vectors (Bakry et al., 2007; Tykhomyrov et al., 2008; Partha and Conyers, 2009; Chen et al., 2012; Matija et al., 2013). Fullerenes also were the pioneering carbon nanomaterials investigatedin vivo for their potential applications in the therapy of brain diseases. However, the raising concerns of their toxicity has contributed to a reduction of the interest from the biomedical scienti c community.\nThere are con icting reports in literature regarding their toxicity. C60 has been documented for ex. both to induce reactive oxygen species (ROS) mediated toxicity and to provide e cient protection from ROS damage (Johnston et al., 2010). While it is generally accepted that pristine C60 displays just moderate toxicity (Tokuyama et al., 1993; Partha and Conyers, 2009; Aschberger et al., 2010; Johnston et al., 2010), its covalent and non-covalent derivatives can be instead very toxic (Trpkovic et al., 2012; Sergio et al., 2013). Furthermore, toxicity of pristine C60 is increased by the presence of surfactants or organic cosolvents (Johnston et al., 2010) and genotoxicity has been also reported (Dhawan et al., 2006). The high a nity of C60 for a number of chemical species along with its ability to permeate the biological membranes allows it to convey toxicants in the cells or to interfere with metabolic processes (Sergio et al., 2013). It\nFIGURE 4 | Schematic representation of C 60 fullerene.\nFrontiers in Neuroscience | www.frontiersin.org 6 June 2016 | Volume 10 | Article 250\nshould be noted however that toxicity evidences show a certain degree of variability that can be ascribed, in large part, to the very di erent experimental conditions and toxicity assays used.\nFullerenes are able to penetrate the neuronal cell membrane both in vitro andin vivo(Yamago et al., 1995; Dugan et al., 2001). They can accumulate in several tissues and, notably, they cross the BBB (Yamago et al., 1995). Despite the general indications of cytotoxicity, on neuronal cell cultures these compounds show neuroprotective and antioxidant e ects (Dugan et al., 1996, 1997; Bisaglia et al., 2000).\nIn vivo, fullerenes are the rst carbon nanomaterials found to distribute in the brain after systemic administration. Biodistribution studies using a14C-radiolabeled carboxylated C60 derivative (14C-C60) in rats after i.v. administration (Yamago et al., 1995) reveal that the nanomaterial rapidly spreads in several organs including brain, indicating that it is able to cross the BBB despite its high molecular weight (995 Da). No toxic e ects are observed afteri.v. administration, while toxicity is observed after intraperitoneal injection. A possible explanation for this di erent behavior can be that the fullerene is able to induce a consistent in ammatory response only when it is administered in a con ned site at high concentrations, while direct dilution in the bloodstream suppresses this accumulation-dependent toxicity. However, as the authors of this study point out, this nanomateri l has a high lipophilicity, which translates into slow excretion kinetics and accumulation in speci c organs. This raises concer s about the possible occurrence of long-term toxicity or toxicity after chronic administration since the fullerene can reach with time toxic concentrations inside speci c sites.\nAlike CNTs, also fullerenes have been probed for their potential therapeutic activity in the CNS, especially for ROSscavenging purposes. The rst and most studied fullerene demonstrating this property is carboxyfullerene, a C60 tris(malonic acid) water soluble derivative. Carboxyfullerene continuousi.p.administration by means of a mini-osmotic pump in transgenic mice carrying a human superoxide dismutase gen mutation related to familial amyotrophic lateral sclerosis(FALS) results in 15% delay in the appearance of FALS symptoms, and 6% increase of survival (Dugan et al., 1997). Carboxyfullerene is also able to protect nigrostriatal dopaminergic neurons against the oxidative stress generated by Iron(II) injection (Lin et al., 2001), used as a Parkinson’s disease model: intracranial co-administration of the nanomaterial at low doses with Iron(II) into mice’ssubstantia nigrais able to inhibit the induced ROS generation, keeping dopamine levels and dopaminergic response similar to basal values. Although the two nanomaterials are co-administered, it is unlikely that neuroprotection occurs thanks to metal sequestration or direct reduction of the metal ion operated by the fullerene, rather it is likely to act as free radical scavenger as demonstrated by EPR spectroscopy experiments (Dugan et al., 1997). Finally, in MCAO stroke model, intraventricular injection of high doses (0.3 mg/rat) of carboxyfullerene in rats brain 30 min prior to infarction is able to fully contrast the ischemia-generated ROS production, providing 83% reduction of the infarcted area (Lin et al., 2002). Nevertheless, in the latter case the authors report adverse e ects such as writhing with stretching of the trunk in more than a third\nof the treated animals, with death occurring in the 60% of these cases. Administration of a lower (but still high) dose (0.1 mg/rat) of the nanomaterial is free of adverse e ects, but has limited e cacy. Systemic administration (6 mg/kg) through the tail vein also demonstrates to be nontoxic, however it has no e ect on the infarction. These results indicate that the nanomateri l displays in general acute toxicity when employed locally in the CNS at high dosage, while it can be considered reasonably safe when it is locally administered at low doses or when systemic administration is employed.\nCarboxyfullerene is proposed also as neuroprotective cerebral antiaging compound: daily administration of the nanomaterial to mice (10 mg/kg/day) in drinking water is able to reduce the superoxide content in brain tissues to levels just above those of control young mice, implying that the nanomaterial is able to cross the BBB (Quick et al., 2008). An improved ability in memory behavioral tests and a 11% lifetime increase is also observed, suggesting a considerable antiaging e ect exerted also to several other organs. A neuroprotective e ect of carboxyfullerene after single systemici.p. administration is evidenced also againstE. Coliinduced meningitis in mice (Tsao et al., 1999): although the nanomaterial has no direct antibacterial activity, preventive administration as well as post-infection treatment with carboxyfullerene (6 40 mg/kg, administered 3 times every 24 h) decreases brain in ammation by modulating the immune response and preventing the BBB leaking due to in ammation, thus delaying or partially preventing (up to 80%) mice death in a dose-dependent way and more e ectively than corticosteroids. The high doses of nanomaterial injected do not cause any toxic e ect in mice, thus strengthening the hypothesis that the systemic administration of this nanomateri l is particularly well tolerated.\nCarboxyfullerene has been also tested for the treatment of Parkinson’s disease (PD) in MPTP treated non-human primates models (Dugan et al., 2014). The nanomaterial is delivered 1 week after MPTP injection by continuous systemic administration(3 mg/kg/day) using either intraperitoneal or subcutaneous osmtic pumps. Signi cant di erences between the placebo group and animals receiving carboxyfullerene are found starting from 30 days after the beginning of the treatment, with treated animals showing motor ability improvements approaching normal values\nt the end of the experiment (Figure 5). This indicates that the continuous administration of carboxyfullerene is able to induce the recovery of dopaminergic neurotransmission even after the MPTP-induced neuronal death process has already begun. Moreover, despite the prolonged duration of the experiment and the continuous administration of the nanomaterial, only little evidences of toxicity are found. Results promote therefore a potential application of this nanomaterial for the cure of Parkinson’s disease in humans.\nAlongside carboxyfullerene, other C60 fullerene derivatives show neuroprotection capabilities: hexasulfobutylated-C60 (FC4S), when administeredi.v., is able to cross the BBB and prevent oxidative damage after MCAO stroke induction (Huang et al., 2001), providing up to 67% reduction of the infarcted brain volume after reperfusion. Intracellular oxidative stress is found to be perfectly normal, while interestingly the presence\nFrontiers in Neuroscience | www.frontiersin.org 7 June 2016 | Volume 10 | Article 250\nFIGURE 5 | (A,B) Positron emission tomography (PET) brain images using fromtwo control primates (M1, M2) and two carboxyfullerene-treated primates (M3, M4) before MPTP injection (pre) and at the end of the treatment (post). [11C] dihydrotetrabenazine (DTBZ) and 6-[18F] uorodopa (FD) are used as probe for evaluating the nigrostriatal dopaminergic activity. As clearly visible placebo-treated animals are showing unsymmetrical distribution of tracers in the two hemispheres indicating partial loss of dopaminergic activity, while carboxyfullerene-treated animals are showing dopaminergic activity in both thehemispheres.(C) Parkinsonian rating score at the end of the treatment, indicating reduction of bradykinesiain carboxyfullerene (C3) treated animals with respect to animals receiving placebo. Data reported as meanC s.e.m. *p D 0.007. Adapted from Dugan et al. (2014)with permission from John Wiley and Sons, Copyright (2014).\nof increased levels of nitric oxide (NO) suggests that FC4S may exert its neuroprotective action by activating speci c cell signaling pathways. Furthermore, the authors report no adverse e ect of the FC4S administration. Thanks to the possibility to use i.v. administration and to the absence of adverse e ects, this nanomaterial therefore is able to overcome the limitations displayed by carboxyfullerene (Lin et al., 2002) in the prevention of stroke-deriving ischemic damage. However, the prevention of brain infarction damages implies that the nanomaterial has to be chronically administered and therefore, prior to envisage possible uses of this nanomaterial in therapy, long-term toxicity studies must be performed. Among noncovalent derivatives of C60 fullerene, its adduct with poly(vinylpyrrolidone) (C60-PVP) displays neuroprotective capabilities: direct injection of the nanomaterial into rats hippocampus is able to protect memory consolidation mechanisms in rats when these are treated with cycloheximide, a protein synthesis inhibitor able to impair the memory consolidation processes (Podolski et al., 2005). Results seem to indicate that the ROS-scavenging ability of the fullerene adduct is the main responsible of preventing the neuronal apoptotic response to the drug. However, although no indications of adverse e ects in the CNS are provided, the choie of local cerebral administration of this therapeutic agent raises concerns regarding the possible occurrence of toxicity.\nAlso unfunctionalized fullerene (C60), in the form of water suspension of the pure nanomaterial as hydrated (C60HyFn), can be used for neuroprotection purposes. The administration of the nanomaterial in rats drinking water provides protection against neuronal damages deriving from chronic alcohol intake (Tykhomyrov et al., 2008). Analyses reveal that the nanomaterial is able to contrast the alcohol-induced depletion of glial brillary acidic protein (GFAP) in astrocytes as well as to preserve the expression of cytoskeletal proteins also in neurons and glia.No adverse e ects due to the nanomaterial intake are observed. Additionally, C60HyFn demonstrates possible neuroprotective activity against Alzheimer disease (AD) neurodegeneration. In\nvitro, the nanomaterial is able in fact to interfere with the formation of A 25 35 amyloid peptide brils structure, resulting in the accumulation of proto brillar structures (Podolski et al., 2007). Rats injected with the amyloid peptide rapidly develop dementia, but when even low doses (maximum 5mg/rat) of C60HyFn are injected intracerebroventricular (i.c.v.) prior to the injection of the amyloid peptide, rats show normal cognitive abilities. Also, no evidence of nanomaterial toxicity is found (Podolski et al., 2007). A recent follow-up in this research indicates that hippocampal injection of C60HyFn is able to restore the cortical-hippocampal EEG interrelations disrupted by the injection in the same site of anA peptide to simulate AD (Vorobyov et al., 2015). As these reports demonstrate, unfunctionalized C60 fullerene show neuroprotective e ects when administered both GI and locally in the CNS. Di erently from carboxyfullerene however, unfunctionalized C60 does not show toxicity when administered directly in the brain tissue . Toxicological investigations on C60 fullerene suggest however a potential long-term toxicity of the nanomaterial (Yamada et al., 2008). Even though no severe acute toxicity is found, thei.c.v. injection of C60 is in fact found to interfere with neurotransmitter homeostasis in rats, causing behavioral changes in the animal. Interestingly,i.p. injection of C60 does not provide alterations in the cerebral neurotransmitters levels.\nThe last fullerene-derived nanomaterial that showed direct neuroprotective capabilitiesin vivo is fullerenol, i.e., polyhydroxylated C60 (C60-OH). This derivative, which is already known fromin vitro studies to display neuroprotective activity (Jin et al., 2000), and its glucosamine conjugate (GlcNF), designed in order to add anti-in ammatory activity to the nanomaterial, demonstrate to be very good neuroprotective agents against stroke insult (MCAO induced) after systemic administration in both normotensive (WKY) and hypertensive (SHR) rats (Fluri et al., 2015). The i.v. administration of 0.5 mg/kg of C60-OH subsequent to reperfusion after MCAO results in 68% reduction and 26% reduction of the infarcted area volume\nFrontiers in Neuroscience | www.frontiersin.org 8 June 2016 | Volume 10 | Article 250\n(compared to control) in WKY and SHR rats respectively. The increase in C60-OH dosage does not provide sensible therapeutic improvements but results in the appearance of adverse e ects and also of death, while the use of GlcN-F (5 mg/kg, equivalent to 0.5 mg/kg of C60-OH), in SHR rats provides a greater reduction of the infarcted volume with respect to C60-OH without evidences of toxicity. However, it is found that thei.c.v. injection in rats of even small doses (0.25 mg/kg) of fullerenol produces important although transitory toxic e ects on the monoamine neurotransmission and animal behavior (Yamada et al., 2010). This raises further and more alarming concerns about the nanomaterial safety, also regarding possible adverse e ects that can arise in case of accumulation of the nanomateri l in the brain also after systemic administration. It should be underlined also that the results provided by C60-OH are in line with those of FC4S (Huang et al., 2001). However, FC4S seems to be e ective at lower doses and it is not toxic. The e ectiveness of GlcN-F in reducing the extent of infarcted brain volume in SHR rats is instead a very appreciable result since itis known that hypertension has a strong detrimental e ect on the prognosis after stroke. It would be interesting then to examine the neuroprotective e ect of FC4S also in hypertensive rats in order to determine if it can be an equally e ective and safer alternative to GlcN-F.\nAlthough extensive researches have been conducted to address the intrinsic neuroprotective properties of fullerenes, therea very few reports regardingin vivo drug delivery and imaging applications within the CNS. Drug delivery has been probed using a C60 derivative having two enzymatically cleavable amantadine molecules, synthesized with the aim to create a new anti-parkinson agent that combined the pharmacological activity of amantadine with the neuroprotective activity ofthe fullerene (Nakazono et al., 2004): studies on Parkinson model rats demonstrate moderate activity of the fullerene drug when systemically administered at 10 mg/kg dose, while at higher doses the drug is ine ective probably because the nanodrug itself is inhibiting the enzyme deputed to the hydrolysis of the fullerene-amantadine bond. On the other hand brain tumors bioimaging using fullerenes derivatives was achieved by means of endohedral gadolinium-C82 fullerenol (Gd@C82-OH), where the paramagnetic Gd3C cation is enclosed in the fullerene cage: afteri.v. injection the nanomaterial can detect, by means of MRI, a C6 glioma tumor in rats brain (Shevtsov et al., 2014). The nanomaterial is accumulating inside the tumor and displays a higher detection e ciency than the standard contrast agents. Gd@C82-OH is found to be nontoxic to the animals unless high concentrations ( 12.5 mg/kg) are used, while it is able to increase their survival time, implying also a potential antitumor activi y.\nIn summary, fullerenes demonstrate a good potential as neuroprotective agents, while their use as drug delivery vectors or imaging agents, at least in the CNS, has been just marginally explored. Most importantly fullerenes, and\nin particular carboxyfullerene, display a not negligible toxic pro le for the CNS that however can be drastically reduced when systemic administration is preferred to local acute administration. However, neuroprotective applications require chronic administration of the therapeutic agent, and long-term\ntoxicological data on these nanomaterials are still scarce.Despite the very good results achieved, fullerenes represent the past of carbon nanomaterials research. This again is due to all the concerns related to their proven accumulation in several organs, their long persistency in the body and their in general unpredictable toxicity. With all these serious impairments,it is not easy to say if the risk-bene t ratio will still provide opportunities for the development of these nanomaterials for biomedical applications.\nGRAPHENE OXIDE AND DERIVED NANOMATERIALS\nGraphene is a thin layer of sp2-hybridized carbon atoms bonded together in a hexagonal honeycomb lattice. Its peculiar electronic properties and structure attract a lot of attentio especially in the eld of semiconductor technologies. Moreover, thanks to its high surface to volume ratio applications as high capacity storage material or as drug delivery system are also proposed. Graphene oxide (GO) is the most common derivative of graphene, made from the exfoliation of graphite by oxidation procedures. GO nanoparticles are usually 1 nm thick while their lateral size can span from few tens of nm to few mm (Figure 6). Albeit the synthetic procedure introduces defective sites that destroy the peculiar electronic properties of graphene, the presence of polarizable functionalities increases its stability as single free-standing layers and allows the dir ct further functionalization of the material. For these reason , graphene oxide has been considered more suitable than graphene for biomedical applications. Moreover, depending on the size, composition, and degree of oxidation, GO can exhibit inherent and tunable optical absorption and emission properties, with emission wavelengths varying from NIR to blue light (Li J. L. et al., 2012; Zhu S. et al., 2012; Cao et al., 2013; Zhang X. et al., 2013).\nGraphene and derived nanomaterials are intensively applied for biomedical purposes and show promising results in toxicants and tumor marker sensing,in vitro and in vivo imaging applications, drugs and nucleic acid delivery, tumor photothermal ablation, as well as stem cell di erentiation substrates (Peng et al., 2010; Zhang L. et al., 2010; Huang, 2011; Kim et al., 2011; Robinson et al., 2011; Lee W. C. et al., 2011;\nFIGURE 6 | (A) Schematic representation of GO. The nanomaterial surface and edges are characterized by the presence of carboxyls, carbonyls, alcohols, and epoxydes.(B) TEM micrograph of GO sheets; adapted from Zhang L. et al. (2010)with permission from John Wiley and Sons, Copyright (2010).\nFrontiers in Neuroscience | www.frontiersin.org 9 June 2016 | Volume 10 | Article 250\nGollavelli and Ling, 2012; Hong et al., 2012; Li M. et al., 2012; Chung et al., 2013; Lalwani et al., 2013; Goenka et al., 2014). Their toxicity pro le is, as for many other carbon nanomaterials, hig ly dependent on the functionalization, size and the aggregation behavior (Jastrzebska et al., 2012; Hu and Zhou, 2013; Wick et al., 2014). GO appears to be less toxic than pristine graphene, reduced graphene oxide or hydrogenated graphene, and the additional functionalization (with PEGs, aminogroups, etc.) contributes to a further reduction of the toxicity; graphene particles with few nm diameter are less toxic than larger particles; highly dispersible particles are less toxic than the aggregating ones. With respect to the other carbon nanomaterials, graphene and derivatives tend to accumulate in lungs and to reside in the organism for a longer time (Wang et al., 2010; Zhang Y. et al., 2010; Zhang X. et al., 2011; Yang et al., 2013b; Chng et al., 2014; Chwalibog et al., 2014; Kanakia et al., 2014; Seabra et al., 2014).\nRecently, graphene and related materials are emerging as a convenient substrate and a powerful tool for neuronal growth and di erentiation. Reports indicate that graphene is a permissive substrate for neuronal cells growth (Li et al., 2011, 2013; Park et al., 2011b; Movia and Giordani, 2012; Hong et al., 2014; Serrano et al., 2014; Tu et al., 2014; Fabbro et al., 2016) and the electrical conductivity of this material can be exploited to direct the elongation of neuronal processes in a controlled way (Li et al., 2011). Moreover, the electrical signals generated from neuronal cells can also be recorded by using graphene-based microelectrodes (Chen et al., 2011; Tang et al., 2013; Park et al., 2014). Surprisingly, it has also been shown that the physicochemical properties of this material favor the di erentiation of neuronal stem cells preferentially toward the neurons fate (Park et al., 2011b; Wang et al., 2012; Akhavan and Ghaderi, 2013; Li et al., 2013). In these studies, toxicity assays show a good compatibility of graphene with neuronal cells (Chen et al., 2011; Li et al., 2011; Hong et al., 2014). In particular, reports show that graphene akes (Zhang Y. et al., 2010) and graphenebased substrates (Hong et al., 2014; Song et al., 2014) may be even more compatible than other carbon-based nanostructures.\nIn vivo biodistribution studies reveal that GO has good potential for applications in the CNS: intravenous administration of radiolabeled GO (188Re-GO, 10 800 nm lateral size) in mice (Zhang X. et al., 2011) indicates that, despite most part of the nanomaterial is sequestrated by lungs, a small quantity (0.04% of injected dose) is able to cross the BBB and migrate into the brain parenchyma. Similar results are obtained by administeringi.v. GO (0.3 1 mm lateral size) as suspension in PBS with the help of a surfactant. Remarkably, the presence of the surfactant allows to reduce lung accumulation, erythrocyte agglutination and macrophage activation (Qu et al., 2013). A further improvement has been made recently by noncovalently functionalizing GO with dextran (GO-DEX, 100 120 nm lateral size): afteri.v. administration in mice, the nanomaterial is found to pass the BBB without exerting toxic e ects in the brain and showing just minor e ects in the other organs at the highest doses (> 125 mg/Kg) (Kanakia et al., 2014). Interestingly, brain GO-DEX concentration is found 3 times higher 1 month after the injection with respect to 24 h after the injection, while it is almost completely cleared from all the other organs, thus indicating slow accumulation and long-term persistency of this\nnanomaterial in the CNS. If this can be considered a strength in view of applications as neuroprotective agents, on the other hand it raises concerns about possibilities of long-term toxicity, which however has not been explored yet.\nContrary to CNTs and fullerenes, GO and derivatives are not showing remarkable ROS scavenging capabilitiesn vitro, therefore no in vivo studies have been performed in order to assess their potential neuroprotective activity. Interestingly, GO and derivatives can be successfully applied forin vivo imaging purposes in the brain. PEG-functionalized GO (GOPEG, 40 nm lateral size), intracranially administered in mice, can be detected thanks to its uorescence emission properties up to 300mm below the brain surface and its 3D distribution map in the brain parenchyma reconstructed (Figure 7) by using the two-photon imaging technique (Qian et al., 2012) in order to achieve high tissue penetration of the excitation light. Although preliminary, these results pave the way to the possible use of this nanomaterial for the imaging of brain cancerous lesions. This can be achieved rstly if GO nanoparticles are endowed of appropriate tumor-targeting functionalizations able to cause the selective accumulation of the nanomaterial inside the tumor mass. Furthermore, there is need to optimize the the nanomaterial characteristics (size, degree of oxidation), in order to shift its emission wavelength from the VIS spectral range that has poor tissue penetration, to the NIR, thus improving the imaging depth that is possible to achieve.\nAlthough GO shows scarce tendency to reach high concentrations in cerebral tissues after systemic administrat on, its high speci c surface area, which endows it of a high loading capacity, makes it a promising candidate also for drug delivery applications in the CNS. Strategies, such as low-invasive physical BBB opening techniques or chemical functionalization with e cient targeting moieties, can be used to overcome the low BBB permeability of GO. GO-PEG nanoparticles (120 150 nm lateral size) loaded with epirubicin (EPI), an anticancer drug, and decorated with magnetic Fe3O4 nanoparticles, can be used against U87 glioma xenographted in mice striatum (Yang H.-W. et al., 2013): after administration in the jugular vein, the nanodrug can be accumulated in the tumor mass by combining the use of low intensity focused ultrasound (LFUS), a physical BBB opening technique, and magnetic targeting. This resultsin a signi cant reduction of the tumor growth rate in the treated mice compared to control mice (Figure 8). It seems also that the use of GO and LFUS in combination is particularly e ective due to the obtainment of local hyperthermia in the tumor. Magnetic GO-PEG-EPI nanoparticles are found to accumulate preferentially in the liver, from which they are completely cleared in 48 h. No organ damages or weight loss, neitherin vitro induction of immune response is found. The relatively rapid GO clearance and the absence of acute toxicity phenomena make this nanomaterial a suitable candidate for implementing the current brain tumor therapies.\nPhysical BBB opening techniques combined with GO can be also used to obtain simultaneous MRI imaging, drug delivery and miRNA delivery in the CNS. GO nanoparticles (140 150 nm lateral size) grafted with Gd-DTPA and poly(amidoamine) dendrimer, and loaded with EPI andLet-7, a tumor suppressor\nFrontiers in Neuroscience | www.frontiersin.org 10 June 2016 | Volume 10 | Article 250\nFIGURE 7 | Imaging of GO nanoparticles in a mouse brain using two-photon luminescence. (A) Schematic representation of the experimental conditions used.(B) Reconstructed 3D luminescence image of GO-PEG nanoparticles inside the brain parenchyma. Reprinted from Qian et al. (2012)with permission from John Wiley and Sons, Copyright (2012).\nmiRNA (Yang H.-W. et al., 2014) can be administered by tail vein injection in mice and allowed to cross the BBB thanks to the application of focused ultrasounds (FUS). The nanomaterial is able to provide very high contrast in MRI, which can be used in order to determine and quantify the distribution of the nanometric drug delivery system insidethe brain tissues. Unfortunately, the study limits the demonstration of EPI internalization by glioma cells and miRNA transfection in their nuclei only toin vitro experiments. Although the results provided are very positive, it will be important to demonstratein vivo the therapeutic e cacy of the nanodrug, and also to obtain pharmacokinetic and toxicological data.\nAlso chemical derivatization with suitable targeting moieties is able to provide the nanomaterial BBB crossing capabilities, making possible to pursue e cient drug delivery in the CNS. Transferrin (Tf) functionalized GO-PEG nanoparticles (Tf-PEGGO, 100 400 nm lateral size) are successful in delivering DOX in a brain tumor (Liu G. et al., 2013): after i.v. administration the nanoparticles are able to migrate from the bloodstream to a C6 glioma that has been implanted in rats striatum, where they are found signi cantly more concentrated than in the rest\nFIGURE 8 | In vivo luminescence imaging of luminescence-labeled U87 tumor xenografted into nude mice brains. Animals receiving the treatment consisting in administration of magnetic GO-PEG-EPI nanoparticles followed by magnetic targeting and LFUS (NMGO mPEG EPI/MT) show an improved tumor reduction at 7 and 13 days after the treatment with respect to control mice. Adapted from Yang H.-W. et al. (2013)with permission from John Wiley and Sons, Copyright (2013).\nof the brain and the other tissues. Also, tumor DOX retention is increased with respect to controls. As result, Tf-PEG-GODOX nanoparticles can signi cantly delay the tumor growth and increase the rats median survival time, although no complete tumor eradication is noticed. Similarly, GO-PEG (100 300 nm lateral size) functionalized with Human Immunode ciency Virus (HIV) Tat protein derived peptide (Tat), which increases the BBB permeability of the nanomaterial, can deliver drug molecules inside the brain tissues (Yang et al., 2015). The targeted nanovector is able to improve the perfenidone (PERF) e cacy in the treatment of subarachnoid hemorrhage, whose success is limited by the scarce BBB penetration of the drug. Photoacusti imaging demonstrates that the nanodrug is able to accumulate in the brain after i.v. administration and that there is a clear improvement with respect to the standard PERF therapy in the PERF-induced water content increase close to the injured site. Finally, evaluation of BBB integrity after the nanocarrier administration reveals that its structure and function arenot a ected by the nanoparticles.\nIn conclusion, the studies above reported suggest that GO and its derivatives have many properties that can make them suitable candidates for both diagnostic and therapeutic applications in the CNS: they display intrinsic uorescence and they can di use inside the brain tissues, they have high loading capacity that allows them to deliver signi cant quantities of drugs or imagin agents inside the brain and, to date, they have not displayed\nFrontiers in Neuroscience | www.frontiersin.org 11 June 2016 | Volume 10 | Article 250\ntoxicity toward CNS tissues yet. Unfortunately, the nanomateri l displays low BBB permeabilityper se, and functionalization with high e ciency targeting molecules or the employment of novel physical BBB opening techniques is mandatory in order to overcome this issue. We have to remark however that researchs aiming to propose possible applications of GO in the CNS are relatively recent and therefore the nanomaterial has not been yet optimized (size, functionalization, dose, etc.) for theb st performances in this body region. For the same reason, toxicity of GO toward CNS has not been deeply investigated, including a careful examination of GO e ects both on single neuronal populations and in the whole CNS systematically evaluating the e ect of size and functionalization. It is expected that the high attention given nowadays to graphene and derivatives will stimulate rapid improvements both in GO engineering for medical applications, including those involving the CNS, andin the understanding of its eventual toxic e ects there.\nNANODIAMONDS\nNanodiamonds (NDs) are carbon particles formed by sp3 carbon atoms arranged in a diamond-like cubic lattice. They can be produced in several diameters, ranging from 4 5 to 100 nm (Figure 9). NDs synthesis is usually performed at high pressurehigh temperature. Although several production methods were developed, the most used is detonation of TNT and nitroamines (RDX) (Galli, 2010; Mochalin et al., 2011). NDs are currently the most abundantly produced carbon nanostructures due to the number of industrial applications where they are employed, especially for the lubricants and polishing industry and as part of novel high-performance nanocomposite materials (Mochalin et al., 2011).\nNanodiamonds surface is highly reactive and can be easily functionalized, as well as passivated (Liu et al., 2008; Vaijayanthimala and Chang, 2009; Chen et al., 2010; Rojas et al., 2011). Furthermore, by irradiating nanodiamonds with highenergy particles and subsequent annealing, it is possible to create nitrogen-vacancy centers that render the nanodiamond particles highly uorescent in the VIS range (500 800 nm, with peak emission at 680 nm) (Fu et al., 2007; Chang et al., 2008; Vaijayanthimala et al., 2012; Hegyi and Yablonovitch,\nFIGURE 9 | (A) Schematic representation of NDs.(B) HRTEM micrograph of 7 nm oxidized diamond nanoparticles; adapted with permission from Rojas et al. (2011). Copiright (2011) American Chemical Society.\n2013; Bartelmess et al., 2015c). Recently, they have started to be probed for possible biomedical applications like bioimaging (Vaijayanthimala and Chang, 2009; Hui et al., 2010; Hegyi and Yablonovitch, 2013; Perevedentseva et al., 2013), drug delivery and nucleic acid delivery (Xing and Dai, 2009; Chen et al., 2010; Zhu Y. et al., 2012; Perevedentseva et al., 2013), also exploiting the functionalization with targeting molecules for improved selectivity (Zhang X.-Q. et al., 2011; Fu et al., 2012). In view of their highly biocompatibility, nanodiamonds are one of the most promising carbon nanomaterials in this eld (Schrand et al., 2007a,b, 2009; Perevedentseva et al., 2013; Monaco and Giugliano, 2014). When administeredin vivo, nanodiamonds accumulate in the liver, in the spleen, and in lymphnodes (Yuan et al., 2009; Vaijayanthimala et al., 2012). Neuronal cells cultured on a surface of nanodiamonds reveal cell growth and electrophysiological properties comparable to neurons grown on classical supports (Thalhammer et al., 2010; Monaco and Giugliano, 2014; Edgington et al., 2013; Hopper et al., 2014). Nanodiamonds are internalized by various cell types, likely by chlatrin-based endocytosis (Liu K.-K. et al., 2009; Zhang X.-Q. et al., 2011), with limited or no cytotoxic e ects being reported. Similar results are observed in neuronal cells (H u et al., 2014; Huang et al., 2014).\nDespite the encouraging results bothin vitro and in vivo for biological applications,in vivo applications of NDs in the CNS are still in their early days. To date only one report suggests the possible use of NDs for therapeutic applications in the CNS: CED (convection-enhanced delivery, an experimental high e ciency intracranial delivery system) of DOX-loaded NDs (4 8 nm) is found to provide e cient treatment of di erent aggressiveness gliomas xenographted in mice striatum (Xi et al., 2014). The treatment allows to extend mice survival (with respect to DOX treatment) 1.4 times in the case of the most aggressive tumorand 1.8 times in the case of the less aggressive one. Notably, in the latter case tumor is eradicated in 3 out of 5 mice, while all mice treated with non-conjugated DOX die. Experiments performed using healthy mice indicate that, while the intracerebral injection of a DOX solution cause the drug to rapidly spread in the whole brain producing tissue damage and brain edema, the use of NDsDOX and CED allows the therapeutic agent to be con ned in the injection site, reducing its toxic e ects on the surroundingtissues and increasing the concentration of the drug at the injection site. Furthermore, while DOX is rapidly excreted from the brain, NDs-DOX display a much lower clearance.\nAlongside the possible applications of NDs in the CNS are being suggested, also toxicological studies in this body region start to be performed. Available data indicate that 100 nm uorescent NDs injected in mice hippocampus do not produce any relevant e ect neither on mice body weight, food or water intake, nor on mice behavior in anovel object recognition test, which should reveal eventual hippocampal damages (Huang et al., 2014). Interestingly, the same NDs have shownin vitro a concentration-dependent negative role in neuronal morphogenesis, although this e ect seems due to a physical impairment of growth cones and not to the interferenc with the cytoskeletal proteins, as on the contrary it has been often evidenced for non-carbon nanoparticles (Tay et al., 2014).\nFrontiers in Neuroscience | www.frontiersin.org 12 June 2016 | Volume 10 | Article 250\nIt is possible to hypothesize that the 3D environment and the presence of glial cells in the living tissue is drastically limiting the nanomaterial e ects on growing neurons.\nGiven the low amount of data available, it is di cult to draw conclusions regarding the possibility of a successful application of nanodiamonds in brain science. The exclusive use ofin situ delivery methods in the CNS raises the question if diamond nanoparticles can cross the BBB and therefore if they are suitable for applications in drug delivery or imaging in the brain. However, the possibility to display bright and photostable uorescence, the encouraging results obtainedi vitro, their ability to provide e cient and prolonged delivery of a drug while con ning its site of action in a limited space and the absence of reports indicating relevant toxicity of the nanomaterial toward neuronal cells suggest that NDs may give precious contributions to the diagnosis and therapy of CNS diseases. It should be underlined again that the nanomaterial is in its early years of development for biomedical applications, especially in the neurosciences eld. We hope that, as in the case of GO, suitable tailoring of the nanomaterial chemical, morphological and physical properties will help to overcome its current limitations.\nCARBON NANOHORNS AND CARBON NANOFIBERS\nSingle-wall carbon nanohorns (SWCNHs) are relatively unexplored carbon nanomaterials, especially in biological studies. They are structurally similar to carbon nanotubes, however the continuous graphitic surface is arranged in a conical shape with a closed tip. They are usually 40 50 nm long and 2 3 nm wide, and they commonly assembly into 80 100 nm spherical aggregates (Iijima et al., 1999; Zhu and Xu, 2010; Figure 10). SWCNHs have been functionalized either covalently and noncovalently using the synthetic strategies developedfor CNTs and graphene (Tagmatarchis et al., 2006; Cio et al., 2007; Pagona et al., 2007; Voiry et al., 2015). They nd possible applications as gas storage materials (Adelene Nisha et al., 2000; Bekyarova et al., 2003; Yang et al., 2005; Sano et al., 2014), as supports for metal catalyst nanoparticles (Yoshitake et al., 2002; Kosaka et al., 2009), as electrode materials and as components of photovoltaic devices (Vizuete et al., 2010; Lodermeyer et al., 2015). Among biomedical applications, biomolecule sensing (Valentini et al., 2014), MRI imaging (as support) (Miyawaki et al., 2006), photodynamic and photothermal therapy of cancer (Zhang et al., 2008; Whitney et al., 2011; Chen et al., 2014) as well as drug and gene delivery (Murakami et al., 2004; Ajima et al., 2005, 2008; Guerra et al., 2014; Ma et al., 2014; Zhao Q. et al., 2015) are successfully achieved bothin vitro and in vivoby SWCNHs.\nAlthough SWCNHs are structurally similar to CNTs, their synthesis is metal-free, therefore no toxic e ects due to metal contaminants are possible. However toxicity reports are con icting: in some studies SWCNHs are found to be biocompatiblein vitro as well asin vivo even at high doses despite their accumulation in several tissues like lung, spleen\nFIGURE 10 | Schematic representation of SWCNHs (A) and stacked-cup CNFs (C). (B) TEM micrograph of 80 nm SWCNHs peapods. (D) TEM micrograph of stacked-cup CNFs.(A,B) adapted from Voiry et al. (2015)with permission from The Royal Society of Chemistry.(C,D) adapted from Sato et al. (2005)with permission from The Royal Society of Chemistry.\nand liver (Lynch et al., 2007; Miyawaki et al., 2008; Tahara et al., 2011), while other reports demonstrate their toxicity toward macrophages even at low doses (Yang M. et al., 2014). Toxicological reports regarding carbon nanohornsi vivo and in vitro are very limited however, and it is not possible to draw clear conclusions basing on state of the art literature, although the relative higher abundance of studies indicating the presence of just low and transitory toxicity suggests their compatibility with living tissues and organs.\nUnfunctionalized SWCNHs are reported to be uptaken by mammalian cells, even if in a negligible amount (Isobe et al., 2006; Zhang M. et al., 2012), while when opportunely functionalized they can e ciently penetrate target cells, potentially allowing higher selectivity than other nanoparticles (Zhang M. et al., 2012; Li N. et al., 2015) and showing good carrier properties (Tahara et al., 2011).\nTo date only one report describes the successful delivery of SWCNHs in the brain. SWCNHs peapods, functionalized with CdSe/ZnSe quantum dots (QDs), encapsulating Gd3N@C80 fullerenes and delivered to U87 tumor bearing mice by CED intratumoral infusion (Zhang et al., 2010c), enable tumor imaging eitherin vivo by MRI (thanks to Gd3C) and ex vivoby confocal microscopy (thanks to QDs). Data demonstrate also that SWCNHs can be retained inside the tumor for at least 3 days. Although this study indicates SWCNHs as a possible brain drug delivery nanoplatform, further reports aiming to determine the in vivo biodistribution of SWCNHs demonstrate that they are not able to cross the BBB (Miyawaki et al., 2009; Tahara et al., 2011). This precludes the SWCNHs to be delivered in the brain by i.v. administration, leaving the more dangerous and complicated intracranial administration as the only feasible option available at the moment.\nFrontiers in Neuroscience | www.frontiersin.org 13 June 2016 | Volume 10 | Article 250\nCarbon nano bers (CNFs) are tubular carbon nanostructures, with diameters in the range of 3 100 nm and lengths that can also exceed 1 cm (De Jong and Geus, 2000; Figure 10). They are essentially made of assembled curved graphitic layers arranged in di erent ways to form long bers, often hollow. They are usually synthesized using CVD methods employing metal catalysts (De Jong and Geus, 2000), or from electrospun polymer bers carbonization (Inagaki et al., 2012). Their surface can be functionalized (Klein et al., 2008; Wang and Lin, 2008) or furthermore graphitized by thermal treatment (Ramos et al., 2013). Since their rst discovery in the early 50’s, these materials have been tested for several applications, like catalysis and energy storage (Rodriguez et al., 1994; Ji and Zhang, 2009; Wang K. et al., 2009; Duan et al., 2015), as well as for the preparation of many composite materials (Hammel et al., 2004). Moreover, they are used as support material for biomolecules sensing (Baker et al., 2006; Wang and Lin, 2008; Huang et al., 2010; Rand et al., 2013; Lim and Ahmed, 2015), gene delivery (McKnight et al., 2003) and in regenerative medicine (Webster et al., 2004; Tran et al., 2009). As for CNTs, several concerns regarding their toxicity have been advanced (Sato et al., 2005; Castranova et al., 2013), pointing out also their non-biodegradability and their asbestos-like accumulation n lungs.\nCarbon nano bers are proposed as coating materials for neural prosthetic devices, as they show good compatibility with neuronal cells and demonstrate to favor neuronalvs. glial/astrocytic proliferation (Webster et al., 2004; Tran et al., 2009). Also, carbon bers can be used to build free-standing vertically aligned arrays that allow to support and organize the neuronal cells growth providing mechanical, chemical and electrical cues at the subcellular scale. They can be also empl yed to produce microelectrode arrays with possible applications for in vivosignal detection and manipulation (McKnight et al., 2006; Nguyen-Vu et al., 2007; de Asis et al., 2009; Zhang H. et al., 2012; Vitale et al., 2015).\nDespite the longstanding experience on these nanomaterials and the deep knowledge of the nano ber-neuron interface for the preparation of e cient microelectrodes,in vivo experiments on their possible application for the treatment of CNS injuries and diseases are limited to just one example (Moon et al., 2012). In this report CNFs impregnated with subventricular stem cells were employed to promote neuroregeneration after MCAO-induced stroke, evaluating also the di erences between hydrophobic CNFs (i.e., thermally graphitized, HP-CNFs, 100 nm < 5 mm) and hydrophilic CNFs (i.e., untreated CNFs, HL-CNFs, 60 nm < 5mm) after their injection in the lesion site. The animals receiving the CNF-based treatment show reduction of the infarcted volume as well as recovery of motor and somatosensory activity, with HP-CNFs treated animals showing moderately better performances. Distribution analysis of stem cells in the brain tissues indicates that while unsupported stem cells are migrating all over the infarcted area, CNFs-supported cells localize near the corpus callosum (HL-CNFs) or the striatum\n(HP-CNFs). Notably, HP-CNFs are able to promote the stem cells di erentiation into neurons, to induce the formation of synapsis and to reduce the astrocytes and microglia recruitment with\nsuperior e ciency with respect to HL-SWCNTs and unsupported cells. These data indicate that CNFs are optimal support material for neuronal tissue regeneration, and that a lower surface wettability is also playing a key role in promoting the stem cell di erentiation toward the neuronal fate.\nAlthough the two studies indicate that both SWCNHs and CNFs can play a role as support materials for imaging or delivery applications, they both do not display BBB crossing capabilities and requirein situ administration. Since their very big size it is unlikely that also advanced physical BBB opening techniques or chemical functionalization can help in this sense. Due to the limited possibilities of use alongside the indications of possible toxicity, few e orts have been dedicated to identify their possible applications in the diagnosis and cure of CNS diseases. However, when used as electrodes or as part of composite nanostructures, CNFs are found to be excellent materials for promoting neuronal stimulation and growth, showing also no local toxicity. While t is likely that SWCNHs applications in the CNS will not be further explored, it is expected that CNFs will have an important role in the development of neuronal recording and stimulating devics as well as in neuroregeneration applications.\nCARBON DOTS\nCarbon dots (CDs), are a recently discovered class of quasispherical carbon-based nanomaterials (Xu et al., 2004) which essentially combine the presence of an amorphous or nanocrystalline (Csp3) core and a graphitic or turbostratic (Csp2) shell (Figure 11). Many strategies have been developed for the synthesis of these materials, either using top-down and bottom-up approaches; however, the industrial scalability of their production is still di cult to date (Baker and Baker, 2010; Li H. et al., 2012; Lim et al., 2015; Zhang and Yu, in press). Their peculiar properties are exploited in photocatalysis (Fernando et al., 2015), electrocatalysis (Shen et al., 2015), as sensitizers for solar cells (Briscoe et al., 2015), as well as for sensing applications (Zhao A. et al., 2015). Due to their high intrinsic uorescence which can span from the VIS to the NIR (Li H. et al., 2012; Strauss et al., 2014), CDs are considered particularly appealing for bioimaging applications (Cao et al.,\nFIGURE 11 | (A) Schematic representation of CDs.(B) HRTEM micrograph of 4 7 nm carbon dots produced by carbonization of chitosan; adapted from Yang et al. (2012)with permission from The Royal Society of Chemistry.\nFrontiers in Neuroscience | www.frontiersin.org 14 June 2016 | Volume 10 | Article 250\n2012; Liu Q. et al., 2013; Luo et al., 2013; Ruan et al., 2014; Zhang and Yu, in press), although the general excitation wavelength dependence of uorescence emission (Sun et al., 2006; Liu et al., 2007; Qiao et al., 2010; Qu et al., 2012) can lead to artifact when they are used in combination with other luminescent probes. Depending on the synthetic strategy adopted, they already expose on their surface functional groups that allow surface passivation with biocompatible polymers and to graft additional relevant molecules (Li et al., 2010; Liu et al., 2012; Wu et al., 2013). Finally, molecules like anticancer drugs and nucleic acids can be noncovalently loaded on their surface, allowing to use these nanomaterials for delivery purposes (Lai et al., 2012; Liu et al., 2012). Among all the carbon nanomaterials described so far, carbon dots seem to display the highest biocompatibility (Zhao et al., 2008; Yang et al., 2009a,b; Li et al., 2010; Liu etal., 2010; Chandra et al., 2011; Wang Y. et al., 2011; Tao et al., 2012; Qian et al., 2014; Ruan et al., 2014). One important contribution to this e ect seems to be the high density of charged groups on their surface, which provides high stability of their suspensio in water and biological uids.\nSeveral authors report that carbon dots penetrate cell lines when appliedin vitro (Qiao et al., 2010; Liu C. et al., 2011; Wang F. et al., 2011; Yang et al., 2012). No toxicity is observed in various studies conducted on cell lines (Liu R. et al., 2009; Yang et al., 2009b; Wang F. et al., 2011) and on animals (Qiao et al., 2010; Tao et al., 2012). However, a recent report indicates that these nanoparticles could interfere with exocytotic mechanisms, and therefore hamper the normal neuronal and brain functions (Borisova et al., 2015). Since the e ect of CDs on cellular biochemistry has not been completely unraveled, caution should be used when investigating these nanomaterials for possible clinically relevant applications.\nGiven their recent discovery, only few studies have been probing CDs in the CNS in view of a potential use in the diagnosis and therapy of CNS diseases. To date,in vivoevidences fostering the CDs use in this eld derive only from biodistribution studies. Interestingly, the CDs used in these studies exhibit very good BBB crossing capabilities and a strong preference to accumulate in the brain over the other organs although they were not endowed of speci c functionalizations: 100 nm uorescent CDs, preparedvia the inexpensive and e cient pyrolysis of a glucose and glutamic acid mixture, demonstrate to be e ciently uptaken by cerebral tissues afteri.v. administration in mice (Qian et al., 2014). Epi uorescence imaging, made possible thanks to the CDs bright uorescence emission, reveals that they can readily cross the BBB after systemic injection and di use in the brain tissues, where they reach the highest concentration within 1 h.Ex vivoimaging of brain slices indicates that these carbon dots are predominantly accumulating at the cortex surface, in the hippocampus and in the ventricles. Authors hypothesize that the presence of still intact glucose and glutamine molecules on the CDs surface endows the nanoparticles of CNS-targeting capabilities. From the available epi uorescence images, the nanomaterial does not show to di use in other speci c body regions apart from the brain and the blood. Interestingly, the nanomaterial is also rapidly cleared from the CNS.In vitro studies demonstrate that CDs dispersions in plasma have high stability, they have good hemocompatibility\nand they are just moderately cytotoxic for brain endothelial cells only at very high concentrations. In summary the providedin vivodata, although referring only to early timepoints, suggest tha the nanomaterial has an adequate safety pro le for biomedical applications in the CNS.\nAlso 3 4 nm glycine-derived CDs are able to cross very ciently the BBB and accumulate in the brain. Moreover, they\nare able to target a human glioma tumor xenographted in mice brain (Ruan et al., 2014). Epi uorescence imaging indicates that they display a maximum brain uptake just 5 min after the tail vein injection, they strongly localize inside the tumor mass and they are also rapidly cleared. Systemically, they are also distributing in liver, kidneys and hearth (Figure 12). In vitro hemolysis, plasma stability and cytotoxicity studies indicate a very high biocompatibility of this nanomaterial. Although tese CDs display fast and consistent accumulation inside the tumor, their potential use as vectors for delivering antitumor drugs in the CNS is not suggested at the moment because of their fast excretion form the tumor lesion and their accumulation in the heart, which is a known target of anticancer drugs toxicity.\nDespite their fast elimination from brain tissues, CDs represent an excellent starting point for the development of novel diagnostic and therapeutic systems against CNS pathologies thanks to their spontaneous BBB crossing capabilities, which seem not to depend from the nanomaterial size. Moreover, these nanomaterials are in the very early stages of development for biomedical applications: opportune chemical modi cations with molecules able to increase their plasma circulation time and/or with targeting moieties will be able to improve their retention in the brain and to allow this way to exploit them for applications like tumor therapy. A deep toxicological evaluation of their e ects in the CNS in particular but also in the whole body however must be undertaken since current data, albeit very promising, are not su cient to draw clear conclusions.\nCONCLUSIONS AND PERSPECTIVES\nCarbon nanomaterials are often proposed as optimal candidates for neurobiomedical applications because of their properties which include low toxicity, high mechanical strength, high thermal and electric conductivity, and, in some cases, intrinsic uorescence. The collection of studies and results presented in this review also demonstrates that these materials can interfac with cerebral tissues, and that they can perform imaging, neuronal growth, neuroprotection and drug delivery tasks with high e ciency. Moreover, the wide variety of available carbon nanomaterials o ers numerous possibilities for tailor-made actions and performances within the CNS (Table 1).\nCarbon nanotubes, amongst carbon nanomaterials, are the most studiedin vivo for possible applications in the diagnosis and cure of brain diseases. CNTs display good compatibility with brain tissues, neuroprotective e ects against stroke-induced neurodegeneration, drug and nucleic acids delivery capabilities as well as support capabilities for neuroregeneration applications. Despite these promising performances, there are still some concerns about their toxicity, which has been shown to depend\nFrontiers in Neuroscience | www.frontiersin.org 15 June 2016 | Volume 10 | Article 250\nFIGURE 12 | In vivo and ex vivo imaging of glioma bearing mice after administration of 3 4 nm glyc ine-derived CDs. (A) Epi uorescence imaging of CDs distribution after i.v. injection, showing the rapid accumulation inside the glioma and the fast excretion of the nanoparticles after few hours. (B) 3-D reconstruction of CDs distribution 2 h after the injection, con rming the localization in the brain.(C) Ex vivo uorescence imaging of main organs 2 h after CDs injection, indicating high accumulation in liver and kidney but also a good retention inside the glioma. Reproduced fromRuan et al. (2014)with permission from The Royal Society of Chemistry.\nmostly on the CNTs administration site, on their agglomeration state and on the presence of metal impurities in the material. The studies reported in this review indicate that CNTs seldom show toxicity toward brain tissues, probably thanks to the high purity and high dispersibility of the nanomaterials used. To date, th biggest impairment to the CNTs implementation in the therapy of CNS diseases is represented by the elimination of the catalyst metal nanoparticles, which requires the use of several procedures that hamper a cost-e ective, large-scale production of high purity material.\nFullerenes have also shown good potential to nd applications in the CNS, given their BBB crossing capabilities. The focus on their applications in the CNS however has been predominantly directed to exploit their intrinsic neuroprotective behavior, while other applications like drug delivery and imaging have been rarely investigated. Despite fullerenes can be synthesizedin large quantities and at relatively low costs, their toxicity, whic s more evident in water-soluble derivatives (i.e., the most appealing for the integration into a drug product) than in unfunctionalized fullerenes, represents a serious obstacle and currently limits their practical use in therapy.\nGraphene oxide and derivatives can be successfully applied in the CNS for imaging applications by exploiting their intrinsic NIR uorescence or the functionalization with MRI contrast agents. Moreover they can deliver therapeutic drugs and genetic material inside cerebral tumors. On the other hand, they are unable to cross the BBB unless appropriately functionalized or\nwith the help of physical BBB opening methodologies. Although they tend to accumulate in lungs and they persist in the body for a longer time than other carbon nanomaterials, their low-toxicity pro le, especially in the presence of extensive functionalization, makes them possible candidates for future implementations in therapy.\nNanodiamonds have been proposed very recently as suitable nanomaterials for biomedical applications. Indeed, studies of their applicationin vivo are still very limited compared to those available for other carbon nanomaterials. Nevertheless, NDs have already shown promising drug delivery capabilities inside the CNS, which allowed to obtain several improvements in the therapy of a cerebral tumor with doxorubicin. Moreover, NDs have not displayed any alarming toxicity. Although the research on possible diagnostic and therapeutic applications of NDs in the brain is in its infancy, the current results suggest that these nanomaterials may have an important role to play in the future brain medicine.\nCarbon nanohorns and nano bers demonstrate to have strong limitations for their direct application in the CNS: both of them do not show BBB crossing capabilities, and there are strong concerns regarding their toxicity and their strong accumulation in several organs. For these reasons the number of studies inthe CNS conducted over the years is limited. We do not envisage therefore a future for the direct use of these nanomaterials in the therapy of CNS diseases.\nFrontiers in Neuroscience | www.frontiersin.org 16 June 2016 | Volume 10 | Article 250\nTABLE 1 | Comparison of the experimental settings and main featur es of the different carbon nanomaterials.\nCarbon nanomaterial Chemical modi cations\nApplication Animal model Administration route and dose\nIn vivo toxicity References\nSWCNTs 13C enrichedC Tween 80 (1%)\nBiodistribution analysis Mouse i.v. 200mg Moderate (lungs, liver) Yang et al., 2007\nNH2 Neuroprotection MCAO stroke model rat i.c.v. 40 ng No Lee H. J. et al., 2011\nPEG Neuroregeneration Spinal cord injury model rat\nLesion site 0.025 to 2.5 mg No Roman et al., 2011\nPEG Toxicity analysis Rat i.cr. 0.5 1.0mg Yes Dal Bosco et al., 2015\ni.cr. 2.1 mg No\nAcetylcholine Drug delivery Mouse g.i. 25 mg/kg N.a Yang Z. et al., 2010\nPEG oligonucleotide (CpG)\nDrug delivery Glioma-bearing mouse\ni.cr. 7.5mg No Zhao et al., 2011\nMWCNTs PF-127 coating Toxicity assessment Mouse i.cr. 30 150 ng No Bardi et al., 2009\n[111In]DTPA BBB crossing analysis Mouse i.v. 50mg N.a. Kafa et al., 2015\nNHC3 C siRNA Neuroprotection Endothelyn-1 stroke model rat i.cr. 0.5mg No Al-Jamal et al., 2011\nOxidation PEG doxorubicin angiopep-2\nTargeted drug delivery Glioma-bearing mouse\ni.v. 1.9 and 6.3 mg/kg\nCardiac, lower than DOX\nRen et al., 2012\nNHC3 Evaluation of internalization and in ammatory potential\nMouse i.cr. 500 ng Weak transient in . Bardi et al., 2013\nShortentingC oxidationC NHC3\nModerate transient in .\nC60 fullerene Neuroprotection Rat g.i. 3mg/kg/die No Tykhomyrov et al., 2008\nRecovery of neuronal functions\nAb amyloid AD model rat\ni.cr. 5mg No Podolski et al., 2007\nToxicity analysis Rat i.c.v. 0.25 mg/kg Yes (moderate) Yamada et al., 2008\ni.p. 0.25 mg/kg No\nCarboxylic acid (14C-labeling)\nToxicity analysis Rat i.p. 500 mg/kg Yes Yamago et al., 1995\nBiodistribution analysis\ni.v. 0.47 mg/rat (est) No\nTris (malonic acid) (carboxyfullerene)\nNeuroprotection ALS model mouse i.p. (cont.) 15 mg/kg/day\nNo Dugan et al., 1997\nTris (malonic acid) (carboxyfullerene)\nNeuroprotection Fe2C - induced PD model mouse\ni.cr. 3.7mg No Lin et al., 2001\nTris (malonic acid) (carboxyfullerene)\nNeuroprotection MCAO stroke model rat i.c.v. 0.1 mg No Lin et al., 2002\ni.c.v. 0.3 mg Yes (severe)\ni.v. 6 mg/kg No\nTris (malonic acid) (carboxyfullerene)\nNeuroprotection Mouse g.i. 10 mg/kg/day No Quick et al., 2008\nTris (malonic acid) (carboxyfullerene)\nNeuroprotection Mouse i.p. 6 40 mg/kg/day, 3 day adm. No Tsao et al., 1999\nTris (malonic acid) (carboxyfullerene)\nRecovery of neuronal functions\nMPTP-induced PD model monkey\ni.p, s.c. (cont.) 3 mg/kg/day\nLow Dugan et al., 2014\nHexa (sodium butylsulfonate)\nNeuroprotection MCAO stroke model rat i.v. 0.1 100 mg/kg No Huang et al., 2001\nPVP coating Recovery of neuronal functions\nCycloheximide memory impaired rat i.cr. 1.7mg No Podolski et al., 2005\n(Continued)\nFrontiers in Neuroscience | www.frontiersin.org 17 June 2016 | Volume 10 | Article 250\nTABLE 1 | Continued\nCarbon nanomaterial Chemical modi cations\nApplication Animal model Administration route and dose\nIn vivo toxicity References\n(OH)24 (fullerenol) Neuroprotection MCAO stroke model normotensive and hypertensive rats i.v. 0.5 mg/kg No Fluri et al., 2015\ni.v. 1.0 2.0 mg/kg Yes (severe)\n(OH)24 (fullerenol) C glucosamine Neuroprotection MCAO stroke model normotensive and hypertensive rats 5 mg/kg (eq to 0.5 mg/kg fullerenol)\nNo\n(OH)24 (fullerenol) Toxicity analysis Rat i.c.v. 0.25 mg/kg Yes (sev re) Yamada et al., 2010\nAmantadine Recovery of neuronal functions\nHaloperidol-induced PD model rat i.p. 10 mg/kg No Nakazono et al., 2004\nGd@C82 fullrene\nGd3C endohedral (OH)n\nTumor imaging Glioma-bearing rat i.v. 9.7 mg/kg No Shevtsov et al., 2014\ni.v 12.5 mg/kg Yes\nGO 188Re-labeled Biodistribution analysis Mouse i.v. 1 10 mg/kg No Zhang X. et al., 2011\nBiocompatibility analysis Mouse i.v. 100mg No Qu et al., 2013\nTween 80 coating i.v. 200mg No\nDextran coating Biocompatibility analysis Mouse i.v.< 125 mg/kg No Kanakia et al., 2014\ni.v. 125 mg/kg Yes (low)\nPEG Imaging Mouse i.cr. 40 ng No Qian et al., 2012\nPEGC Fe3O4 NPs Cepirubicin Targeted drug delivery Mouse i.v.C LFUS 0.5mg No Yang H.-W. et al., 2013\nGd-DTPAC PAMAM C epirubicynC miRNA (Let-7)\nImaging drug delivery gene delivery\nMouse i.v. dose n.a. No Yang H.-W. et al., 2014\nPEGC transferrin C doxorubicin\nTargeted drug delivery Glioma-bearing rat i.v. 5.6 mg/kg No Liu G. et al., 2013\nPEGC Tat-peptide C perfenidone Drug delivery Subarachnoid hemorrhage model mouse\ni.c.v. 20 mg. No Yang et al., 2015\nNDs Doxorubicin Drug delivery Glioma-bearing mouse\ni.cr. 30mg No Xi et al., 2014\nToxicity analysis Mouse i.cr. 1mg No Huang et al., 2014\nSWCNHs QDsC Gd3N@C80 Imaging Glioma-bearing mouse\ni.cr. dose n.a. No Zhang et al., 2010c\nCNFs Impregnated with stem cells\nNeuroregeneration MCAO stroke model rat i.cr. dose n.a. No Moon et al., 2012\nGraphitizedC impregnated with stem cells\ni.cr dose n.a. No\nCDs Imaging Mice i.v. 100 mg/kg No Qian et al., 2014\nImaging Glioma-bearing mouse\ni.v. 100 mg/kg No Ruan et al., 2014\ng.i., gastrointestinal; i.cr., intracranial; i.p., intraperitoneal; i.v., intravenous; i.c.v., intraventricular; s.c., subcutaneous.\nCarbon dots are the latter discovered materials that have been examined for their possible implementation in the diagnosis and therapy of CNS diseases. For this reason, drug delivery or neuroprotection applications have not been evaluatedin vivo yet. Nevertheless, biodistribution data indicate that carbon dots can cross the BBB very e ciently, and have a low retention in the body. Furthermore, there are only little evidences indicating their possible toxicity, which in any case seems to be very mild. Along with NDs, CDs therefore represent a very promising family of nanomaterials for future applications in brain diseass\nFrontiers in Neuroscience | www.frontiersin.org 18 June 2016 | Volume 10 | Article 250\ntherapy and diagnosis. One current drawback is related to thefact that large-scale industrial production is still not technologically possible, even though the synthesis is relatively easy and cheap on a laboratory scale.\nAs highlighted in this review, research on carbon nanomaterials for brain-related applications is very active, and is taking full advantage of a combination of a broad spectrum of nanomaterials di ering in their shape and properties and of a wealth of functional molecules that can provide them with additional tailored features.In vivo studies in the CNS represent a springboard for the implementation of carbon nanomaterials in the diagnosis and treatment of brain diseases. With this in mind, the studies herein presented o er an intriguing glimpse of what the continuous advancements in carbon nanomaterials technology will be able to provide in the near future. The number of di erent carbon nanostructures employed in brain research has increased dramatically in the last few years, yet there are some carbon nanomaterials that have not been investigated in this context already. Also, the success of NDs and CDs for biomedical applications indicates a higher potential for spherical carbon nanoparticles, both in\nterms of biocompatibility and e ciency in cell penetration. In this sense carbon nano-onions, which have been recently tested for possible biomedical use, have the potential to contribute positively to neurobiomedical applications. We are con dent that in the near future the knowledge acquired on the di erent carbon nanomaterials features and on their toxicology, alongside with the progress made in maximizing their performancesin vivo, will allow these nanomaterials to assume an important role in the diagnosis and treatment of brain diseases.\nAUTHOR CONTRIBUTIONS\nSG and RT conceived the work. MB and MT performed the bibliographical search and drafted the manuscript. All authors contributed to the critical revision of the manuscript.\nACKNOWLEDGMENTS\nI tituto Italiano di Tecnologia (IIT) is greatly acknowledged for funding.\nREFERENCES\nAdelene Nisha, J., Yudasaka, M., Bandow, S., Kokai, F., Takahashi, K., and Iijima, S. (2000). Adsorption and catalytic properties of single-wall carbonnanohorns. Chem. Phys. Lett.328, 381 386. doi: 10.1016/S0009-2614(00)00956-8 Ajima, K., Yudasaka, M., Murakami, T., MaignØ, A., Shiba, K., and Iijima, S. (2005). Carbon nanohorns as anticancer drug carriers.Mol. Pharm.2, 475 480. doi: 10.1021/mp0500566 Ajima, K., Murakami, T., Mizoguchi, Y., Tsuchida, K., Ichihashi, T., Iijima, S., et al. (2008). Enhancement ofin vivo anticancer e ects of cisplatin by incorporation inside single-wall carbon nanohorns.ACS Nano2, 2057 2064. doi: 10.1021/nn800395t Akhavan, O., and Ghaderi, E. (2013). Di erentiation of human neural stem cells into neural networks on graphene nanogrids.J. Mater. Chem. B1, 6291. doi: 10.1039/c3tb21085e Ali-Boucetta, H., Nunes, A., Sainz, R., Herrero, M. A., Tian, B., Prato, M., et al. (2013). Asbestos-like pathogenicity of long carbon nanotubes alleviated by chemical functionalization.Angew. Chemie Int. Ed.52, 2274 2278. doi: 10.1002/anie.201207664 Al-Jamal, K. T., Toma, F. M., Yilmazer, A., Ali-Boucetta, H., Nunes, A., Herrero, M.-A., Tian, B., et al. (2010). Enhanced cellular internalizationand gene silencing with a series of cationic dendron-multiwalled carbon nanotube:siRNA complexes.FASEB J.24, 4354 4365. doi: 10.1096/fj.09-141036 Al-Jamal, K. T., Gherardini, L., Bardi, G., Nunes, A., Guo, C., Bussy, C., et al. (2011). Functional motor recovery from brain ischemic insult by carbon nanotube-mediated siRNA silencing.Proc. Natl. Acad. Sci. U.S.A.108, 10952 10957. doi: 10.1073/pnas.1100930108 Andón, F. T., Kapralov, A. A., Yanamala, N., Feng, W., Baygan, A., Chambers, B. J., et al. (2013). Biodegradation of single-walled carbon nanotubesby eosinophil peroxidase.Small9, 2720 2729. doi: 10.1002/smll.201202508 Andrews, R., Jacques, D., Qian, D., and Rantell, T. (2002). Multiwall Carbon Nanotubes: Synthesis and Application.Acc. Chem. Res.35, 1008 1017. doi: 10.1021/ar010151m Aschberger, K., Johnston, H. J., Stone, V., Aitken, R. J., Tran, C. L., Hankin, S. M., et al. (2010). Review of fullerene toxicity and exposure Appraisal ofhuman health risk assessment, based on open literature.Regul. Toxicol. Pharmacol.58, 455 473. doi: 10.1016/j.yrtph.2010.08.017 de Asis, E. D., Nguyen-Vu, T. D. B., Arumugam, P. U., Chen, H., Cassell, A. M., Andrews, R. J., et al. (2009). High e cient electrical stimulation of hippocampal\nslices with vertically aligned carbon nano ber microbrush array.Biomed. Microdevices11, 801 808. doi: 10.1007/s10544-009-9295-7\nBaena, J. R., Gallego, M., and ValcÆrcel, M. (2002). Fullerenes in tha alytical sciences.TrAC Trends Anal. Chem.21, 187 198. doi: 10.1016/S01659936(02)00306-0 Baker, S. E., Tse, K.-Y., Lee, C.-S., and Hamers, R. J. (2006).Fabrication and characterization of vertically aligned carbon nano ber electrodes for biosensing applications.Diam. Relat. Mater. 15, 433 439. doi: 10.1016/j.diamond.2005.08.019 Baker, S. N., and Baker, G. A. (2010). Luminescent carbon nanodots: emergent nanolights.Angew. Chemie Int. Ed.49, 6726 6744. doi: 10.1002/anie.2009 06623 Bakry, R., Vallant, R. M., Najam-ul-Haq, M., Rainer, M., Szabo, Z., Huck, C. W., et al. (2007). Medicinal applications of fullerenes.Int J. Nanomed.2, 639 649. Bardi, G., Tognini, P., Ciofani, G., Ra a, V., Costa, M., and Pizzorusso, T. (2009). Pluronic-coated carbon nanotubes do not induce degeneration of cortical neuronsin vivoand in vitro. Nanomed. Nanotechnol. Biol. Med.5, 96 104. doi: 10.1016/j.nano.2008.06.008 Bardi, G., Nunes, A., Gherardini, L., Bates, K., Al-Jamal, K. T., Gaillard, C., et al. (2013). Functionalized carbon nanotubes in the brain: cellular internalization and neuroin ammatory responses.PLoS ONE8:e80964. doi: 10.1371/journal.pone.0080964 Bartelmess, J., Baldrighi, M., Nardone, V., Parisini, E., Buck, D.,Echegoyen, L., et al. (2015c). Synthesis and characterization of far-red/NIR- uorescent BODIPY dyes, solid-state uorescence, and application as uorescent tags attached to carbon nano-onions.Chem. A Eur. J.21, 9727 9732. doi: 10.1002/chem.201500877 Bartelmess, J., Frasconi, M., Balakrishnan, P. B., Signorelli, A., Echegoyen, L., Pellegrino, T., et al. (2015b). Non-covalent functionalization of carbon nanoonions with pyrene BODIPY dyads for biological imaging.RSC Adv.5, 50253 50258. doi: 10.1039/C5RA07683H Bartelmess, J., De Luca, E., Signorelli, A., Baldrighi, M., Becce, M., Brescia, R., et al. (2014). Boron dipyrromethene (BODIPY) functionalized carbon nanoonions for high resolution cellular imaging.Nanoscale6, 13761 13769. doi: 10.1039/C4NR04533E Bartelmess, J., Quinn, S. J., and Giordani, S. (2015a). Carbon nan materials: multifunctional agents for biomedical uorescence and Raman imaging. Chem. Soc. Rev.44, 4672 4698. doi: 10.1039/C4CS00306C\nFrontiers in Neuroscience | www.frontiersin.org 19 June 2016 | Volume 10 | Article 250\nBates, K., and Kostarelos, K. (2013). Carbon nanotubes as vectors for gene therapy: past achievements, present challenges and future goals.Adv. Drug Deliv. Rev. 65, 2023 2033. doi: 10.1016/j.addr.2013.10.003 Battigelli, A., MØnard-Moyon, C., Da Ros, T., Prato, M., and Bianco, A. (2013a). Endowing carbon nanotubes with biological and biomedical properties by chemical modi cations.Adv. Drug Deliv. Rev.65, 1899 1920. doi: 10.1016/j.addr.2013.07.006 Battigelli, A., Wang, J. T.-W., Russier, J., Da Ros, T., Kostarelos, K., Al-Jamal, K. T., et al. (2013b). Ammonium and guanidinium dendron-carbon nanotubes by amidation and click chemistry and their use for siRNA Delivery.Small9, 3610 3619. doi: 10.1002/smll.201300264 Bekyarova, E., Murata, K., Yudasaka, M., Kasuya, D., Iijima, S., Tanaka, H., et al. (2003). Single-wall nanostructured carbon for methane storage.J. Phys. Chem. B107, 4681 4684. doi: 10.1021/jp0278263 Bhattacharya, K., Sacchetti, C., El-Sayed, R., Fornara, A., Kotchey, G. P., Gaugler, J., et al. (2014). Enzymatic stripping and degradation of PEGylated carbon nanotubes.Nanoscale6, 14686 14690. doi: 10.1039/c4nr03604b Bianco, A., Kostarelos, K., Partidos, C. D., and Prato, M. (2005b). Biomedical applications of functionalised carbon nanotubes.Chem. Commun.571 577. doi: 10.1039/b410943k Bianco, A., Kostarelos, K., and Prato, M. (2005a). Applications ofcarbon nanotubes in drug delivery.Curr. Opin. Chem. Biol.9, 674 679. doi: 10.1016/j.cbpa.2005.10.005 Bisaglia, M., Natalini, B., Pellicciari, R., Straface, E., Malorni,W., Monti, C., et al. (2000). C3-Fullero-tris-methanodicarboxylic acid protects cerebellar granule cells from apoptosis.J. Neurochem.74, 1197 1204. doi: 10.1046/j.14714159.2000.741197.x Borisova, T., Nazarova, A., Dekaliuk, M., Krisanova, N., Pozdnyakova, N., Borysov, A., et al. (2015). Neuromodulatory properties of uorescent carbon dots: e ect on exocytotic release, uptake and ambient level of glutamate and GABA in brain nerve terminals.Int. J. Biochem. Cell Biol.59, 203 215. doi: 10.1016/j.biocel.2014.11.016 Brabec, C. J., Gowrisanker, S., Halls, J. J. M., Laird, D., Jia, S.,and Williams, S. P. (2010). Polymer-fullerene bulk-heterojunction solar cells.Adv. Mater.22, 3839 3856. doi: 10.1002/adma.200903697 Briscoe, J., Marinovic, A., Sevilla, M., Dunn, S., and Titirici, M. (2015). Biomass-derived carbon quantum dot sensitizers for solid-state n nostructured solar cells.Angew. Chemie Int. Ed.54, 4463 4468. doi: 10.1002/anie.2014 09290 Bussy, C., Al-Jamal, K. T., Boczkowski, J., Lanone, S., Prato, M., Bianco, A., et al. (2015). Microglia determine brain region-speci c neurotoxic responses to chemically functionalized carbon nanotubes.ACS Nano9, 7815 7830. doi: 10.1021/acsnano.5b02358 Bussy, C., Hadad, C., Prato, M., Bianco, A., and Kostarelos, K. (2016). Intracellular degradation of chemically functionalized carbon nanotubes using a long-term primary microglial culture model.Nanoscale590 601. doi: 10.1039/c5nr06625e Cao, J., Wang, Q., and Dai, H. (2003). Electromechanical properties of metallic, quasimetallic, and semiconducting carbon nanotubes under stretching.Phys. Rev. Lett.90, 157601. doi: 10.1103/PhysRevLett.90.157601 Cao, L., Yang, S.-T., Wang, X., Luo, P. G., Liu, J.-H., Sahu, S.,et al. (2012). Competitive performance of carbon quantum dots in optical bioimagin . Theranostics2, 295 301. doi: 10.7150/thno.3912 Cao, L., Meziani, M. J., Sahu, S., and Sun, Y.-P. (2013). Photoluminescence properties of graphene versus other carbon nanomaterials.Acc. Chem. Res.46, 171 180. doi: 10.1021/ar300128j Cassell, A. M., Raymakers, J. A., Kong, J., and Dai, H. (1999). Large scale CVD synthesis of single-walled carbon nanotubes.J. Phys. Chem. B103, 6484 6492. doi: 10.1021/jp990957s Castranova, V., Schulte, P. A., and Zumwalde, R. D. (2013). Occupational nanosafety considerations for carbon nanotubes and carbon nano bers.Acc. Chem. Res.46, 642 649. doi: 10.1021/ar300004a Cellot, G., Cilia, E., Cipollone, S., Rancic, V., Sucapane, A., Giordani, S., Gambazzi, L., Markram, H., Grandolfo, M., Scaini, D., et al. (2009). Carbon nanotubes might improve neuronal performance by favouring electrical shortcuts.Nat. Nanotechnol.4, 126 133. doi: 10.1038/nnano.2008.374 Cellot, G., Ballerini, L., Prato, M., and Bianco, A. (2010). Neuronsare able to internalize soluble carbon nanotubes: new opportunities or old risks?Small6, 2630 2633. doi: 10.1002/smll.201000906 Cellot, G., Toma, F. M., Kasap Varley, Z., Laishram, J., Villari, A., Quintana, M., et al. (2011). Carbon nanotube sca olds tune synaptic strength in cultured neural circuits: novel frontiers in nanomaterial-tissue interactions.J. Neurosci. 31, 12945 12953. doi: 10.1523/JNEUROSCI.1332-11.2011 Chandra, S., Das, P., Bag, S., Laha, D., and Pramanik, P. (2011).Synthesis, functionalization and bioimaging applications of highly uorescent carbon nanoparticles.Nanoscale3, 1533. doi: 10.1039/c0nr00735h Chang, Y.-R., Lee, H.-Y., Chen, K., Chang, C.-C., Tsai, D.-S., Fu, C.-C., et al. (2008). Mass production and dynamic imaging of uorescent nanodiamonds. Nat. Nanotechnol.3, 284 288. doi: 10.1038/nnano.2008.99 Chao, T.-I., Xiang, S., Chen, C.-S., Chin, W.-C., Nelson, A. J., Wang, C., et al. (2009). Carbon nanotubes promote neuron di erentiation fromhuman embryonic stem cells.Biochem. Biophys. Res. Commun.384, 426 430. doi: 10.1016/j.bbrc.2009.04.157 Chen, M., Zhang, X.-Q., Man, H. B., Lam, R., Chow, E. K., and Ho, D. (2010). Nanodiamond vectors functionalized with polyethylenimi e for siRNA delivery. J. Phys. Chem. Lett.1, 3167 3171. doi: 10.1021/jz10 13278 Chen, C. H., Lin, C. T., Chen, J. J., Hsu, W. L., Chang, Y. C., YehS. R., et al. (2011). A graphene-based microelectrode for recording neural signals, in 2011 16th International Solid-State Sensors, Actuators and Microsystems Conference (IEEE), 1883 1886. doi: 10.1109/TRANSDUCERS.2011.5969794 Chen, Z., Ma, L., Liu, Y., and Chen, C. (2012). Applications of functionalized fullerenes in tumor theranostics. Theranostics 2, 238 250. doi: 10.7150/thno.3509 Chen, D., Wang, C., Jiang, F., Liu, Z., Shu, C., and Wan, L.-J.(2014). In vitro and in vivo photothermally enhanced chemotherapy by single-walled carbon nanohorns as a drug delivery system.J. Mater. Chem. B2, 4726. doi: 10.1039/c4tb00249k Cheung, W., Pontoriero, F., Taratula, O., Chen, A. M., and He, H. (2010). DNA and carbon nanotubes as medicine.Adv. Drug Deliv. Rev.62, 633 649. doi: 10.1016/j.addr.2010.03.007 Chng, E. L. K., Sofer, Z., and Pumera, M. (2014). Cytotoxicity pro le of highly hydrogenated graphene.Chem. A Eur. J.20, 6366 6373. doi: 10.1002/chem.201304911 Chung, C., Kim, Y.-K., Shin, D., Ryoo, S.-R., Hong, B. H., and Min, D.-H. (2013). Biomedical applications of graphene and graphene oxide.Acc Chem. Res.46, 2211 2224. doi: 10.1021/ar300159f Chwalibog, A., Sawosz, E., Jaworski, S., Kutwin, M., Hotowy, A., Wierzbicki, M., et al. (2014). Toxicity of pristine graphene in experiments in a chicken embryo model.Int. J. Nanomedicine9, 3913. doi: 10.2147/IJN.S65633 Cio , C., Campidelli, S., Sooambar, C., Marcaccio, M., Marcolongo, G., Meneghetti, M., et al. (2007). Synthesis, Characterization, and Photoinduced Electron Transfer in Functionalized Single Wall Carbon Nanohorns.J. Am. Chem. Soc.129, 3938 3945. doi: 10.1021/ja068007p Dai, H. (2002). Carbon nanotubes: synthesis, integration, and properties.Acc. Chem. Res.35, 1035 1044. doi: 10.1021/ar0101640 Dal Bosco, L., Weber, G. E. B., Par tt, G. M., Paese, K., Gonçalves, C. O. F., Serodre, T. M., et al. (2015). PEGylated carbon nanotubes impair retrieval of contextual fear memory and alter oxidative stress parameters in the rat hippocampus. Biomed Res. Int.2015, 1 11. doi: 10.1155/2015/104135 David-Pur, M., Bareket-Keren, L., Beit-Yaakov, G., Raz-Prag,D., and Hanein, Y. (2014). All-carbon-nanotube exible multi-electrode array for neuronal recording and stimulation.Biomed. Microdevices16, 43 53. doi: 10.1007/s10544-013-9804-6 De Jong, W. H., and Geus, J. W. (2000). Carbon nano bers: catalytic synthesis and applications.Catal. Rev.42, 481 510. doi: 10.1081/CR-100101954 De Volder, M. F. L., Taw ck, S. H., Baughman, R. H., and Hart, a J. (2013). Carbon nanotubes: present and future commercial applications.Science339, 535 539. doi: 10.1126/science.1222453 Dhawan, A., Taurozzi, J. S., Pandey, A. K., Shan, W., Miller, S. M., Hashsham, S., et al. (2006). Stable colloidal dispersions of C 60 fullerenes in water: evidence for genotoxicity . Environ. Sci. Technol.40, 7394 7401. doi: 10.1021/es06 09708 Duan, X., Ji, J., Qian, G., Zhou, X., and Chen, D. (2015). Recentadvances in synthesis of reshaped Fe and Ni particles at the tips of carbon nano bers and their catalytic applications.Catal. Today249, 2 11. doi: 10.1016/j.cattod.2014.11.018\nFrontiers in Neuroscience | www.frontiersin.org 20 June 2016 | Volume 10 | Article 250\nDubin, R. A., Callegari, G. C., Kohn, J., and Neimark, A. V. (2008).Carbon nanotube bers are compatible with mammalian cells and neurons.IEEE Trans. Nanobiosci.7, 11 14. doi: 10.1109/TNB.2008.2000144 Dugan, L. L., Gabrielsen, J. K., Yu, S. P., Lin, T.-S., and Choi,D. W. (1996). Buckminsterfullerenol free radical scavengers reduce excitoto ic and apoptotic death of cultured cortical neurons.Neurobiol. Dis.3, 129 135. doi: 10.1006/nbdi.1996.0013 Dugan, L. L., Turetsky, D. M., Du, C., Lobner, D., Wheeler, M., Almli, C. R., et al. (1997). Carboxyfullerenes as neuroprotective agents.Proc Natl. Acad. Sci. U.S.A.94, 9434 9439. doi: 10.1073/pnas.94.17.9434 Dugan, L. L., Lovett, E. G., Quick, K. L., Lotharius, J., Lin, T. T., and O’Malley, K. L. (2001). Fullerene-based antioxidants and neurodegenerativ disorders. Parkinsonism Relat. Disord.7, 243 246. doi: 10.1016/S1353-8020(00)00064-X Dugan, L. L., Tian, L., Quick, K. L., Hardt, J. I., Karimi, M., Brown, C., et al. (2014). Carboxyfullerene neuroprotection postinjury in Parkinsonian nonhuman primates.Ann. Neurol.76, 393 402. doi: 10.1002/ana.24220 Edgington, R. J., Thalhammer, A., Welch, J. O., Bongrain, A., Bergonzo, P., Scorsone, E., et al. (2013). Patterned neuronal networks using na odiamonds and the e ect of varying nanodiamond properties on neuronal adhesion and outgrowth.J. Neural Eng.10:056022. doi: 10.1088/1741-2560/10/5/056022 Elgrabli, D., Dachraoui, W., MØnard-Moyon, C., Liu, X. J., BØgin, D., BØginColin, S., et al. (2015). Carbon nanotube degradation in macrophages: live nanoscale monitoring and understanding of biological pathway.ACS Nano9, 10113 10124. doi: 10.1021/acsnano.5b03708 Fabbro, C., Ali-Boucetta, H., Ros, T., Da Kostarelos, K., Bianco,A., and Prato, M. (2012). Targeting carbon nanotubes against cancer.Chem. Commun.48, 3911. doi: 10.1039/c2cc17995d Fabbro, A., Villari, A., Laishram, J., Scaini, D., Toma, F. M., Turco, A., et al. (2012). Spinal cord explants use carbon nanotube interfaces to enhance neurite outgrowth and to fortify synaptic inputs.ACS Nano6, 2041 2055. doi: 10.1021/nn203519r Fabbro, A., Sucapane, A., Toma, F. M., Calura, E., Rizzetto, L., Carrieri, C., Roncaglia, P., Martinelli, V., Scaini, D., Masten, L., et al. (2013). Adhesion to carbon nanotube conductive sca olds forces action-potential appearance in immature rat spinal neurons.PLoS ONE8:e73621. doi: 10.1371/journal.pone.0073621 Fabbro, A., Scaini, D., León, V., VÆzquez, E., Cellot, G., Privitera, G., et al. (2016). Graphene-based interfaces do not alter target nerve cells. ACS Nano 10, 615 623. doi: 10.1021/acsnano.5b05647 Farrera, C., Bhattacharya, K., Lazzaretto, B., Andón, F. T., Hultenby, K., Kotchey, G. P., et al. (2014). Extracellular entrapment and degradation of single-walled carbon nanotubes.Nanoscale6, 6974 6983. doi: 10.1039/c3nr06047k Fernando, K. A. S., Sahu, S., Liu, Y., Lewis, W. K., Guliants, E.a., Jafariyan, A., et al. (2015). Carbon quantum dots and applications in photocatalytic energy conversion.ACS Appl. Mater. Interfaces7, 8363 8376. doi: 10.1021/acsami.5b00448 Fluri, F., Grünstein, D., Cam, E., Ungethuem, U., Hatz, F., Schäfer,J., et al. (2015). Fullerenols and glucosamine fullerenes reduce infarct volume and cerebral in ammation after ischemic stroke in normotensive and hypertensiverats.Exp. Neurol.265, 142 151. doi: 10.1016/j.expneurol.2015.01.005 Frasconi, M., Ma eis, V., Bartelmess, J., Echegoyen, L., and Giordani, S. (2015a). Highly surface functionalized carbon nano-onions for bright light bioimaging. Methods Appl. Fluoresc.3:044005. doi: 10.1088/2050-6120/3/4/044005 Frasconi, M., Marotta, R., Markey, L., Flavin, K., Spampinato, V., Ceccone, G., et al. (2015b). Multi-functionalized carbon nano-onions as imaging probes for cancer cells.Chem. A Eur. J.21, 19071 19080. doi: 10.1002/chem.201503166 Freitas, R., A. (2005). What is nanomedicine?Nanomed. Nanotechnol. Biol. Med. 1, 2 9. doi: 10.1016/j.nano.2004.11.003 Fu, C.-C., Lee, H.-Y., Chen, K., Lim, T.-S., Wu, H.-Y., Lin, P.-K., et al. (2007). Characterization and application of single uorescent nanodiamonds as cellular biomarkers.Proc. Natl. Acad. Sci. U. S. A.104, 727 732. doi: 10.1073/pnas.0605409104 Fu, Y., An, N., Zheng, S., Liang, A., and Li, Y. (2012). BmK CT-conjugated uorescence nanodiamond as potential glioma-targeted imaging and drug. Diam. Relat. Mater.21, 73 76. doi: 10.1016/j.diamond.2011.10.010 Gabay, T., Jakobs, E., Ben-Jacob, E., and Hanein, Y. (2005).Engineered selforganization of neural networks using carbon nanotube clusters.Phys. A Stat. Mech. its Appl.350, 611 621. doi: 10.1016/j.physa.2004.11.007 Gadd, G. E., Evans, P. J., Kennedy, S., James, M., Elcombe, M., Cassidy, D., Moricca, S., Holmes, J., Webb, N., Dixon, A., et al. (1999). Gas Storage in Fullerenes.Fuller. Sci. Technol.7, 1043 1143. doi: 10.1080/106412299093 50304 Gaillard, C., Cellot, G., Li, S., Toma, F. M., Dumortier, H., Spalluto, G., et al. (2009). Carbon nanotubes carrying cell-adhesion peptides donot interfere with neuronal functionality.Adv. Mater. 21, 2903 2908. doi: 10.1002/adma.200900050 Galli, G. (2010). Structure, stability and electronic properties of nanodiamonds, in Computer-Based Modeling of Novel Carbon Systems and Their Properties Carbon Materials: Chemistry and Physics, eds L. Colombo and A. Fasolino (Dordrecht: Springer), 37 57. doi: 10.1007/978-1-4020-9718-8 Gheith, M. K., Sinani, V. A., Wicksted, J. P., Matts, R. L., and Kotov, N. A. (2005). Single-walled carbon nanotube polyelectrolyte multilayers and freestanding lms as a biocompatible platform for neuroprosthetic implants.Adv. Mater. 17, 2663 2670. doi: 10.1002/adma.200500366 Gheith, M. K., Pappas, T. C., Liopo, A. V., Sinani, V. A., Shim, B. S., Motamedi, M., et al. (2006). Stimulation of neural cells by lateral currents in conductive layerby-layer lms of single-walled carbon nanotubes.Adv. Mater.18, 2975 2979. doi: 10.1002/adma.200600878 Ghosh, M., Sonkar, S. K., Saxena, M., and Sarkar, S. (2011). Carbon nano-onions for imaging the life cycle of Drosophila melanogaster.Small7, 3170 3177. doi: 10.1002/smll.201101158 Giordani, S., Bartelmess, J., Frasconi, M., Biondi, I., Cheung, S., Grossi, M., et al. (2014). NIR uorescence labelled carbon nano-onions: synthesis, analysis and cellular imaging.J. Mater. Chem. B2, 7459 7463. doi: 10.1039/C4TB01087F Goenka, S., Sant, V., and Sant, S. (2014). Graphene-based nanomaterials for drug delivery and tissue engineering.J Control. Release173, 75 88. doi: 10.1016/j.jconrel.2013.10.017 Gollavelli, G., and Ling, Y.-C. (2012). Multi-functional grapheneas an in vitro and in vivo imaging probe. Biomaterials 33, 2532 2545. doi: 10.1016/j.biomaterials.2011.12.010 Gong, H., Peng, R., and Liu, Z. (2013). Carbon nanotubes for bimedical imaging: the recent advances.Adv. Drug Deliv. Rev.65, 1951 1963. doi: 10.1016/j.addr.2013.10.002 Guerra, J., Herrero, M. A., and VÆzquez, E. (2014). Carbon nanohornsas alternative gene delivery vectors.RSC Adv.4, 27315. doi: 10.1039/c4ra03251a Hahn, M., a., Singh, A. K., Sharma, P., Brown, S. C., and Moudgil, B. M. (2011). Nanoparticles as contrast agents forin-vivo bioimaging: current status and future perspectives.Anal. Bioanal. Chem.399, 3 27. doi: 10.1007/s00216-0104207-5 Hammel, E., Tang, X., Trampert, M., Schmitt, T., Mauthner, K., Eder, A., et al. (2004). Carbon nano bers for composite applications.Carbon42, 1153 1158. doi: 10.1016/j.carbon.2003.12.043 Hegyi, A., and Yablonovitch, E. (2013). Molecular imaging by optically detected electron spin resonance of nitrogen-vacancies in nanodiamonds.Nano Lett.13, 1173 1178. doi: 10.1021/nl304570b Hong, H., Zhang, Y., Engle, J. W., Nayak, T. R., Theuer, C. P., Nickles, R. J., et al. (2012).In vivo targeting and positron emission tomography imaging of tumor vasculature with 66Ga-labeled nano-graphene.Biomaterials33, 4147 4156. doi: 10.1016/j.biomaterials.2012.02.031 Hong, S. W., Lee, J. H., Kang, S. H., Hwang, E. Y., Hwang, Y. S., Lee, M. H., et al. (2014). Enhanced neural cell adhesion and neurite outgrow h n graphene-based biomimetic substrates.Biomed Res. Int.2014:212149. doi: 10.1155/2014/212149 Hong, G., Diao, S., Antaris, A. L., and Dai, H. (2015). Carbon nanomaterials for biological imaging and nanomedicinal therapy.Chem. Rev.115, 10816 10906. doi: 10.1021/acs.chemrev.5b00008 Hopper, A. P., Dugan, J. M., Gill, A. A., Fox, O. J. L., May, P. W., Haycock, J. W., et al. (2014). Amine functionalized nanodiamond promotes cellular adhesion, proliferation and neurite outgrowth.Biomed. Mater.9:045009. doi: 10.1088/1748-6041/9/4/045009 Hsu, T.-C., Liu, K.-K., Chang, H.-C., Hwang, E., and Chao, J.-I. (2014). Labeling of neuronal di erentiation and neuron cells with biocompatible uorescent nanodiamonds.Sci. Rep.4:5004. doi: 10.1038/srep05004 Hu, H., Ni, Y., Montana, V., Haddon, R. C., and Parpura, V. (2004). Chemically functionalized carbon nanotubes as substrates for neuronal growth. Nano Lett. 4, 507 511. doi: 10.1021/nl035193d\nFrontiers in Neuroscience | www.frontiersin.org 21 June 2016 | Volume 10 | Article 250\nHu, X., and Zhou, Q. (2013). Health and ecosystem risks of graphene.Chem. Rev. 113, 3815 3835. doi: 10.1021/cr300045n Huang, S. S., Tsai, S. K., Chih, C. L., Chiang, L.-Y., Hsieh, H. M., Teng, C. M., et al. (2001). Neuroprotective e ect of hexasulfobutylated C60 on rats subjected to focal cerebral ischemia.Free Radic. Biol. Med.30, 643 649. doi: 10.1016/S0891-5849(00)00505-0 Huang, J., Liu, Y., and You, T. (2010). Carbon nano ber based el ctrochemical biosensors: a review.Anal. Methods2, 202. doi: 10.1039/b9ay00312f Huang, P. (2011). Folic Acid-conjugated graphene oxide loaded with photosensitizers for targeting photodynamic therapy.Theranostics1:240. doi: 10.7150/thno/v01p0240 Huang, Y.-A., Kao, C.-W., Liu, K.-K., Huang, H.-S., Chiang, M.-H., Soo, C.-R., et al. (2014). The e ect of uorescent nanodiamonds on neuronal survival and morphogenesis.Sci. Rep.4:6919. doi: 10.1038/srep06919 Hui, Y. Y., Cheng, C.-L., and Chang, H.-C. (2010). Nanodiamondsfor optical bioimaging.J. Phys. D. Appl. Phys.43:374021. doi: 10.1088/0022- 3727/43/37/374021 Iijima, S. (1991). Helical microtubules of graphitic carbon.Nature354, 56 58. doi: 10.1038/354056a0 Iijima, S., Yudasaka, M., Yamada, R., Bandow, S., Suenaga, K.,Kokai F., et al. (1999). Nano-aggregates of single-walled graphitic carbon nano-horns.Chem. Phys. Lett.309, 165 170. doi: 10.1016/S0009-2614(99)00642-9 Inagaki, M., Yang, Y., and Kang, F. (2012). Carbon nano bersprepared via electrospinning.Adv. Mater.24, 2547 2566. doi: 10.1002/adma.201104940 Isobe, H., Tanaka, T., Maeda, R., Noiri, E., Solin, N., Yudasaka, M., et al. (2006). Preparation, puri cation, characterization, and cytotoxicity assessment of water-soluble, transition-metal-free carbon nanotube aggregates. Angew. Chemie Int. Ed.45, 6676 6680. doi: 10.1002/anie.200601718 Jan, E., Hendricks, J. L., Husaini, V., Richardson-Burns, S. M., Sereno, A., Martin, D. C., et al. (2009). Layered carbon nanotube-polyelectrolyte electrodes outperform traditional neural interface materials.Nano Lett.9, 4012 4018. doi: 10.1021/nl902187z Jastrzebska, A. M., Kurtycz, P., and Olszyna, A. R. (2012). Recent advances in graphene family materials toxicity investigations.J. Nanoparticle Res.14, 1 21. doi: 10.1007/s11051-012-1320-8 Ji, L., and Zhang, X. (2009). Fabrication of porous carbon nano bers and their application as anode materials for rechargeable lithium-ion batteries. Nanotechnology20, 155705. doi: 10.1088/0957-4484/20/15/155705 Jin, H., Chen, W. Q., Tang, X. W., Chiang, L. Y., Yang, C. Y., Schloss, J. V., et al. (2000). Polyhydroxylated C60, fullerenols, as glutamate receptor antagonists and neuroprotective agents.J Neurosci. Res.62, 600 607. doi: 10.1002/1097- 4547(20001115)62:4< 600::AID-JNR15> 3.0.CO;2-F Jin, G.-Z., Kim, M., Shin, U. S., and Kim, H.-W. (2011). Neurite outgrowth of dorsal root ganglia neurons is enhanced on aligned nano brous biopolymer sca old with carbon nanotube coating.Neurosci. Lett.501, 10 14. doi: 10.1016/j.neulet.2011.06.023 Johnston, H. J., Hutchison, G. R., Christensen, F. M., Aschberger, K., and Stone, V. (2010). The biological mechanisms and physicochemical characteristics responsible for driving fullerene toxicity.Toxicol. Sci.114, 162 182. doi: 10.1093/toxsci/kfp265 Kafa, H., Wang, J. T.-W., Rubio, N., Venner, K., Anderson, G.,Pach, E., et al. (2015). The interaction of carbon nanotubes with anin vitro bloodbrain barrier model and mouse braini vivo. Biomaterials53, 437 452. doi: 10.1016/j.biomaterials.2015.02.083 Kagan, V. E., Kapralov, A. A., St. Croix, C. M., Watkins, S. C., Kisin, E. R., Kotchey, G. P., et al. (2014). Lung macrophages Digest carbon nanotubes using a superoxide/peroxynitrite oxidative pathway.ACS Nano8, 5610 5621. doi: 10.1021/nn406484b Kam, N. W. S., Jan, E., and Kotov, N. A. (2009). Electrical stimulation of neural stem cells mediated by humanized carbon nanotube composite made with extracellular matrix protein.Nano Lett.9, 273 278. doi: 10.1021/nl802859a Kanakia, S., Toussaint, J. D., Mullick Chowdhury, S., Tembulkar,T., Lee, S., Jiang, Y.-P., et al. (2014). Dose ranging, expanded acute toxicity and safety pharmacology studies for intravenously administered functio al zed graphene nanoparticle formulations.Biomaterials 35, 7022 7031. doi: 10.1016/j.biomaterials.2014.04.066 Kateb, B., Van Handel, M., Zhang, L., Bronikowski, M. J., Manohara, H., and Badie, B. (2007). Internalization of MWCNTs by microglia: possible application in immunotherapy of brain tumors.Neuroimage37, S9 S17. doi: 10.1016/j.neuroimage.2007.03.078 Keefer, E. W., Botterman, B. R., Romero, M. I., Rossi, A. F., and Gross, G. W. (2008). Carbon nanotube coating improves neuronal recordings.Nat Nanotechnol.3, 434 439. doi: 10.1038/nnano.2008.174 Kim, H., Namgung, R., Singha, K., Oh, I.-K., and Kim, W. J. (2011). Graphene oxide polyethylenimine nanoconstruct as a gene delivery vector and bioimaging tool.Bioconjug. Chem.22, 2558 2567. doi: 10.1021/bc200397j Kirner, S., Sekita, M., and Guldi, D. M. (2014). 25th anniversary article: 25 years of fullerene research in electron transfer chemistry.Adv. Mater.26, 1482 1493. doi: 10.1002/adma.201304928 Klein, K. L., Melechko, A. V., McKnight, T. E., Retterer, S. T., Rack, P. D., Fowlkes, J. D., et al. (2008). Surface characterization and functionalization of carbon nano bers.J. Appl. Phys.103, 061301. doi: 10.1063/1.2840049 Kolosnjaj, J., Szwarc, H., and Moussa, F. (2007). Toxicity studies of fullerenes and derivatives, inAdvances in Experimental Medicine and Biology, Vol. 620, ed W. C. W. Chan (New York, NY: Springer New York), 168 180. Kosaka, M., Kuroshima, S., Kobayashi, K., Sekino, S., Ichihashi, T., Nakamura, S., et al. (2009). Single-wall carbon nanohorns supporting pt catalyst in direct methanol fuel cells.J. Phys. Chem. C113, 8660 8667. doi: 10.1021/jp8105293 Kotchey, G. P., Hasan, S., a., Kapralov, A., a., Ha, S. H., Kim, K., Shvedova, A., et al. (2012). A natural vanishing act: the enzyme-catalyzed degradation of carbon nanomaterials.Acc. Chem. Res.45, 1770 1781. doi: 10.1021/ar300106h Kotchey, G. P., Zhao, Y., Kagan, V. E., and Star, A. (2013). Peroxidase-mediated biodegradation of carbon nanotubesin vitro and in vivo. Adv. Drug Deliv. Rev. 65, 1921 1932. doi: 10.1016/j.addr.2013.07.007 Ladeira, M. S., Andrade, V. A, Gomes, E. R. M., Aguiar, C. J., Moraes, E. R., Soares, J. S., et al. (2010). Highly e cient siRNA delivery system into human and murine cells using single-wall carbon nanotubes.Nanotechnology21, 385101. doi: 10.1088/0957-4484/21/38/385101 Lai, C.-W., Hsiao, Y.-H., Peng, Y.-K., and Chou, P.-T. (2012). Facile synthesis of highly emissive carbon dots from pyrolysis of glycerol; gram scale production of carbon dots/mSiO2 for cell imaging and drug release.J. Mater. Chem.22, 14403. doi: 10.1039/c2jm32206d Lalwani, G., Cai, X., Nie, L., Wang, L. V., and Sitharaman, B. (2013). Graphenebased contrast agents for photoacoustic and thermoacoustic tomography. Photoacoustics1, 62 67. doi: 10.1016/j.pacs.2013.10.001 Lamberti, M., Pedata, P., Sannolo, N., Porto, S., De Rosa, A., andC raglia, M. (2015). Carbon nanotubes: properties, biomedical applications, advantages and risks in patients and occupationally-exposed workers.Int. J. Immunopathol. Pharmacol.28, 4 13. doi: 10.1177/0394632015572559 Lee, H. J., Park, J., Yoon, O. J., Kim, H. W., Lee, D. Y., Kim, D. H., et al. (2011). Amine-modi ed single-walled carbon nanotubes protect neurons from injury in a rat stroke model.Nat. Nanotechnol.6, 121 125. doi: 10.1038/nnano.2010.281 Lee, W. C., Lim, C. H. Y. X., Shi, H., Tang, L. A. L., Wang, Y., Lim, C. T., et al. (2011). Origin of enhanced stem cell growth and di erentiation ographene and graphene oxide.ACS Nano5, 7334 7341. doi: 10.1021/nn202190c Li, Q., Ohulchanskyy, T. Y., Liu, R., Koynov, K., Wu, D., Best,A., et al. (2010). Photoluminescent carbon dots as biocompatible nanoprobes for targeting cancer cellsin vitro. J. Phys. Chem. C114, 12062 12068. doi: 10.1021/jp911539r Li, N., Zhang, X., Song, Q., Su, R., Zhang, Q., Kong, T., et al. (2011). The promotion of neurite sprouting and outgrowth of mouse hippocampal cells in culture by graphene substrates.Biomaterials32, 9374 9382. doi: 10.1016/j.biomaterials.2011.08.065 Li, J. L., Bao, H. C., Hou, X. L., Sun, L., Wang, X. G., and Gu, M. (2012). Graphene oxide nanoparticles as a nonbleaching optical probe for two-photon luminescence imaging and cell therapy.Angew. Chem. Int. Ed.51, 1830 1834. doi: 10.1002/anie.201106102 Li, M., Yang, X., Ren, J., Qu, K., and Qu, X. (2012). Using grapheneoxid high near-infrared absorbance for photothermal treatment of Alzheimer’sdisease. Adv. Mater.24, 1722 1728. doi: 10.1002/adma.201104864 Li, H., Kang, Z., Liu, Y., and Lee, S.-T. (2012). Carbon nanodots: synthesis, properties and applications.J. Mater. Chem.22, 24230 24253. doi: 10.1039/c2jm34690g Li, N., Zhang, Q., Gao, S., Song, Q., Huang, R., Wang, L., et al. (2013). Threedimensional graphene foam as a biocompatible and conductive sca old for neural stem cells.Sci. Rep.3, 1604. doi: 10.1038/srep01604\nFrontiers in Neuroscience | www.frontiersin.org 22 June 2016 | Volume 10 | Article 250\nLi, J., Ying, G.-G., Jones, K. C., and Martin, F. L. (2015). Real-world carbon nanoparticle exposures induce brain and gonadal alterations in zebra sh (Danio rerio) as determined by biospectroscopy techniques.Analyst 140, 2687 2695. doi: 10.1039/C4AN02227K Li, N., Zhao, Q., Shu, C., Ma, X., Li, R., Shen, H., et al. (2015). Targeted killing of cancer cellsin vivo and in vitro with IGF-IR antibody-directed carbon nanohorns based drug delivery.Int. J. Pharm.478, 644 654. doi: 10.1016/j.ijpharm.2014.12.015 Lim, S. A., and Ahmed, M. U. (2015). A carbon nano ber-based label free immunosensor for high sensitive detection of recombinant bovine somatotropin. Biosens. Bioelectron.70, 48 53. doi: 10.1016/j.bios.2015. 03.022 Lim, S. Y., Shen, W., and Gao, Z. (2015). Carbon quantum dots and their applications.Chem. Soc. Rev.44, 362 381. doi: 10.1039/C4CS00269E Lin, A. M. Y., Chyi, B. Y., Wang, S. D., Yu, H.-H., Kanakamma, P. P.,Luh, T.-Y., et al. (2001). Carboxyfullerene prevents iron-induced oxidative stress in rat brain. J. Neurochem.72, 1634 1640. doi: 10.1046/j.1471-4159.1999.7 21634.x Lin, A. M.-Y., Fang, S.-F., Lin, S.-Z., Chou, C.-K., Luh, T.-Y., and Ho, L.-T. (2002). Local carboxyfullerene protects cortical infarction in rat brain.Neurosci. Res. 43, 317 321. doi: 10.1016/S0168-0102(02)00056-1 Liu, H., Ye, T., and Mao, C. (2007). Fluorescent carbon nanoparticles derived from candle soot.Angew. Chem. Int. Ed.46, 6473 6475. doi: 10.1002/anie.200701271 Liu, K.-K., Chen, M.-F., Chen, P.-Y., Lee, T. J. F., Cheng, C.-L., Chang, C.C., et al. (2008). Alpha-bungarotoxin binding to target cell in a developing visual system by carboxylated nanodiamond.Nanotechnology19, 205102. doi: 10.1088/0957-4484/19/20/205102 Liu, Z., Tabakman, S., Welsher, K., and Dai, H. (2009). Carbon nanotubes in biology and medicine:in vitro andin vivodetection, imaging and drug delivery. Nano Res.2, 85 120. doi: 10.1007/s12274-009-9009-8 Liu, K.-K., Wang, C.-C., Cheng, C.-L., and Chao, J.-I. (2009). Endocytic carboxylated nanodiamond for the labeling and tracking of cell division and di erentiation in cancer and stem cells.Biomaterials30, 4249 4259. doi: 10.1016/j.biomaterials.2009.04.056 Liu, R., Wu, D., Liu, S., Koynov, K., Knoll, W., and Li, Q. (2009). An aqueous route to multicolor photoluminescent carbon dots using silica spheres as carriers. Angew. Chemie Int. Ed.48, 4598 4601. doi: 10.1002/anie.200900652 Liu, J.-H., Anilkumar, P., Cao, L., Wang, X., Yang, S.-T., Luo, P.G., et al. (2010). Cytotoxicity evaluations of uorescent carbon nanoparticles.Nano Life01, 153 161. doi: 10.1142/S1793984410000158 Liu, Z., Yang, K., and Lee, S.-T. (2011). Single-walled carbon nanotubes in biomedical imaging.J. Mater. Chem.21, 586 598. doi: 10.1039/C0JM02020F Liu, C., Zhang, P., Tian, F., Li, W., Li, F., and Liu, W. (2011). One-step synthesis of surface passivated carbon nanodots by microwave assisted pyrolysis for enhanced multicolor photoluminescence and bioimaging.J. Mater. Chem.21, 13163. doi: 10.1039/c1jm12744f Liu, C., Zhang, P., Zhai, X., Tian, F., Li, W., Yang, J., et al. (2012). Nanocarrier for gene delivery and bioimaging based on carbon dots with PEI-passivation enhanced uorescence.Biomaterials 33, 3604 3613. doi: 10.1016/j.biomaterials.2012.01.052 Liu, G., Shen, H., Mao, J., Zhang, L., Jiang, Z., Sun, T., et al. (2013). Transferrin modi ed graphene oxide for glioma-targeted drug delivery:in vitro and in vivo evaluations.ACS Appl. Mater. Interfaces5, 6909 6914. doi: 10.1021/am402128s Liu, Q., Guo, B., Rao, Z., Zhang, B., and Gong, J. R. (2013). Strong twophoton-induced uorescence from photostable, biocompatible nitrogen-doped graphene quantum dots for cellular and deep-tissue imaging.Nano Lett.13, 2436 2441. doi: 10.1021/nl400368v Lodermeyer, F., Costa, R. D., Casillas, R., Kohler, F. T. U., Wasserscheid, P., Prato, M., et al. (2015). Carbon nanohorn-based electrolyte for dye-sensitized solar cells.Energy Environ. Sci.8, 241 246. doi: 10.1039/C4EE02037E Lovat, V., Pantarotto, D., Lagostena, L., Cacciari, B., Grandolfo, M., Righi, M., et al. (2005). Carbon nanotube substrates boost neuronal electrical signaling.Nano Lett.5, 1107 1110. doi: 10.1021/nl050637m Luo, X., Weaver, C. L., Zhou, D. D., Greenberg, R., and Cui, X. T. (2011). Highly stable carbon nanotube doped poly(3,4-ethylenedioxythiophene) for chronic neural stimulation. Biomaterials 32, 5551 5557. doi: 10.1016/j.biomaterials.2011.04.051 Luo, P. G., Sahu, S., Yang, S.-T., Sonkar, S. K., Wang, J., Wang, H., et al. (2013). Carbon quantum dots for optical bioimaging.J. Mater. Chem. B1, 2116. doi: 10.1039/c3tb00018d Lynch, R. M., Voy, B. H., Glass, D. F., Mahurin, S. M., Zhao, B., Hu,H., et al. (2007). Assessing the pulmonary toxicity of single-walled carbon nanohorns. Nanotoxicology1, 157 166. doi: 10.1080/17435390701598496 Ma, X., Shu, C., Guo, J., Pang, L., Su, L., Fu, D., et al. (2014). Targeted cancer therapy based on single-wall carbon nanohorns with doxorubicinn vitro andin vivo. J. Nanoparticle Res.16, 2497. doi: 10.1007/s11051-014-2497-9 Magrez, A., Kasas, S., Salicio, V., Pasquier, N., Seo, J. W., Celio, M., et al. (2006). Cellular toxicity of carbon-based nanomaterials.Nano Lett.6, 1121 1125. doi: 10.1021/nl060162e Matija, L., Tsenkova, R., Mun·can, J., Miyazaki, M., Banba, K., Tomi·c, M., et al. (2013). Fullerene based nanomaterials for biomedical applications: engineering, functionalization and characterization.Adv. Mater. Res.633, 224 238. doi: 10.4028/www.scienti c.net/AMR.633.224 Mattson, M. P., Haddon, R. C., and Rao, A. M. (2000). Molecular fnctionalization of carbon nanotubes and use as substrates for neuronal growth.J. Mol. Neurosci. 14, 175 182. doi: 10.1385/JMN:14:3:175 Mazzatenta, A., Giugliano, M., Campidelli, S., Gambazzi, L., Businaro, L., Markram, H., et al. (2007). Interfacing neurons with carbon nanotubes: electrical signal transfer and synaptic stimulation in cultured brain circuits.J. Neurosci.27, 6931 6936. doi: 10.1523/JNEUROSCI.1051-07.2007 McKnight, T. E., Melechko, A. V., Gri n, G. D., Guillorn, M., a, Merkulov, V. I., Serna, F., et al. (2003). Intracellular integration of synthetic nanostructures with viable cells for controlled biochemical manipulation.Nanotechnology14, 551 556. doi: 10.1088/0957-4484/14/5/313 McKnight, T. E., Melechko, A. V., Fletcher, B. L., Jones, S. W.,Hensley, D. K., Peckys, D. B., et al. (2006). Resident neuroelectrochemical interfacing using carbon nano ber arrays.J. Phys. Chem. B110, 15317 15327. doi: 10.1021/jp056467j Mintmire, J. W., and White, C. T. (1995). Electronic and structuralproperties of carbon nanotubes.Carbon33, 893 902. doi: 10.1016/0008-6223(95)00018-9 Miyawaki, J., Yudasaka, M., Imai, H., Yorimitsu, H., Isobe, H., Nakamura, E., et al. (2006).In vivomagnetic resonance imaging of single-walled carbon nanohorns by labeling with magnetite nanoparticles.Adv. Mater. 18, 1010 1014. doi: 10.1002/adma.200502174 Miyawaki, J., Yudasaka, M., Azami, T., Kubo, Y., and Iijima, S.(2008). Toxicity of single-walled carbon nanohorns.ACS Nano2, 213 226. doi: 10.1021/nn700185t Miyawaki, J., Matsumura, S., Yuge, R., Murakami, T., Sato, S., Tomida, A., et al. (2009). Biodistribution and ultrastructural localization of single-walled carbon nanohorns determinedin vivo with embedded Gd2O3 labels.ACS Nano3, 1399 1406. doi: 10.1021/nn9004846 Mochalin, V. N., Shenderova, O., Ho, D., and Gogotsi, Y. (2011).The properties and applications of nanodiamonds.Nat. Nanotechnol.7, 11 23. doi: 10.1038/nnano.2011.209 Monaco, A. M., and Giugliano, M. (2014). Carbon-based smart nanomaterials in biomedicine and neuroengineering.Beilstein J. Nanotechnol.5, 1849 1863. doi: 10.3762/bjnano.5.196 Moon, S. U., Kim, J., Bokara, K. K., Kim, J. Y., Khang, D., Webster,T. J., et al. (2012). Carbon nanotubes impregnated with subventricular zone neural progenitor cells promotes recovery from stroke.Int. J. Nanomed.7, 2751 2765. doi: 10.2147/IJN.S30273 Mouchet, F., Landois, P., Sarremejean, E., Bernard, G., Puech, P., Pinelli, E., et al. (2008). Characterisation andin vivoecotoxicity evaluation of double-wall carbon nanotubes in larvae of the amphibian Xenopus laevis.Aquat. Toxicol. 87, 127 137. doi: 10.1016/j.aquatox.2008.01.011 Movia, D., Prina-Mello, A., Bazou, D., Volkov, Y., and Giordani, S. (2011). Screening the cytotoxicity of single-walled carbon nanotubes using novel 3D tissue-mimetic models.ACS Nano5, 9278 9290. doi: 10.1021/nn203659m Movia, D., and Giordani, S. (2012). Toxicity of carbon nanotubes, inHandbook of Green Chemistry, edsA. Perosa and M. Selva (Weinheim: Wiley - VCH), 175 216. Muller, J., Huaux, F., Moreau, N., Misson, P., Heilier, J.-F., Delos, M., et al. (2005). Respiratory toxicity of multi-wall carbon nanotubes.Toxicol. Appl. Pharmacol. 207, 221 231. doi: 10.1016/j.taap.2005.01.008\nFrontiers in Neuroscience | www.frontiersin.org 23 June 2016 | Volume 10 | Article 250\nMurakami, T., Ajima, K., Miyawaki, J., Yudasaka, M., Iijima, S.,and Shiba, K. (2004). Drug-loaded carbon nanohorns: adsorption and release of dexamethasonein vitro. Mol. Pharm. 1, 399 405. doi: 10.1021/mp04 9928e Nakazono, M., Hasegawa, S., Yamamoto, T., and Zaitsu, K. (2004). Synthesis of 61-bis(1-adamantylcarbamoyl)-1,2-methano[60]fullerene and itsantagonistic e ect on haloperidol-induced catalepsy in mice.Bioorg. Med. Chem. Lett.14, 5619 5621. doi: 10.1016/j.bmcl.2004.08.053 Nguyen-Vu, T. D. B., Chen, H., Cassell, A. M., Andrews, R. J., Meyyappan, M., and Li, J. (2007). Vertically aligned carbon nano ber architecture as a multifunctional 3-D neural electrical interface.IEEE Trans. Biomed. Eng.54, 1121 1128. doi: 10.1109/TBME.2007.891169 Nunes, A., Bussy, C., Gherardini, L., Meneghetti, M., Herrero, M. A., Bianco, A., et al. (2012).In vivo degradation of functionalized carbon nanotubes after stereotactic administration in the brain cortex.Nanomedicine7, 1485 1494. doi: 10.2217/nnm.12.33 Odom, T. W., Huang, J., Kim, P., and Lieber, C. M. (2000). Structureand electronic properties of carbon nanotubes.J. Phys. Chem. B104, 2794 2809. doi: 10.1021/jp993592k Pagona, G., Fan, J., MaignŁ, A., Yudasaka, M., Iijima, S., andT gmatarchis, N. (2007). Aqueous carbon nanohorn pyrene porphyrin nanoensembles: controlling charge-transfer interactions.Diam. Relat. Mater.16, 1150 1153. doi: 10.1016/j.diamond.2006.11.071 Park, S. Y., Choi, D. S., Jin, H. J., Park, J., Byun, K.-E., Lee, K.-B., et al. (2011a). Polarization-controlled di erentiation of human neural stem cells using synergistic cues from the patterns of carbon nanotube monolayer coating. ACS Nano5, 4704 4711. doi: 10.1021/nn2006128 Park, S. Y., Park, J., Sim, S. H., Sung, M. G., Kim, K. S., Hong, B. H., etal. (2011b). Enhanced di erentiation of human neural stem cells into neurons ongraphene. Adv. Mater.23, H263 H267. doi: 10.1002/adma.201101503 Park, D.-W., Schendel, A. A., Mikael, S., Brodnick, S. K., Richner, T. J., Ness, J. P., et al. (2014). Graphene-based carbon-layered electrode array technology for neural imaging and optogenetic applications.Nat. Commun.5, 5258. doi: 10.1038/ncomms6258 Partha, R., and Conyers, J. L. (2009). Biomedical applications offunctionalized fullerene-based nanomaterials.Int. J. Nanomed. 4, 261 275. doi: 10.2147/IJN.S5964 Peng, C., Hu, W., Zhou, Y., Fan, C., and Huang, Q. (2010). Intracellular imaging with a graphene-based uorescent probe.Small 6, 1686 1692. doi: 10.1002/smll.201000560 Perevedentseva, E., Lin, Y.-C., Jani, M., and Cheng, C.-L. (2013). Biomedical applications of nanodiamonds in imaging and therapy.Nanomedicine8, 2041 2060. doi: 10.2217/nnm.13.183 Podolski, I. Y., Kondratjeva, E. V., Gurin, S. S., Dumpis, M. A., and Piotrovsky, L. B. (2005). Fullerene C 60 complexed with Poly(N-Vinyl-pyrrolidone) (C60 /PVP) prevents the disturbance of long-term memory consolidation induced by cycloheximide.Fullerenes Nanotub. Carbon Nanostruct.12, 421 424. doi: 10.1081/FST-120027201 Podolski, I. Y., Podlubnaya, Z. A, Kosenko, E. A, Mugantseva, E. A Makarova, E. G., Marsagishvili, L. G., et al. (2007). E ects of hydrated forms of C60 fullerene on amyloid peptide brillization in vitro and performance of the cognitive task.J. Nanosci. Nanotechnol.7, 1479 1485. doi: 10.1166/jnn.2007.330 Poland, C. A, Du n, R., Kinloch, I., Maynard, A., Wallace, W. A, H., et al. (2008). Carbon nanotubes introduced into the abdominal cavity of mice show asbestos-like pathogenicity in a pilot study.Nat. Nanotechnol.3, 423 428. doi: 10.1038/nnano.2008.111 Popov, V. (2004). Carbon nanotubes: properties and application.Mater. Sci. Eng. R Reports43, 61 102. doi: 10.1016/j.mser.2003.10.001 Pulskamp, K., DiabatØ, S., and Krug, H. F. (2007). Carbon nanotubes show no sign of acute toxicity but induce intracellular reactive oxygen species in dependence on contaminants.Toxicol. Lett.168, 58 74. doi: 10.1016/j.toxlet.2006.11.001 Qian, J., Wang, D., Cai, F.-H., Xi, W., Peng, L., Zhu, Z.-F., et al. (2012). Observation of multiphoton-induced uorescence from graphene oxide nanoparticles and applications in in vivo functional bioimaging.Angew. Chemie Int. Ed.51, 10570 10575. doi: 10.1002/anie.201206107 Qian, J., Ruan, S., Cao, X., Cun, X., Chen, J., Shen, S., et al. (2014). Fluorescent carbonaceous nanospheres as biological probe for noninvasive brain im ging. J. Colloid Interface Sci.436, 227 233. doi: 10.1016/j.jcis.2014.08.059 Qiao, Z.-A., Wang, Y., Gao, Y., Li, H., Dai, T., Liu, Y., et al. (2010). Commercially activated carbon as the source for producing multicolor photoluminescent carbon dots by chemical oxidation.Chem. Commun.46, 8812. doi: 10.1039/c0cc02724c Qu, S., Wang, X., Lu, Q., Liu, X., and Wang, L. (2012). A biocompatible uorescent ink based on water-soluble luminescent carbon nanodots.Angew. Chemie Int. Ed.51, 12215 12218. doi: 10.1002/anie.201206791 Qu, G., Wang, X., Liu, Q., Liu, R., Yin, N., Ma, J., et al. (2013).The ex vivo and in vivo biological performances of graphene oxide and the impact of surfactant on graphene oxide’s biocompatibility.J. Environ. Sci.25, 873 881. doi: 10.1016/S1001-0742(12)60252-6 Quick, K. L., Ali, S. S., Arch, R., Xiong, C., Wozniak, D., and Dugan, L. L. (2008). A carboxyfullerene SOD mimetic improves cognition and extends the lifespan of mice.Neurobiol. Aging29, 117 128. doi: 10.1016/j.neurobiolaging.2006.09.014 Ramos, A., CameÆn, I., and García, A. B. (2013). Graphitization thermal treatment of carbon nano bers.Carbon59, 2 32. doi: 10.1016/j.carbon.2013.03.031 Rand, E., Periyakaruppan, A., Tanaka, Z., Zhang, D. A., Marsh, M.P., Andrews, R. J., et al. (2013). A carbon nano ber based biosensor for simultaneous detection of dopamine and serotonin in the presence of ascorbicacid.Biosens. Bioelectron. 42, 434 438. doi: 10.1016/j.bios.2012.10.080 Ren, J., Shen, S., Wang, D., Xi, Z., Guo, L., Pang, Z., et al. (2012). The targeted delivery of anticancer drugs to brain glioma by PEGylated oxi ized multi-walled carbon nanotubes modi ed with angiopep-2.Biomaterials33, 3324 3333. doi: 10.1016/j.biomaterials.2012.01.025 Robinson, J. T., Tabakman, S. M., Liang, Y., Wang, H., Sanchez Casalongue, H., Vinh, D., et al. (2011). Ultrasmall reduced graphene oxide with high near-infrared absorbance for photothermal therapy.J. Am. Chem. Soc.133, 6825 6831. doi: 10.1021/ja2010175 Rodriguez, N. M., Kim, M.-S., and Baker, R. T. K. (1994). CarbonNa o bers: a unique catalyst support medium.J. Phys. Chem.98, 13108 13111. doi: 10.1021/j100101a003 Rojas, S., Gispert, J. D., Martín, R., Abad, S., Menchón, C., Pareto, D. R., et al. (2011). Biodistribution of Amino-functionalized diamond nanoparticlesin vivo studies based on 18 F radionuclide emission.ACS Nano5, 5552 5559. doi: 10.1021/nn200986z Roman, J. A., Niedzielko, T. L., Haddon, R. C., Parpura, V., and Floyd, C. L. (2011). Single-walled carbon nanotubes chemically functionalized with polyethylene glycol promote tissue repair in a rat model of spinal cord injury.J. Neurotrauma 28, 2349 2362. doi: 10.1089/neu.2010.1409 Ruan, S., Qian, J., Shen, S., Zhu, J., Jiang, X., He, Q., et al. (2014). A simple one-step method to prepare uorescent carbon dots and their potential application in non-invasive glioma imaging.Nanoscale6, 10040. doi: 10.1039/C4NR02657H Ruo , R. S., and Lorents, D. C. (1995). Mechanical and thermal properties of carbon nanotubes.Carbon33, 925 930. doi: 10.1016/0008-6223(95)00021-5 Salvetat, J.-P., Bonard, J.-M., Thomson, N. H., Kulik, A. J., Forrand, L., Benoit, W., et al. (1999). Mechanical properties of carbon nanotubes.Appl. Phys. A Mater. Sci. Process.69, 255 260. doi: 10.1007/s003390050999 Sano, N., Taniguchi, K., and Tamon, H. (2014). Hydrogen storage inporous singlewalled carbon nanohorns dispersed with Pd Ni alloy nanoparticles.J. Phys. Chem. C118, 3402 3408. doi: 10.1021/jp4098155 Sato, Y., Shibata, K., Kataoka, H., Ogino, S., Bunshi, F., Yokoyama, A., et al. (2005). Strict preparation and evaluation of water-soluble hat-stacked carbon nano bers for biomedical application and their high biocompatibility: in uence of nano ber-surface functional groups on cytotoxicity. Mol. Biosyst. 1, 142. doi: 10.1039/b501222h Schrand, A. M., Dai, L., Schlager, J. J., Hussain, S. M., and Osawa, E. (2007a). Di erential biocompatibility of carbon nanotubes and nanodiamonds. Diam. Relat. Mater. 16, 2118 2123. doi: 10.1016/j.diamond.2007. 07.020 Schrand, A. M., Huang, H., Carlson, C., Schlager, J. J.,flOsawa, E., Hussain, S. M., et al. (2007b). Are diamond nanoparticles cytotoxic?J. Phys. Chem. B111, 2 7. doi: 10.1021/jp066387v Schrand, A., Hens, S.,A., C., and Shenderova, O. (2009). Nanodiam nd Particles: properties and perspectives for bioapplications.Crit. Rev. Solid State Mater. Sci. 34, 18 74. doi: 10.1080/10408430902831987 Seabra, A. B., Paula, A. J., de Lima, R., Alves, O. L., and DurÆn, N. (2014). Nanotoxicity of graphene and graphene oxide.Chem. Res. Toxicol.27, 159 168. doi: 10.1021/tx400385x\nFrontiers in Neuroscience | www.frontiersin.org 24 June 2016 | Volume 10 | Article 250\nSergio, M., Behzadi, H., Otto, A., and van der Spoel, D. (2013). Fullerenes toxicity and electronic properties.Environ. Chem. Lett.11, 105 118. doi: 10.1007/s10311-012-0387-x Serrano, M. C., Patiæo, J., García-Rama, C., Ferrer, M. L., Fierro, J. L. G., Tamayo, A., et al. (2014). 3D free-standing porous sca olds made of graphene oxide as substrates for neural cell growth.J. Mater. Chem. B2, 5698. doi: 10.1039/C4TB00652F Shari , S., Behzadi, S., Laurent, S., Laird Forrest, M., Stroeve, P., and Mahmoudi, M. (2012). Toxicity of nanomaterials.Chem. Soc. Rev.41, 2323 2343. doi: 10.1039/C1CS15188F Shein, M., Greenbaum, A., Gabay, T., Sorkin, R., David-Pur, M.,Ben-Jacob, E., et al. (2009). Engineered neuronal circuits shaped and interfac d with carbon nanotube microelectrode arrays.Biomed. Microdevices11, 495 501. doi: 10.1007/s10544-008-9255-7 Shen, J., Zhu, Y., Yang, X., and Li, C. (2012). Graphene quantum dots: emergent nanolights for bioimaging, sensors, catalysis and photovoltaicdevices.Chem. Commun.48, 3686. doi: 10.1039/c2cc00110a Shen, J., Li, Y., Su, Y., Zhu, Y., Jiang, H., Yang, X., et al. (2015). Photoluminescent carbon nitrogen quantum dots as e cient electrocatalysts for oxygen reduction.Nanoscale7, 2003 2008. doi: 10.1039/C4NR06484D Sherigara, B. S., Kutner, W., and D’Souza, F. (2003). Electrocatalytic properties and sensor applications of fullerenes and carbon nanotubes.El ctroanalysis15, 753 772. doi: 10.1002/elan.200390094 Shevtsov, M.A., Nikolaev, B. P., Marchenko, Y. Y., Yakovleva,L. Y. Dobrodumova, V., Török, G., et al., (2014). Magnetic resonance imaging of rat C6glioma model enhanced by using water-soluble gadolinium fullerene.Appl. Magn. Reson.45, 303 314. doi: 10.1007/s00723-014-0519-5 Shoval, A. (2009). Carbon nanotube electrodes for e ective interfacing with retinal tissue.Front. Neuroeng.2:4. doi: 10.3389/neuro.16.004.2009 Smith, C. J., Shaw, B. J., and Handy, R. D. (2007). Toxicity of single walled carbon nanotubes to rainbow trout, (Oncorhynchus mykiss): respiratory toxicity, organ pathologies, and other physiological e ects.Aquat. Toxicol.82, 94 109. doi: 10.1016/j.aquatox.2007.02.003 Sohaebuddin, S. K., Thevenot, P. T., Baker, D., Eaton, J. W.,and Tang, L. (2010). Nanomaterial cytotoxicity is composition, size, and cell type dependent.Part. Fibre Toxicol.7:22. doi: 10.1186/1743-8977-7-22 Song, Q., Jiang, Z., Li, N., Liu, P., Liu, L., Tang, M., et al. (2014). Anti-in ammatory e ects of three-dimensional graphene foams cultured with microglial cel s. Biomaterials35, 6930 6940. doi: 10.1016/j.biomaterials.2014.05.002 Sonkar, S. K., Ghosh, M., Roy, M., Begum, A., and Sarkar, S. (2012). Carbon nanoonions as nontoxic and high- uorescence bioimaging agent in food chain an in vivostudy from unicellularE. coli to multicellular C. elegans. Mater. Express 2, 105 114. doi: 10.1166/mex.2012.1064 Strauss, V., Margraf, J. T., Dolle, C., Butz, B., Nacken, T. J., Walter, J., et al. (2014). Carbon Nanodots: toward a comprehensive understanding of their photoluminescence.J. Am. Chem. Soc.136, 17308 17316. doi: 10.1021/ja510183c Sun, Y. P., Zhou, B., Lin, Y., Wang, W., Fernando, K. A. S., Pathak, P., et al. (2006). Quantum-sized carbon dots for bright and colorful photoluminescen .J. Am. Chem. Soc.128, 7756 7757. doi: 10.1021/ja062677d Sureshbabu, A. R., Kurapati, R., Russier, J., MØnard-Moyon, C.,Bartolini, I., Meneghetti, M., et al. (2015). Degradation-by-design: surface modi cation with functional substrates that enhance the enzymatic degradation of carbon nanotubes.Biomaterials72, 20 28. doi: 10.1016/j.biomaterials.2015. 08.046 Tagmatarchis, N., MaignØ, A., Yudasaka, M., and Iijima, S. (2006). Functionalization of carbon nanohorns with azomethine ylides:towards solubility enhancement and electron-transfer processes.Small2, 490 494. doi: 10.1002/smll.200500393 Tahara, Y., Miyawaki, J., Zhang, M., Yang, M., Waga, I., Iijima, S., et al. (2011). Histological assessments for toxicity and functionalization-dependent biodistribution of carbon nanohorns.Nanotechnology22:265106. doi: 10.1088/0957-4484/22/26/265106 Tang, M., Song, Q., Li, N., Jiang, Z., Huang, R., and Cheng, G. (2013). Enhancement of electrical signaling in neural networks on graphene lms.Biomaterials34, 6402 6411. doi: 10.1016/j.biomaterials.2013.05.024 Tao, H., Yang, K., Ma, Z., Wan, J., Zhang, Y., Kang, Z., et al. (2012). In vivo NIR uorescence imaging, biodistribution, and toxicology of photoluminescent carbon dots produced from carbon nanotubes and graphite.Small8, 281 290. doi: 10.1002/smll.201101706 Tasis, D., Tagmatarchis, N., Bianco, A., and Prato, M. (2006).Chemistry of carbon nanotubes.Chem. Rev.106, 1105 1136. doi: 10.1021/cr050569o Tay, C. Y., Cai, P., Setyawati, M. I., Fang, W., Tan, L. P., Hong, C. H. L., et al. (2014). Nanoparticles strengthen intracellular tension and retard cellular migration. Nano Lett.14, 83 88. doi: 10.1021/nl4032549 Thalhammer, A., Edgington, R. J., Cingolani, L. A., Schoepfer, R., and Jackman, R. B. (2010). The use of nanodiamond monolayer coatings to promote the formation of functional neuronal networks.Biomaterials31, 2097 2104. doi: 10.1016/j.biomaterials.2009.11.109 Tokuyama, H., Yamago, S., Nakamura, E., Shiraki, T., and Sugiura, Y.(1993). Photoinduced biochemical activity of fullerene carboxylic acid. J. Am. Chem. Soc.115, 7918 7919. doi: 10.1021/ja00070a064 Tran, P. A., Zhang, L., and Webster, T. J. (2009). Carbon nano bers and carbon nanotubes in regenerative medicine.Adv. Drug Deliv. Rev.61, 1097 1114. doi: 10.1016/j.addr.2009.07.010 Trpkovic, A., Todorovic-Markovic, B., and Trajkovic, V. (2012).Toxicity of pristine versus functionalized fullerenes: mechanisms of cell damageand the role of oxidative stress.Arch. Toxicol.86, 1809 1827. doi: 10.1007/s00204-0120859-6 Tsao, N., Kanakamma, P. P., Luh, T. Y., Chou, C. K., and Lei, H. Y. (1999). Inhibition ofEscherichia coli-induced meningitis by carboxyfullerence. Antimicrob. Agents Chemother.43, 2273 2277. Tu, Q., Pang, L., Chen, Y., Zhang, Y., Zhang, R., Lu, B., et al. (2014). E ects of surface charges of graphene oxide on neuronal outgrowth and branching. Analyst139, 105 115. doi: 10.1039/C3AN01796F Tykhomyrov, A. A., Nedzvetsky, V. S., Klochkov, V. K., and Andrievsky, G. V. (2008). Nanostructures of hydrated C60 fullerene (C60HyFn) protect rat brain against alcohol impact and attenuate behavioral impairments of alcoho ized animals.Toxicology246, 158 165. doi: 10.1016/j.tox.2008.01.005 Vaijayanthimala, V., and Chang, H.-C. (2009). Functionalized uorescent nanodiamonds for biomedical applications.Nanomedicine4, 47 55. doi: 10.2217/17435889.4.1.47 Vaijayanthimala, V., Cheng, P.-Y., Yeh, S.-H., Liu, K.-K., Hsiao, C.-H., Chao, J.I., et al. (2012). The long-term stability and biocompatibility of uorescent nanodiamond as anin vivo contrast agent.Biomaterials33, 7794 7802. doi: 10.1016/j.biomaterials.2012.06.084 Valentini, F., Ciambella, E., Conte, V., Sabatini, L., Ditaranto, N., Cataldo, F., et al. (2014). Highly selective detection of Epinephrine at oxidized SingleWall Carbon Nanohorns modi ed Screen Printed Electrodes (SPEs).Biosens. Bioelectron.59, 94 98. doi: 10.1016/j.bios.2014.02.065 Vitale, F., Summerson, S. R., Aazhang, B., Kemere, C., and Pasquali, M. (2015). Neural stimulation and recording with bidirectional, soft carbon nanotube ber microelectrodes. ACS Nano 9, 4465 4474. doi: 10.1021/acsnano.5 b01060 Vittorio, O., Ra a, V., and Cuschieri, A. (2009). In uence of purity and surface oxidation on cytotoxicity of multiwalled carbon nanotubes withhuman neuroblastoma cells.Nanomed. Nanotechnol. Biol. Med.5, 424 431. doi: 10.1016/j.nano.2009.02.006 Vizuete, M., Gómez-Escalonilla, M. J., Fierro, J. L. G., Sandanayaka, A. S. D., Hasobe, T., Yudasaka, M., et al. (2010). A carbon nanohorn-p phyrin supramolecular assembly for photoinduced electron-transfer processes.Ch m. A Eur. J.16, 10752 10763. doi: 10.1002/chem.201000299 Voiry, D., Pagona, G., Canto, E., Del Ortolani, L., NoØ, L., Morandi, V., et al. (2015). Reductive dismantling and functionalization of carbon nanohorns. Chem. Commun.51, 5017 5019. doi: 10.1039/C4CC10389K Vorobyov, V., Kaptsov, V., Gordon, R., Makarova, E., Podolski, I., and Sengpiel, F. (2015). Neuroprotective e ects of hydrated fullerene C60: cortical and hippocampal EEG interplay in an amyloid-infused rat model of Alzheimer’s disease.J. Alzheimers. Dis.45, 217 233. doi: 10.3233/JAD-142469 Wang, J., and Lin, Y. (2008). Functionalized carbon nanotubes and nano bers for biosensing applications.Trends Anal. Chem.27, 619 626. doi: 10.1016/j.trac.2008.05.009 Wang, C.-H., Huang, Y.-J., and Peng, C.-A. (2009). Photothermal ablation of stem-cell like glioblastoma using carbon nanotubes functionalized with antiCD133, in 13th International Conference on Biomedical Engineering,(Berlin; Heidelberg: Springer Berlin Heidelberg), 888 891.\nFrontiers in Neuroscience | www.frontiersin.org 25 June 2016 | Volume 10 | Article 250\nWang, K., Wang, Y., Wang, Y., Hosono, E., and Zhou, H. (2009). Mesoporous carbon nano bers for supercapacitor application.J Phys. Chem. C113, 1093 1097. doi: 10.1021/jp807463u Wang, K., Ruan, J., Song, H., Zhang, J., Wo, Y., Guo, S., et al. (2010). Biocompatibility of graphene oxide.Nanoscale Res. Lett.6, 1 8. doi: 10.1007/s11671-010-9751-6 Wang, Y., Anilkumar, P., Cao, L., Liu, J.-H., Luo, P. G., Tackett, K. N., et al. (2011). Carbon dots of di erent composition and surface functionalization: cytotoxicity issues relevant to uorescence cell imaging.Exp. Biol. Med.236, 1231 1238. doi: 10.1258/ebm.2011.011132 Wang, F., Xie, Z., Zhang, H., Liu, C., and Zhang, Y. (2011). Highlyluminescent organosilane-functionalized carbon dots.Adv. Funct. Mater.21, 1027 1031. doi: 10.1002/adfm.201002279 Wang, Y., Lee, W. C., Manga, K. K., Ang, P. K., Lu, J., Liu, Y. P., et al. (2012). Fluorinated graphene for promoting neuro-induction of stem cells.Adv. Mater. 24, 4285 4290. doi: 10.1002/adma.201200846 Webster, T. J., Waid, M. C., McKenzie, J. L., Price, R. L., and Ejiofor, J. U. (2004). Nano-biotechnology: carbon nano bres as improved neural and orthopaedic implants.Nanotechnology15, 48 54. doi: 10.1088/0957-4484/ 15/1/009 Whitney, J. R., Sarkar, S., Zhang, J., Do, T., Young, T., Manson, M. K., et al. (2011). Single walled carbon nanohorns as photothermal cancer agents.Lasers Surg. Med.43, 43 51. doi: 10.1002/lsm.21025 Wick, P., Louw-Gaume, A. E., Kucki, M., Krug, H. F., Kostarelos, K., Fadeel, B., et al. (2014). Classi cation framework for graphene-based materials.Angew. Chemie Int. Ed.53, 7714 7718. doi: 10.1002/anie.201403335 Wu, H.-C., Chang, X., Liu, L., Zhao, F., and Zhao, Y. (2010). Chemistry of carbon nanotubes in biomedical applications.J Mater. Chem.20, 1036 1052. doi: 10.1039/B911099M Wu, L., Luderer, M., Yang, X., Swain, C., Zhang, H., Nelson, K., etal. (2013). Surface passivation of carbon nanoparticles with branched macromolecules in uences near infrared bioimaging.Theranostics3, 677 686. doi: 10.7150/thn o.6535 Xi, G., Robinson, E., Mania-Farnell, B., Vanin, E. F., Shim, K.-W., Takao, T., et al. (2014). Convection-enhanced delivery of nanodiamond drugdelivery platforms for intracranial tumor treatment.Nanomed. Nanotechnol. Biol. Med. 10, 381 391. doi: 10.1016/j.nano.2013.07.013 Xing, Y., and Dai, L. (2009). Nanodiamonds for nanomedicine.Nanomedicine4, 207 218. doi: 10.2217/17435889.4.2.207 Xu, X., Ray, R., Gu, Y., Ploehn, H. J., Gearheart, L., Raker, K., et al. a (2004). Electrophoretic analysis and puri cation of uorescent single-walled carbon nanotube fragments.J. Am. Chem. Soc.126, 12736 12737. doi: 10.1021/ja040082h Yamada, T., Jung, D.-Y., Sawada, R., Matsuoka, A., Nakaoka, R., nd Tsuchiya, T. (2008). E ects intracerebral microinjection and intraperitoneal injection of [60]fullerene on brain functions di er in rats.J. Nanosci. Nanotechnol.8, 3973 3980. doi: 10.1166/jnn.2008.414 Yamada, T., Nakaoka, R., Sawada, R., Matsuoka, A., and Tsuchiya, T. (2010). E ects of intracerebral microinjection of hydroxylated-[60]fulleren on brain monoamine concentrations and locomotor behavior in rats.J. Nanosci. Nanotechnol.10, 604 611. doi: 10.1166/jnn.2010.1720 Yamago, S., Tokuyama, H., Nakamura, E., Kikuchi, K., Kananishi, S., Sueki, K., et al. (1995).In vivo biological behavior of a water-miscible fullerene: 14C labeling, absorption, distribution, excretion and acute toxicity.Chem. Biol.2, 385 389. doi: 10.1016/1074-5521(95)90219-8 Yang, C.-M., Noguchi, H., Murata, K., Yudasaka, M., Hashimoto,A., Iijima, S., et al. (2005). Highly ultramicroporous single-walled carbon nanohorn assemblies. Adv. Mater.17, 866 870. doi: 10.1002/adma.200400712 Yang, S.-T., Guo, W., Lin, Y., Deng, X.-Y., Wang, H.-F., Sun, H.-F., et al. (2007). Biodistribution of pristine single-walled carbon nanotubesin vivo. J. Phys. Chem. C111, 17761 17764. doi: 10.1021/jp070712c Yang, S.-T., Wang, X., Jia, G., Gu, Y., Wang, T., Nie, H., et al. (2008). Long-term accumulation and low toxicity of single-walled carbon nanotubes in intravenously exposed mice.Toxicol. Lett. 181, 182 189. doi: 10.1016/j.toxlet.2008.07.020 Yang, S.-T., Cao, L., Luo, P. G., Lu, F., Wang, X., Wang, H., et al.(2009a). Carbon dots for optical imagingin vivo. J. Am. Chem. Soc.131, 11308 11309. doi: 10.1021/ja904843x Yang, S.-T., Wang, X., Wang, H., Lu, F., Luo, P. G., Cao, L., et al.(2009b). Carbon dots as nontoxic and high-performance uorescence imaging agents. J. Phys. Chem. C113, 18110 18114. doi: 10.1021/jp9085969 Yang, K., Zhang, S., Zhang, G., Sun, X., Lee, S.-T., and Liu, Z.(2010). Graphene in mice: ultrahigh in vivotumor uptake and e cient photothermal therapy.Nano Lett.10, 3318 3323. doi: 10.1021/nl100996u Yang, Z., Zhang, Y., Yang, Y., Sun, L., Han, D., Li, H., et al. (2010). Pharmacological and toxicological target organelles and safe useof inglewalled carbon nanotubes as drug carriers in treating Alzheimer disease. Nanomed. Nanotechnol. Biol. Med.6, 427 441. doi: 10.1016/j.nano.2009.11.007 Yang, Y., Cui, J., Zheng, M., Hu, C., Tan, S., Xiao, Y., et al. (2012). Onestep synthesis of amino-functionalized uorescent carbon nanoparticles by hydrothermal carbonization of chitosan.Chem. Commun.48, 380 382. doi: 10.1039/C1CC15678K Yang, K., Feng, L., Shi, X., and Liu, Z. (2013a). Nano-graphene in biomedicine: theranostic applications.Chem. Soc. Rev.42, 530 547. doi: 10.1039/C2CS35342C Yang, M., Flavin, K., Kopf, I., Radics, G., Hearnden, C. H.A., McManus, G. J., et al. (2013). Functionalization of carbon nanoparticles modulates in ammatory cell recruitment and NLRP3 in ammasome activation.Small9, 4194 4206. doi: 10.1002/smll.201300481 Yang, H.-W., Hua, M.-Y., Hwang, T.-L., Lin, K.-J., Huang, C.-Y.,Tsai, R.-Y., et al. (2013). Non-invasive synergistic treatment of brain tumors by targeted chemotherapeutic delivery and ampli ed focused ultrasound-hyperthermia using magnetic nanographene oxide.Adv. Mater. 25, 3605 3611. doi: 10.1002/adma.201301046 Yang, K., Li, Y., Tan, X., Peng, R., and Liu, Z. (2013b). Behavior nd toxicity of graphene and its functionalized derivatives in biological system .Small9, 1492 1503. doi: 10.1002/smll.201201417 Yang, H.-W., Huang, C.-Y., Lin, C.-W., Liu, H.-L., Huang, C.-W.,Liao, S.-S., et al. (2014). Gadolinium-functionalized nanographene oxide forc mbined drug and microRNA delivery and magnetic resonance imaging.Biomaterials 35, 6534 6542. doi: 10.1016/j.biomaterials.2014.04.057 Yang, M., Zhang, M., Tahara, Y., Chechetka, S., Miyako, E., Iijima, S., et al. (2014). Lysosomal membrane permeabilization: carbon nanohorn-induced reactiv oxygen species generation and toxicity by this neglected mechanism. Toxicol. Appl. Pharmacol.280, 117 126. doi: 10.1016/j.taap.2014.07.022 Yang, L., Wang, F., Han, H., Yang, L., Zhang, G., and Fan, Z. (2015). Functionalized graphene oxide as a drug carrier for loading pirfenidone in treatment of subarachnoid hemorrhage.Colloids Surf. B Biointerfaces129, 21 29. doi: 10.1016/j.colsurfb.2015.03.022 Yoshitake, T., Shimakawa, Y., Kuroshima, S., Kimura, H., Ichihash, T., Kubo, Y., et al. (2002). Preparation of ne platinum catalyst supported on singlewall carbon nanohorns for fuel cell application.Phys. B Condens. Matter323, 124 126. doi: 10.1016/S0921-4526(02)00871-2 Yuan, Y., Chen, Y., Liu, J.-H., Wang, H., and Liu, Y. (2009). Biodistribution and fate of nanodiamondsin vivo. Diam. Relat. Mater.18, 95 100. doi: 10.1016/j.diamond.2008.10.031 Zhang, M., Murakami, T., Ajima, K., Tsuchida, K., Sandanayaka,A. S. D., Ito, O., et al. (2008). Fabrication of ZnPc/protein nanohorns fordouble photodynamic and hyperthermic cancer phototherapy.Proc. Natl. Acad. Sci. 105, 14773 14778. doi: 10.1073/pnas.0801349105 Zhang, Y., Ali, S. F., Dervishi, E., Xu, Y., Li, Z., Casciano, D., et al. (2010). Cytotoxicity e ects of graphene and single-wall carbon nanotubes in neural phaeochromocytoma-derived PC12 cells.ACS Nano 4, 3181 3186. doi: 10.1021/nn1007176 Zhang, L., Xia, J., Zhao, Q., Liu, L., and Zhang, Z. (2010). Functional graphene oxide as a nanocarrier for controlled loading and targeted delivery of mixed anticancer drugs.Small6, 537 544. doi: 10.1002/smll.200901680 Zhang, J., Ge, J., Shultz, M. D., Chung, E., Singh, G., Shu, C.,et al (2010c).In vitro and in vivo studies of single-walled carbon nanohorns with encapsulated metallofullerenes and exohedrally functionalized quantum dots.Nano Lett.10, 2843 2848. doi: 10.1021/nl1008635 Zhang, X., Yin, J., Peng, C., Hu, W., Zhu, Z., Li, W., et al. (2011). Distribution and biocompatibility studies of graphene oxide in mice after intravenous administration.Carbon49, 986 995. doi: 10.1016/j.carbon.2010.11.005 Zhang, Y., Xu, Y., Li, Z., Chen, T., Lantz, S. M., Howard, P. C., etal. (2011). Mechanistic toxicity evaluation of uncoated and PEGylated single-walled\nFrontiers in Neuroscience | www.frontiersin.org 26 June 2016 | Volume 10 | Article 250\ncarbon nanotubes in neuronal PC12 cells.ACS Nano5, 7020 7033. doi: 10.1021/nn2016259\nZhang, X.-Q., Lam, R., Xu, X., Chow, E. K., Kim, H.-J., and Ho, D. (2011). Multimodal nanodiamond drug delivery carriers for selective targeting, imaging, and enhanced chemotherapeutic e cacy.Adv. Mater.23, 4770 4775. doi: 10.1002/adma.201102263 Zhang, H., Yu, M., Xie, L., Jin, L., and Yu, Z. (2012). Carbon-nao bers-based micro-/nanodevices for neural-electrical and neural-chemical interfaces.J. Nanomater.2012, 1 6. doi: 10.1155/2012/280902 Zhang, Y., Nayak, T. R., Hong, H., and Cai, W. (2012). Graphene: a versatile nanoplatform for biomedical applications.Nanoscale4, 3833. doi: 10.1039/c2nr31040f Zhang, M., Zhou, X., Iijima, S., and Yudasaka, M. (2012). Small-sized carbon nanohorns enabling cellular uptake control.Small 8, 2524 2531. doi: 10.1002/smll.201102595 Zhang, H., Grüner, G., and Zhao, Y. (2013). Recent advancementsof graphene in biomedicine.J. Mater. Chem. B1, 2542. doi: 10.1039/c3tb20405g Zhang, X., Wang, S., Liu, M., Yang, B., Feng, L., Ji, Y., et al. (2013). Size tunable uorescent nano-graphite oxides: preparation and cell imaging applications. Phys. Chem. Chem. Phys.15, 19013. doi: 10.1039/c3cp52883a Zhang, J., and Yu, S. (in press). Carbon dots : large-scale syntheis, s nsing and bioimaging.Biochem. Pharmacol.doi: 10.1016/j.mattod.2015.11.008 Zhao, Q.-L., Zhang, Z.-L., Huang, B.-H., Peng, J., Zhang, M., and Pang, D.-W. (2008). Facile preparation of low cytotoxicity uorescent carbon nanocrystals by electrooxidation of graphite.Chem. Commun.5116 5118. doi: 10.1039/b812420e Zhao, D., Alizadeh, D., Zhang, L., Liu, W., Farrukh, O., Manuel, E., et al. (2011). Carbon nanotubes enhance cpg uptake and potentiate antiglioma immunity. Clin. Cancer Res.17, 771 782. doi: 10.1158/1078-0432.CCR10-2444\nZhao, Q., Li, N., Shu, C., Li, R., Ma, X., Li, X., et al. (2015). Docetaxel-loaded single-wall carbon nanohorns using anti-VEGF antibody as a targeting agent: characterization,in vitro and in vivoantitumor activity.J. Nanoparticle Res.17, 207. doi: 10.1007/s11051-015-3015-4 Zhao, A., Chen, Z., Zhao, C., Gao, N., Ren, J., and Qu, X. (2015). Recent advances in bioapplications of C-dots.Carbon 85, 309 327. doi: 10.1016/j.carbon.2014.12.045 Zhu, S., Oberdörster, E., and Haasch, M. L. (2006). Toxicity of an engineered nanoparticle (fullerene, C60) in two aquatic species, Daphnia and fathead minnow. Mar. Environ. Res.62, S5 S9. doi: 10.1016/j.marenvres.2006. 04.059 Zhu, S., and Xu, G. (2010). Single-walled carbon nanohorns and their applications. Nanoscale2, 2538. doi: 10.1039/c0nr00387e Zhu, S., Tang, S., Zhang, J., and Yang, B. (2012). Control the size and surface chemistry of graphene for the rising uorescent materials.Chem. Commun.48, 4527. doi: 10.1039/c2cc31201h Zhu, Y., Li, J., Li, W., Zhang, Y., Yang, X., Chen, N., et al. (2012). The biocompatibility of nanodiamonds and their application in drug delivry systems.Theranostics2, 302 312. doi: 10.7150/thno.3627\nCon ict of Interest Statement: The authors declare that the research was conducted in the absence of any commercial or nancial relationship that could be construed as a potential con ict of interest.\nCopyright ' 2016 Baldrighi, Trusel, Tonini and Giordani. This isan open-access article distributed under the terms of the Creative CommonsAttribution License (CC BY). The use, distribution or reproduction in other forums ispermitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.\nFrontiers in Neuroscience | www.frontiersin.org 27 June 2016 | Volume 10 | Article 250"
    } ],
    "references" : [ {
      "title" : "PEG oligonucleotide (CpG",
      "author" : [ "Z Yang" ],
      "venue" : null,
      "citeRegEx" : "Yang,? \\Q2010\\E",
      "shortCiteRegEx" : "Yang",
      "year" : 2010
    }, {
      "title" : "Tris (malonic acid) (carboxyfullerene",
      "author" : [ "Lin" ],
      "venue" : null,
      "citeRegEx" : "Lin,? \\Q2001\\E",
      "shortCiteRegEx" : "Lin",
      "year" : 2001
    }, {
      "title" : "Tris (malonic acid) (carboxyfullerene",
      "author" : [ "Tsao" ],
      "venue" : null,
      "citeRegEx" : "Tsao,? \\Q1999\\E",
      "shortCiteRegEx" : "Tsao",
      "year" : 1999
    }, {
      "title" : "PEGC Fe3O4 NPs Cepirubicin",
      "author" : [ "Qian" ],
      "venue" : null,
      "citeRegEx" : "Qian,? \\Q2012\\E",
      "shortCiteRegEx" : "Qian",
      "year" : 2012
    }, {
      "title" : "PEGC Tat-peptide C perfenidone",
      "author" : [ "G Liu" ],
      "venue" : null,
      "citeRegEx" : "Liu,? \\Q2013\\E",
      "shortCiteRegEx" : "Liu",
      "year" : 2013
    }, {
      "title" : "Adsorption and catalytic properties of single-wall carbon",
      "author" : [ "K. ashi", "S. Iijima" ],
      "venue" : null,
      "citeRegEx" : "ashi and Iijima,? \\Q2000\\E",
      "shortCiteRegEx" : "ashi and Iijima",
      "year" : 2000
    }, {
      "title" : "Carbon nanohorns as anticancer drug carriers",
      "author" : [ "S. d Iijima" ],
      "venue" : null,
      "citeRegEx" : "Iijima,? \\Q2005\\E",
      "shortCiteRegEx" : "Iijima",
      "year" : 2005
    }, {
      "title" : "Enhanced cellular internalization",
      "author" : [ "Herrero", "M.-A", "B Tian" ],
      "venue" : null,
      "citeRegEx" : "Herrero et al\\.,? \\Q2010\\E",
      "shortCiteRegEx" : "Herrero et al\\.",
      "year" : 2010
    }, {
      "title" : "Biodegradation of single-walled carbon nanotubes",
      "author" : [ "hambers", "B. J" ],
      "venue" : null,
      "citeRegEx" : "hambers and J,? \\Q2013\\E",
      "shortCiteRegEx" : "hambers and J",
      "year" : 2013
    }, {
      "title" : "Review of fullerene toxicity and exposure",
      "author" : [ "L. C", "Hankin", "M S" ],
      "venue" : null,
      "citeRegEx" : "C. et al\\.,? \\Q2010\\E",
      "shortCiteRegEx" : "C. et al\\.",
      "year" : 2010
    }, {
      "title" : "High e cient electrical stimulation",
      "author" : [ "Andrews", "R. J" ],
      "venue" : null,
      "citeRegEx" : "Andrews and J,? \\Q2009\\E",
      "shortCiteRegEx" : "Andrews and J",
      "year" : 2009
    }, {
      "title" : "Luminescent carbon nano",
      "author" : [ "G.A. Baker" ],
      "venue" : null,
      "citeRegEx" : "10",
      "shortCiteRegEx" : "10",
      "year" : 2010
    }, {
      "title" : "Medicinal applications of fullerenes",
      "author" : [ ],
      "venue" : null,
      "citeRegEx" : "W,? \\Q2007\\E",
      "shortCiteRegEx" : "W",
      "year" : 2007
    }, {
      "title" : "Functionalized carbon nanotubes in the brain",
      "author" : [ ],
      "venue" : null,
      "citeRegEx" : "C,? \\Q2013\\E",
      "shortCiteRegEx" : "C",
      "year" : 2013
    }, {
      "title" : "Synthesis and characterization of far-red/N",
      "author" : [ ],
      "venue" : null,
      "citeRegEx" : "L,? \\Q2015\\E",
      "shortCiteRegEx" : "L",
      "year" : 2015
    }, {
      "title" : "Non-covalent functionalization",
      "author" : [ "T Pellegrino" ],
      "venue" : null,
      "citeRegEx" : "Pellegrino,? \\Q2015\\E",
      "shortCiteRegEx" : "Pellegrino",
      "year" : 2015
    }, {
      "title" : "Boron dipyrromethene (BODIPY) functionalized carbo",
      "author" : [ "R Brescia" ],
      "venue" : null,
      "citeRegEx" : "Brescia,? \\Q2014\\E",
      "shortCiteRegEx" : "Brescia",
      "year" : 2014
    }, {
      "title" : "Carbon nanotubes as vect",
      "author" : [ "K. Bates", "K. Kostarelos" ],
      "venue" : null,
      "citeRegEx" : "Bates and Kostarelos,? \\Q2013\\E",
      "shortCiteRegEx" : "Bates and Kostarelos",
      "year" : 2013
    }, {
      "title" : "Endowing carbon nanotubes with biological and biomedical propert",
      "author" : [ "A. co" ],
      "venue" : null,
      "citeRegEx" : "co,? \\Q2013\\E",
      "shortCiteRegEx" : "co",
      "year" : 2013
    }, {
      "title" : "Ammonium and guanidinium dendron-carbon nan",
      "author" : [ "K. los", "Al-Jamal", "K. T" ],
      "venue" : null,
      "citeRegEx" : "los et al\\.,? \\Q2013\\E",
      "shortCiteRegEx" : "los et al\\.",
      "year" : 2013
    }, {
      "title" : "Enzymatic stripping and degradation of PEGylat",
      "author" : [ ],
      "venue" : null,
      "citeRegEx" : "J,? \\Q2014\\E",
      "shortCiteRegEx" : "J",
      "year" : 2014
    }, {
      "title" : "C3-Fullero-tris-methanodicarboxylic acid protects c",
      "author" : [ "C Monti" ],
      "venue" : null,
      "citeRegEx" : "W. and Monti,? \\Q2000\\E",
      "shortCiteRegEx" : "W. and Monti",
      "year" : 2000
    }, {
      "title" : "Neuromodulatory properties of uorescent carbon dot",
      "author" : [ ],
      "venue" : null,
      "citeRegEx" : "A,? \\Q2015\\E",
      "shortCiteRegEx" : "A",
      "year" : 2015
    }, {
      "title" : "Microglia determine brain region-speci c neurotoxic",
      "author" : [ "A Bianco" ],
      "venue" : null,
      "citeRegEx" : "Bianco,? \\Q2015\\E",
      "shortCiteRegEx" : "Bianco",
      "year" : 2015
    }, {
      "title" : "Electromechanical properties o",
      "author" : [ "J. Cao", "Q. Wang", "H. Dai" ],
      "venue" : null,
      "citeRegEx" : "Cao et al\\.,? \\Q2003\\E",
      "shortCiteRegEx" : "Cao et al\\.",
      "year" : 2003
    }, {
      "title" : "Carbon nanotubes promote neuron di erentiation",
      "author" : [ "C Wang" ],
      "venue" : null,
      "citeRegEx" : "Wang,? \\Q2009\\E",
      "shortCiteRegEx" : "Wang",
      "year" : 2009
    }, {
      "title" : "A graphene-based microelectrode for recording neural signa",
      "author" : [ "R S" ],
      "venue" : null,
      "citeRegEx" : "S.,? \\Q2011\\E",
      "shortCiteRegEx" : "S.",
      "year" : 2011
    }, {
      "title" : "PEGylated carbon nanotubes impair retrieval",
      "author" : [ "C.O.F. lves", "Serodre", "T. M" ],
      "venue" : null,
      "citeRegEx" : "lves et al\\.,? \\Q2015\\E",
      "shortCiteRegEx" : "lves et al\\.",
      "year" : 2015
    }, {
      "title" : "All-carbon-nanotube exible multi-electrode a",
      "author" : [ "Y. Hanein" ],
      "venue" : null,
      "citeRegEx" : "D. and Hanein,? \\Q2014\\E",
      "shortCiteRegEx" : "D. and Hanein",
      "year" : 2014
    }, {
      "title" : "Carbon nano bers: cataly",
      "author" : [ "W.H. De Jong", "J.W. Geus" ],
      "venue" : null,
      "citeRegEx" : "10",
      "shortCiteRegEx" : "10",
      "year" : 2000
    }, {
      "title" : "Stable colloidal dispersions of C 60 fullerenes in wate",
      "author" : [ "S Hashsham" ],
      "venue" : null,
      "citeRegEx" : "Hashsham,? \\Q2006\\E",
      "shortCiteRegEx" : "Hashsham",
      "year" : 2006
    }, {
      "title" : "Buckminsterfullerenol free radical scavengers reduce exc",
      "author" : [ "W. D" ],
      "venue" : null,
      "citeRegEx" : "D.,? \\Q1996\\E",
      "shortCiteRegEx" : "D.",
      "year" : 1996
    }, {
      "title" : "Fullerene-based antioxidants and neurodegenerati",
      "author" : [ "L. K" ],
      "venue" : null,
      "citeRegEx" : "K.,? \\Q2001\\E",
      "shortCiteRegEx" : "K.",
      "year" : 2001
    }, {
      "title" : "Patterned neuronal networks using n",
      "author" : [ "E Scorsone" ],
      "venue" : null,
      "citeRegEx" : "Scorsone,? \\Q2013\\E",
      "shortCiteRegEx" : "Scorsone",
      "year" : 2013
    }, {
      "title" : "Carbon nanotube degradation in macrophag",
      "author" : [ "S Colin" ],
      "venue" : null,
      "citeRegEx" : "Colin,? \\Q2015\\E",
      "shortCiteRegEx" : "Colin",
      "year" : 2015
    }, {
      "title" : "Targeting carbon nanotubes against cancer",
      "author" : [ "M. Prato" ],
      "venue" : null,
      "citeRegEx" : "A. and Prato,? \\Q2012\\E",
      "shortCiteRegEx" : "A. and Prato",
      "year" : 2012
    }, {
      "title" : "Extracellular entrapment and degradation of sing",
      "author" : [ "P G" ],
      "venue" : null,
      "citeRegEx" : "G.,? \\Q2014\\E",
      "shortCiteRegEx" : "G.",
      "year" : 2014
    }, {
      "title" : "Carbon quantum dots and application",
      "author" : [ "A Jafariyan" ],
      "venue" : null,
      "citeRegEx" : "Jafariyan,? \\Q2015\\E",
      "shortCiteRegEx" : "Jafariyan",
      "year" : 2015
    }, {
      "title" : "Fullerenols and glucosamine fullerenes reduce infarct volume and cerebral in ammation after ischemic stroke in normotensive and hypertensive",
      "author" : [ ],
      "venue" : null,
      "citeRegEx" : "J,? \\Q2015\\E",
      "shortCiteRegEx" : "J",
      "year" : 2015
    }, {
      "title" : "Multi-functionalized carbon nano-onions as ima",
      "author" : [ "G eccone" ],
      "venue" : null,
      "citeRegEx" : "eccone,? \\Q2015\\E",
      "shortCiteRegEx" : "eccone",
      "year" : 2015
    }, {
      "title" : "What is nanomedicine",
      "author" : [ "R. Freitas" ],
      "venue" : null,
      "citeRegEx" : "Freitas and A.,? \\Q2005\\E",
      "shortCiteRegEx" : "Freitas and A.",
      "year" : 2005
    }, {
      "title" : "Carbon nanotubes carrying cell-adhesion peptides",
      "author" : [ "C. Gaillard", "G. Cellot", "S. Li", "F.M. Toma", "H. Dumortier", "G Spalluto" ],
      "venue" : null,
      "citeRegEx" : "Gaillard et al\\.,? \\Q2009\\E",
      "shortCiteRegEx" : "Gaillard et al\\.",
      "year" : 2009
    }, {
      "title" : "Structure, stability and electronic properties of na",
      "author" : [ "G. 1002/adma.200900050 Galli" ],
      "venue" : null,
      "citeRegEx" : "10",
      "shortCiteRegEx" : "10",
      "year" : 2010
    }, {
      "title" : "Single-walled carbon nanotube polyelectrolyte multilayers and freesta",
      "author" : [ "N.A. d Kotov" ],
      "venue" : null,
      "citeRegEx" : "Kotov,? \\Q2005\\E",
      "shortCiteRegEx" : "Kotov",
      "year" : 2005
    }, {
      "title" : "Graphene-based nano",
      "author" : [ "S. Goenka", "V. Sant", "S. Sant" ],
      "venue" : null,
      "citeRegEx" : "Goenka et al\\.,? \\Q2014\\E",
      "shortCiteRegEx" : "Goenka et al\\.",
      "year" : 2014
    }, {
      "title" : "Multi-functional graphene",
      "author" : [ "Ling", "Y.-C" ],
      "venue" : null,
      "citeRegEx" : "10",
      "shortCiteRegEx" : "10",
      "year" : 2012
    }, {
      "title" : "Carbon nanotubes for bi",
      "author" : [ "R. Peng", "Z. Liu" ],
      "venue" : null,
      "citeRegEx" : "10",
      "shortCiteRegEx" : "10",
      "year" : 2013
    }, {
      "title" : "Molecular imaging by optic",
      "author" : [ "A. Hegyi", "E. Yablonovitch" ],
      "venue" : null,
      "citeRegEx" : "Hegyi and Yablonovitch,? \\Q2013\\E",
      "shortCiteRegEx" : "Hegyi and Yablonovitch",
      "year" : 2013
    }, {
      "title" : "2012).In vivo targeting and positron emission tomography imaging of tumor vasculature with 66Ga-labeled nano-graphene",
      "author" : [ "kles", "R. J" ],
      "venue" : null,
      "citeRegEx" : "kles and J,? \\Q2012\\E",
      "shortCiteRegEx" : "kles and J",
      "year" : 2012
    }, {
      "title" : "Enhanced neural cell adhesion and neurite outgro",
      "author" : [ ],
      "venue" : null,
      "citeRegEx" : "H,? \\Q2014\\E",
      "shortCiteRegEx" : "H",
      "year" : 2014
    }, {
      "title" : "Amine functionalized nanodiamond promotes cellu",
      "author" : [ "W J" ],
      "venue" : null,
      "citeRegEx" : "J.,? \\Q2014\\E",
      "shortCiteRegEx" : "J.",
      "year" : 2014
    }, {
      "title" : "Health and ecosystem risks of graphene",
      "author" : [ "X. Hu", "Q. Zhou" ],
      "venue" : null,
      "citeRegEx" : "Hu and Zhou,? \\Q2013\\E",
      "shortCiteRegEx" : "Hu and Zhou",
      "year" : 2013
    }, {
      "title" : "Neuroprotective e ect of hexasulfobutylated",
      "author" : [ "Teng", "C. M" ],
      "venue" : null,
      "citeRegEx" : "Teng and M,? \\Q2001\\E",
      "shortCiteRegEx" : "Teng and M",
      "year" : 2001
    }, {
      "title" : "Carbon nano ber based e",
      "author" : [ "J. Huang", "Y. Liu", "T. You" ],
      "venue" : null,
      "citeRegEx" : "10",
      "shortCiteRegEx" : "10",
      "year" : 2010
    }, {
      "title" : "The e ect of uorescent nanodiamonds on neuronal s",
      "author" : [ "Soo", "C.-R" ],
      "venue" : null,
      "citeRegEx" : "H. et al\\.,? \\Q2014\\E",
      "shortCiteRegEx" : "H. et al\\.",
      "year" : 2014
    }, {
      "title" : "Helical microtubules of graphitic carbon",
      "author" : [ "S. Iijima" ],
      "venue" : null,
      "citeRegEx" : "Iijima,? \\Q1991\\E",
      "shortCiteRegEx" : "Iijima",
      "year" : 1991
    }, {
      "title" : "Carbon nano bers",
      "author" : [ "M. Inagaki", "Y. Yang", "F. Kang" ],
      "venue" : null,
      "citeRegEx" : "Inagaki et al\\.,? \\Q2012\\E",
      "shortCiteRegEx" : "Inagaki et al\\.",
      "year" : 2012
    }, {
      "title" : "Layered carbon nanotube-polyelectroly",
      "author" : [ "Martin", "D. C" ],
      "venue" : null,
      "citeRegEx" : "Martin and C,? \\Q2009\\E",
      "shortCiteRegEx" : "Martin and C",
      "year" : 2009
    }, {
      "title" : "Fabrication of porous carbon nano b",
      "author" : [ "L. Ji", "X. Zhang" ],
      "venue" : null,
      "citeRegEx" : "Ji and Zhang,? \\Q2009\\E",
      "shortCiteRegEx" : "Ji and Zhang",
      "year" : 2009
    }, {
      "title" : "Lung macrophages Digest carbon",
      "author" : [ "E.R. in", "Kotchey", "G. P" ],
      "venue" : null,
      "citeRegEx" : "in et al\\.,? \\Q2014\\E",
      "shortCiteRegEx" : "in et al\\.",
      "year" : 2014
    }, {
      "title" : "Dose ranging, expanded acute",
      "author" : [ "Jiang", "Y.-P" ],
      "venue" : null,
      "citeRegEx" : "S. et al\\.,? \\Q2014\\E",
      "shortCiteRegEx" : "S. et al\\.",
      "year" : 2014
    }, {
      "title" : "Internalization of MWCNTs by microglia: poss",
      "author" : [ "H. ara", "B. Badie" ],
      "venue" : null,
      "citeRegEx" : "ara and Badie,? \\Q2007\\E",
      "shortCiteRegEx" : "ara and Badie",
      "year" : 2007
    }, {
      "title" : "Carbon nanotube coating improves neuronal recordings",
      "author" : [ "G.W. ss" ],
      "venue" : null,
      "citeRegEx" : "ss,? \\Q2008\\E",
      "shortCiteRegEx" : "ss",
      "year" : 2008
    }, {
      "title" : "Graphene oxidepolyethylenimine nanoconstruct as a gene delivery",
      "author" : [ "H. Kim", "R. Namgung", "K. Singha", "Oh", "I.-K", "W.J. Kim" ],
      "venue" : null,
      "citeRegEx" : "Kim et al\\.,? \\Q2011\\E",
      "shortCiteRegEx" : "Kim et al\\.",
      "year" : 2011
    }, {
      "title" : "Surface characterization and functionaliz",
      "author" : [ "D J" ],
      "venue" : null,
      "citeRegEx" : "J.,? \\Q2008\\E",
      "shortCiteRegEx" : "J.",
      "year" : 2008
    }, {
      "title" : "Single-wall carbon nanohorns supporting pt catalys",
      "author" : [ "T. hi", "S Nakamura" ],
      "venue" : null,
      "citeRegEx" : "hi and Nakamura,? \\Q2009\\E",
      "shortCiteRegEx" : "hi and Nakamura",
      "year" : 2009
    }, {
      "title" : "A natural vanishing act: the enzyme-catalyzed degradat",
      "author" : [ "A hvedova" ],
      "venue" : null,
      "citeRegEx" : "hvedova,? \\Q2012\\E",
      "shortCiteRegEx" : "hvedova",
      "year" : 2012
    }, {
      "title" : "Highly e cient siRNA delivery system into huma",
      "author" : [ "S J" ],
      "venue" : null,
      "citeRegEx" : "J.,? \\Q2010\\E",
      "shortCiteRegEx" : "J.",
      "year" : 2010
    }, {
      "title" : "Using graphene",
      "author" : [ "M. Li", "X. Yang", "J. Ren", "K. Qu", "X. Qu" ],
      "venue" : null,
      "citeRegEx" : "Li et al\\.,? \\Q2012\\E",
      "shortCiteRegEx" : "Li et al\\.",
      "year" : 2012
    }, {
      "title" : "A carbon nano ber-based label",
      "author" : [ "M.U. Ahmed" ],
      "venue" : null,
      "citeRegEx" : "10",
      "shortCiteRegEx" : "10",
      "year" : 2015
    }, {
      "title" : "Carbon quantum dots",
      "author" : [ "S.Y. Lim", "W. Shen", "Z. Gao" ],
      "venue" : null,
      "citeRegEx" : "Lim et al\\.,? \\Q2015\\E",
      "shortCiteRegEx" : "Lim et al\\.",
      "year" : 2015
    }, {
      "title" : "Carboxyfullerene prevents iron-induced oxid",
      "author" : [ "Luh", "T.-Y" ],
      "venue" : null,
      "citeRegEx" : "Luh and T..Y,? \\Q2001\\E",
      "shortCiteRegEx" : "Luh and T..Y",
      "year" : 2001
    }, {
      "title" : "Fluorescent carbon nanopartic",
      "author" : [ "H. Liu", "T. Ye", "C. Mao" ],
      "venue" : null,
      "citeRegEx" : "Liu et al\\.,? \\Q2007\\E",
      "shortCiteRegEx" : "Liu et al\\.",
      "year" : 2007
    }, {
      "title" : "Alpha-bungarotoxin binding to target cell in a d",
      "author" : [ "Chang", "C.C" ],
      "venue" : null,
      "citeRegEx" : "L. et al\\.,? \\Q2008\\E",
      "shortCiteRegEx" : "L. et al\\.",
      "year" : 2008
    }, {
      "title" : "Cytotoxicity evaluations of uorescent carbon nanoparticles",
      "author" : [ ],
      "venue" : null,
      "citeRegEx" : "G,? \\Q2010\\E",
      "shortCiteRegEx" : "G",
      "year" : 2010
    }, {
      "title" : "Single-walled carbon n",
      "author" : [ "Z. Liu", "K. Yang", "Lee", "S.-T" ],
      "venue" : null,
      "citeRegEx" : "Liu et al\\.,? \\Q2011\\E",
      "shortCiteRegEx" : "Liu et al\\.",
      "year" : 2011
    }, {
      "title" : "Carbon nanohorn-based electrolyte for dye-sen",
      "author" : [ ],
      "venue" : null,
      "citeRegEx" : "M,? \\Q2015\\E",
      "shortCiteRegEx" : "M",
      "year" : 2015
    }, {
      "title" : "Interfacing neurons with carbon nanotu",
      "author" : [ "L. naro", "H Markram" ],
      "venue" : null,
      "citeRegEx" : "naro and Markram,? \\Q2007\\E",
      "shortCiteRegEx" : "naro and Markram",
      "year" : 2007
    }, {
      "title" : "Intracellular integration of syntheti",
      "author" : [ "F Serna" ],
      "venue" : null,
      "citeRegEx" : "I. and Serna,? \\Q2003\\E",
      "shortCiteRegEx" : "I. and Serna",
      "year" : 2003
    }, {
      "title" : "Resident neuroelectrochemical i",
      "author" : [ "Peckys", "B D" ],
      "venue" : null,
      "citeRegEx" : "K. et al\\.,? \\Q2006\\E",
      "shortCiteRegEx" : "K. et al\\.",
      "year" : 2006
    }, {
      "title" : "Electronic and structural",
      "author" : [ "J.W. 1021/jp056467j Mintmire", "C.T. White" ],
      "venue" : null,
      "citeRegEx" : "10",
      "shortCiteRegEx" : "10",
      "year" : 1995
    }, {
      "title" : "2006).In vivomagnetic resonance imaging of single-walled carbon nanohorns by labeling with magnetite nanoparticles",
      "author" : [ "E amura" ],
      "venue" : null,
      "citeRegEx" : "amura,? \\Q2006\\E",
      "shortCiteRegEx" : "amura",
      "year" : 2006
    }, {
      "title" : "Biodistribution and ultrastructural localization of sing",
      "author" : [ "A mida" ],
      "venue" : null,
      "citeRegEx" : "mida,? \\Q2009\\E",
      "shortCiteRegEx" : "mida",
      "year" : 2009
    }, {
      "title" : "Carbon-based smart nan",
      "author" : [ "A.M. 1038/nnano.2011.209 Monaco", "M. Giugliano" ],
      "venue" : null,
      "citeRegEx" : "10",
      "shortCiteRegEx" : "10",
      "year" : 2014
    }, {
      "title" : "Toxicity of carbon nanot",
      "author" : [ "D. Movia", "S. Giordani" ],
      "venue" : "ACS Nano5,",
      "citeRegEx" : "Movia and Giordani,? \\Q2012\\E",
      "shortCiteRegEx" : "Movia and Giordani",
      "year" : 2012
    }, {
      "title" : "Drug-loaded carbon nanohorns: adsorption and release of dexamethasonein vitro",
      "author" : [ "K. Shiba" ],
      "venue" : "Mol. Pharm",
      "citeRegEx" : "Shiba,? \\Q2004\\E",
      "shortCiteRegEx" : "Shiba",
      "year" : 2004
    }, {
      "title" : "Vertically aligned carbon nano ber archit",
      "author" : [ "J. Li" ],
      "venue" : null,
      "citeRegEx" : "M. and Li,? \\Q2007\\E",
      "shortCiteRegEx" : "M. and Li",
      "year" : 2007
    }, {
      "title" : "Polarization-controlled di erentiation of human neural s",
      "author" : [ ],
      "venue" : null,
      "citeRegEx" : "B,? \\Q2011\\E",
      "shortCiteRegEx" : "B",
      "year" : 2011
    }, {
      "title" : "Graphene-based carbon-layered electrode array tec",
      "author" : [ ],
      "venue" : null,
      "citeRegEx" : "P,? \\Q2014\\E",
      "shortCiteRegEx" : "P",
      "year" : 2014
    }, {
      "title" : "Fullerene C 60 complexed with Poly(N-Vinyl-pyrrolidone",
      "author" : [ "B. L" ],
      "venue" : null,
      "citeRegEx" : "L.,? \\Q2005\\E",
      "shortCiteRegEx" : "L.",
      "year" : 2005
    }, {
      "title" : "A carboxyfullerene SOD mimetic improves cognition and extends the life",
      "author" : [ "L.L. gan" ],
      "venue" : null,
      "citeRegEx" : "gan,? \\Q2008\\E",
      "shortCiteRegEx" : "gan",
      "year" : 2008
    }, {
      "title" : "A carbon nano ber based biosensor for simulta",
      "author" : [ ],
      "venue" : null,
      "citeRegEx" : "J,? \\Q2013\\E",
      "shortCiteRegEx" : "J",
      "year" : 2013
    }, {
      "title" : "Ultrasmall reduced graphene oxide with high near-infrared absorbance for photothermal therapy",
      "author" : [ "H. asalongue", "D Vinh" ],
      "venue" : null,
      "citeRegEx" : "asalongue and Vinh,? \\Q2011\\E",
      "shortCiteRegEx" : "asalongue and Vinh",
      "year" : 2011
    }, {
      "title" : "Mechanical and thermal prope",
      "author" : [ "R.S. Ruo", "D.C. Lorents" ],
      "venue" : null,
      "citeRegEx" : "Ruo and Lorents,? \\Q1995\\E",
      "shortCiteRegEx" : "Ruo and Lorents",
      "year" : 1995
    }, {
      "title" : "Mechanical properties of carbon nanotubes",
      "author" : [ "L. d", "W Benoit" ],
      "venue" : null,
      "citeRegEx" : "d and Benoit,? \\Q1999\\E",
      "shortCiteRegEx" : "d and Benoit",
      "year" : 1999
    }, {
      "title" : "Hydrogen storage",
      "author" : [ "N. Sano", "K. Taniguchi", "H. Tamon" ],
      "venue" : null,
      "citeRegEx" : "Sano et al\\.,? \\Q2014\\E",
      "shortCiteRegEx" : "Sano et al\\.",
      "year" : 2014
    }, {
      "title" : "Strict preparation and evaluation of water-soluble hat",
      "author" : [ "A oyama" ],
      "venue" : null,
      "citeRegEx" : "oyama,? \\Q2005\\E",
      "shortCiteRegEx" : "oyama",
      "year" : 2005
    }, {
      "title" : "3D free-standing porous sca olds made",
      "author" : [ "L. G", "A Tamayo" ],
      "venue" : null,
      "citeRegEx" : "G. and Tamayo,? \\Q2014\\E",
      "shortCiteRegEx" : "G. and Tamayo",
      "year" : 2014
    }, {
      "title" : "Toxicity of nanomaterials",
      "author" : [ "M. Mahmoudi" ],
      "venue" : null,
      "citeRegEx" : "Mahmoudi,? \\Q2012\\E",
      "shortCiteRegEx" : "Mahmoudi",
      "year" : 2012
    }, {
      "title" : "Engineered neuronal circuits shaped and inter",
      "author" : [ "E Ben-Jacob" ],
      "venue" : null,
      "citeRegEx" : "Ben.Jacob,? \\Q2009\\E",
      "shortCiteRegEx" : "Ben.Jacob",
      "year" : 2009
    }, {
      "title" : "Graphene quantum d",
      "author" : [ "J. 1007/s10544-008-9255-7 Shen", "Y. Zhu", "X. Yang", "C. Li" ],
      "venue" : null,
      "citeRegEx" : "10",
      "shortCiteRegEx" : "10",
      "year" : 2012
    }, {
      "title" : "Magnetic resonance imaging of rat",
      "author" : [ "G Török" ],
      "venue" : null,
      "citeRegEx" : "V. and Török,? \\Q2014\\E",
      "shortCiteRegEx" : "V. and Török",
      "year" : 2014
    }, {
      "title" : "Toxicity of s",
      "author" : [ "C.J. Smith", "B.J. Shaw", "R.D. Handy" ],
      "venue" : null,
      "citeRegEx" : "Smith et al\\.,? \\Q2007\\E",
      "shortCiteRegEx" : "Smith et al\\.",
      "year" : 2007
    }, {
      "title" : "ood chainan in vivostudy from unicellularE. coli to multicellular C",
      "author" : [ "V. Strauss", "J.T. Margraf", "C. Dolle", "B. Butz", "T.J. Nacken", "Wa" ],
      "venue" : "elegans. Mater. Express",
      "citeRegEx" : "Strauss et al\\.,? \\Q2012\\E",
      "shortCiteRegEx" : "Strauss et al\\.",
      "year" : 2012
    }, {
      "title" : "Quantum-sized carbon dots for bright and colorful photoluminesce",
      "author" : [ "P ak" ],
      "venue" : null,
      "citeRegEx" : "ak,? \\Q2006\\E",
      "shortCiteRegEx" : "ak",
      "year" : 2006
    }, {
      "title" : "Histological assessments for toxicity and functionali",
      "author" : [ ],
      "venue" : null,
      "citeRegEx" : "S,? \\Q2011\\E",
      "shortCiteRegEx" : "S",
      "year" : 2011
    }, {
      "title" : "The use of nanodiamond monolayer coatings",
      "author" : [ "R.B. Jackman" ],
      "venue" : null,
      "citeRegEx" : "Jackman,? \\Q2010\\E",
      "shortCiteRegEx" : "Jackman",
      "year" : 2010
    }, {
      "title" : "Inhibition ofEscherichia coli",
      "author" : [ "N. Tsao", "P.P. Kanakamma", "T.Y. Luh", "C.K. Chou", "H.Y. Lei" ],
      "venue" : "Arch. Toxicol.86,",
      "citeRegEx" : "Tsao et al\\.,? \\Q1999\\E",
      "shortCiteRegEx" : "Tsao et al\\.",
      "year" : 1999
    }, {
      "title" : "The long-term stability and biocompatibility",
      "author" : [ ],
      "venue" : null,
      "citeRegEx" : "I,? \\Q2012\\E",
      "shortCiteRegEx" : "I",
      "year" : 2012
    }, {
      "title" : "Highly selective detection of Epinephrine at oxidize",
      "author" : [ "F Cataldo" ],
      "venue" : null,
      "citeRegEx" : "N. and Cataldo,? \\Q2014\\E",
      "shortCiteRegEx" : "N. and Cataldo",
      "year" : 2014
    }, {
      "title" : "A carbon nanohorn",
      "author" : [ "T. Hasobe", "M Yudasaka" ],
      "venue" : null,
      "citeRegEx" : "D. et al\\.,? \\Q2010\\E",
      "shortCiteRegEx" : "D. et al\\.",
      "year" : 2010
    }, {
      "title" : "Reductive dismantling and functionalization of carbo",
      "author" : [ "V di" ],
      "venue" : null,
      "citeRegEx" : "di,? \\Q2015\\E",
      "shortCiteRegEx" : "di",
      "year" : 2015
    }, {
      "title" : "Neuroprotective e ects of hydrated fullerene C60: cortic",
      "author" : [ "F. Sengpiel" ],
      "venue" : null,
      "citeRegEx" : "Sengpiel,? \\Q2015\\E",
      "shortCiteRegEx" : "Sengpiel",
      "year" : 2015
    }, {
      "title" : "Functionalized carbon nanotube",
      "author" : [ "J. Wang", "Y. Lin" ],
      "venue" : null,
      "citeRegEx" : "Wang and Lin,? \\Q2008\\E",
      "shortCiteRegEx" : "Wang and Lin",
      "year" : 2008
    }, {
      "title" : "Classi cation framework for graphene-based materials",
      "author" : [ "B Fadeel" ],
      "venue" : null,
      "citeRegEx" : "Fadeel,? \\Q2014\\E",
      "shortCiteRegEx" : "Fadeel",
      "year" : 2014
    }, {
      "title" : "Nanodiamonds for nanomedicine",
      "author" : [ "Y. Xing", "L. Dai" ],
      "venue" : null,
      "citeRegEx" : "Xing and Dai,? \\Q2009\\E",
      "shortCiteRegEx" : "Xing and Dai",
      "year" : 2009
    }, {
      "title" : "1995).In vivo biological behavior of a water-miscible fullerene: 14C labeling, absorption, distribution, excretion and acute toxicity",
      "author" : [ "K Sueki" ],
      "venue" : null,
      "citeRegEx" : "Sueki,? \\Q1995\\E",
      "shortCiteRegEx" : "Sueki",
      "year" : 1995
    }, {
      "title" : "Highly ultramicroporous single-walled carbon nanohorn assemblie",
      "author" : [ "S Iijima" ],
      "venue" : null,
      "citeRegEx" : "A. and Iijima,? \\Q2005\\E",
      "shortCiteRegEx" : "A. and Iijima",
      "year" : 2005
    }, {
      "title" : "Preparation of ne platinum catalyst supported on",
      "author" : [ ],
      "venue" : null,
      "citeRegEx" : "Y,? \\Q2002\\E",
      "shortCiteRegEx" : "Y",
      "year" : 2002
    }, {
      "title" : "Fabrication of ZnPc/protein nanohorns",
      "author" : [ "O Ito" ],
      "venue" : null,
      "citeRegEx" : "Ito,? \\Q2008\\E",
      "shortCiteRegEx" : "Ito",
      "year" : 2008
    }, {
      "title" : "Graphene: a versatile nanoplatform for biomedical applications",
      "author" : [ "Y. Zhang", "T.R. Nayak", "H. Hong", "W. Cai" ],
      "venue" : "rfaces.J. Nanomater.2012,",
      "citeRegEx" : "Zhang et al\\.,? \\Q2012\\E",
      "shortCiteRegEx" : "Zhang et al\\.",
      "year" : 2012
    }, {
      "title" : "Single-walled carbon nanohorns and the",
      "author" : [ "S. Zhu", "G. Xu" ],
      "venue" : null,
      "citeRegEx" : "04",
      "shortCiteRegEx" : "04",
      "year" : 2010
    } ],
    "referenceMentions" : [ {
      "referenceID" : 55,
      "context" : "Carbon Nanotubes (CNTs) ( Iijima, 1991) are the mostknown and widest studied carbon nanomaterials.",
      "startOffset" : 24,
      "endOffset" : 39
    }, {
      "referenceID" : 103,
      "context" : "Zhang Y. et al. (2010) , Copyright (2010) American Chemical Society.",
      "startOffset" : 6,
      "endOffset" : 23
    }, {
      "referenceID" : 85,
      "context" : "Reprinted fromBardi et al. (2009) , Copyright (2009), with permission from Elsevier.",
      "startOffset" : 14,
      "endOffset" : 34
    }, {
      "referenceID" : 13,
      "context" : "(2009) , Copyright (2009), with permission from Elsevier.",
      "startOffset" : 9,
      "endOffset" : 26
    }, {
      "referenceID" : 12,
      "context" : "results from Rotarod tests indicating complete recovery of motor coordination in SWCNTs-NH2 treated mice. Data reported as meanC s.e.m. *P < 0.001 vs. pre-MCAO. Reprinted by permission from Mcmillan Publisher s Ltd.: Nature Nanotechnology,Lee H. J. et al. (2011) , Copyright (2011).",
      "startOffset" : 82,
      "endOffset" : 263
    }, {
      "referenceID" : 12,
      "context" : "results from Rotarod tests indicating complete recovery of motor coordination in SWCNTs-NH2 treated mice. Data reported as meanC s.e.m. *P < 0.001 vs. pre-MCAO. Reprinted by permission from Mcmillan Publisher s Ltd.: Nature Nanotechnology,Lee H. J. et al. (2011) , Copyright (2011).",
      "startOffset" : 82,
      "endOffset" : 282
    }, {
      "referenceID" : 19,
      "context" : "Adapted from Dugan et al. (2014)with permission from John Wiley and Sons, Copyright (2014).",
      "startOffset" : 0,
      "endOffset" : 33
    }, {
      "referenceID" : 11,
      "context" : "Zhang L. et al. (2010)with permission from John Wiley and Sons, Copyright",
      "startOffset" : 6,
      "endOffset" : 23
    }, {
      "referenceID" : 84,
      "context" : "Reports indicate that graphene is a permissi ve substrate for neuronal cells growth ( Li et al., 2011, 2013; Park et al., 2011b; Movia and Giordani, 2012; Hong et al., 2014; Serrano et al., 2014; Tu et al., 2014; Fabbro et al., 2016) and the electrical conductivity of this material can be exploited to direct the elongation of neuronal processes in a controlled way ( Li et al.",
      "startOffset" : 84,
      "endOffset" : 233
    }, {
      "referenceID" : 0,
      "context" : "Adapted from Yang H.-W. et al. (2013)with permission from John Wiley",
      "startOffset" : 13,
      "endOffset" : 38
    }, {
      "referenceID" : 25,
      "context" : "from Sato et al. (2005)with permission from The Royal Society of Chemistry.",
      "startOffset" : 5,
      "endOffset" : 24
    } ],
    "year" : 0,
    "abstractText" : "Developing new tools that outperform current state of the ar t technologies for imaging, drug delivery or electrical sensing in neuronal tissues is o ne of the great challenges in neurosciences. Investigations into the potential use of ca rbon nanomaterials for such applications started about two decades ago. Since then, numerous in vitrostudies have examined interactions between these nanomaterials and neu rons, either by evaluating their compatibility, as vectors for drug delivery, or for th eir potential use in electric activity sensing and manipulation. The results obtained indicate th at carbon nanomaterials may be suitable for medical therapies. However, a relativel y small number of in vivo studies have been carried out to date. In order to facilitatethe transformation of carbon nanomaterial into practical neurobiomedical application s, it is essential to identify and highlight in the existing literature the strengths and weak ness that different carbon nanomaterials have displayed when probedin vivo. Unfortunately the current literature is sometimes sparse and confusing. To offer a clearer pictur e of the in vivo studies on carbon nanomaterials in the central nervous system, we pr ovide a systematic and critical review. Hereby we identify properties and behavio r of carbon nanomaterialsin vivo inside the neural tissues, and we examine key achievements a nd potentially problematic toxicological issues.",
    "creator" : null
  }
}